
<html lang="en"     class="pb-page"  data-request-id="a8dd0147-784c-4f2e-b1c8-94d8ffc86ced"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm400895s;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2013.56.issue-20"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging" /></meta><meta name="dc.Creator" content="Naoya  Harada" /></meta><meta name="dc.Creator" content="Hiroyuki  Kimura" /></meta><meta name="dc.Creator" content="Masahiro  Ono" /></meta><meta name="dc.Creator" content="Hideo  Saji" /></meta><meta name="dc.Description" content="Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer. (S)-2-[3-[(R)-1-Carboxy-2-mercaptoethyl]ureido-pentanedioic acid (Cys-CO-Gl..." /></meta><meta name="Description" content="Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer. (S)-2-[3-[(R)-1-Carboxy-2-mercaptoethyl]ureido-pentanedioic acid (Cys-CO-Gl..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 9, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400895s" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400895s" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400895s" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400895s" /></link>
        
    
    

<title>Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400895s" /></meta><meta property="og:title" content="Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0010.jpeg" /></meta><meta property="og:description" content="Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer. (S)-2-[3-[(R)-1-Carboxy-2-mercaptoethyl]ureido-pentanedioic acid (Cys-CO-Glu) were used to design novel PSMA targeting probes by nucleophilic conjugate addition between cysteine and maleimide based reagents. 3 ([123I]IGLCE) was synthesized by this strategy and showed high affinity for PSMA. Results of binding inhibition assays of these derivatives suggested the importance of an aromatic group and succinimide moiety for high affinity. [123I]3 was evaluated in vivo with PSMA positive LNCaP and PSMA negative PC-3 human prostate cancer xenograft bearing mice. [125I]3 accumulated in LNCaP tumors but not in PC-3 tumors, and the accumulation was inhibited by 2-(phosphonomethyl)pentanedioic acid (2-PMPA). Use of [123I]3 provided positive images of LNCaP tumors in single photon emission tomography scans. These results warrant further evaluation of [123I]3 and its derivatives as radiolabeled probes for the diagnosis of prostate cancer." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400895s"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400895s">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400895s&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400895s&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400895s&amp;href=/doi/10.1021/jm400895s" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 7890-7901</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401463y" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400906z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Harada">Naoya Harada</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hiroyuki++Kimura">Hiroyuki Kimura</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Masahiro++Ono">Masahiro Ono</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hideo++Saji">Hideo Saji</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Department of Patho-Functional Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div><div class="corresp-info"><strong>*</strong>Phone: +81-75-753-4566. Fax: +81-75-753-4568. E-mail: <a href="/cdn-cgi/l/email-protection#afc7dccec5c6efdfc7ceddc281c4d6c0dbc082da81cecc81c5df"><span class="__cf_email__" data-cfemail="bdd5cedcd7d4fdcdd5dccfd093d6c4d2c9d290c893dcde93d7cd">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400895s&amp;href=/doi/10.1021%2Fjm400895s" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 7890–7901</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">September 24, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>17 June 2013</li><li><span class="item_label"><b>Published</b> online</span>9 October 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 October 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400895s" title="DOI URL">https://doi.org/10.1021/jm400895s</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7890%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DNaoya%2BHarada%252C%2BHiroyuki%2BKimura%252C%2BMasahiro%2BOno%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D20%26contentID%3Djm400895s%26title%3DPreparation%2Bof%2BAsymmetric%2BUrea%2BDerivatives%2Bthat%2BTarget%2BProstate-Specific%2BMembrane%2BAntigen%2Bfor%2BSPECT%2BImaging%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7901%26publicationDate%3DOctober%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400895s"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2813</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">23</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400895s" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Harada&quot;},{&quot;first_name&quot;:&quot;Hiroyuki&quot;,&quot;last_name&quot;:&quot;Kimura&quot;},{&quot;first_name&quot;:&quot;Masahiro&quot;,&quot;last_name&quot;:&quot;Ono&quot;},{&quot;first_name&quot;:&quot;Hideo&quot;,&quot;last_name&quot;:&quot;Saji&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;7890-7901&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400895s&quot;},&quot;abstract&quot;:&quot;Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer. (S)-2-[3-[(R)-1-Carboxy-2-mercaptoethyl]ureido-pentanedioic acid (Cys-CO-Glu) were used to design novel PSMA targeting probes by nucleophilic conjugate addition between cysteine and maleimide based reagents. 3 ([123I]IGLCE) was synthesized by this strategy and showed high affinity for PSMA. Results of binding inhibition assays of these derivatives suggested the importance of an aromatic group and succinimide moiety for high affinity. [123I]3 was evaluated in vivo with PSMA positive LNCaP and PSMA negative PC-3 human prostate cancer xenograft bearing mice. [125I]3 accumulated in LNCaP tumors but not in PC-3 tumors, and the accumulation was inhibited by 2-(phosphonomethyl)pentanedioic acid (2-PMPA). Use of [123I]3 provided positive images of LNCaP tumors in single photon emission tomography scans. These results warrant further evaluation of [123I]3 and its derivatives as radiolabeled probes &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400895s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400895s" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400895s&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400895s" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400895s&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400895s" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400895s&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400895s&amp;href=/doi/10.1021/jm400895s" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400895s" /></input><a href="/doi/pdf/10.1021/jm400895s" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400895s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400895s%26sid%3Dliteratum%253Aachs%26pmid%3D24063417%26genre%3Darticle%26aulast%3DHarada%26date%3D2013%26atitle%3DPreparation%2Bof%2BAsymmetric%2BUrea%2BDerivatives%2Bthat%2BTarget%2BProstate-Specific%2BMembrane%2BAntigen%2Bfor%2BSPECT%2BImaging%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D20%26spage%3D7890%26epage%3D7901%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291651" title="Anions">Anions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=292017" title="Solvents">Solvents</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jmcmar.2013.56.issue-20/production/jmcmar.2013.56.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Prostate-specific membrane antigen (PSMA) has been identified as a diagnostic and therapeutic target for prostate cancer. (<i>S</i>)-2-[3-[(<i>R</i>)-1-Carboxy-2-mercaptoethyl]ureido-pentanedioic acid (Cys-CO-Glu) were used to design novel PSMA targeting probes by nucleophilic conjugate addition between cysteine and maleimide based reagents. <b>3</b> ([<sup>123</sup>I]IGLCE) was synthesized by this strategy and showed high affinity for PSMA. Results of binding inhibition assays of these derivatives suggested the importance of an aromatic group and succinimide moiety for high affinity. [<sup>123</sup>I]<b>3</b> was evaluated in vivo with PSMA positive LNCaP and PSMA negative PC-3 human prostate cancer xenograft bearing mice. [<sup>125</sup>I]<b>3</b> accumulated in LNCaP tumors but not in PC-3 tumors, and the accumulation was inhibited by 2-(phosphonomethyl)pentanedioic acid (2-PMPA). Use of [<sup>123</sup>I]<b>3</b> provided positive images of LNCaP tumors in single photon emission tomography scans. These results warrant further evaluation of [<sup>123</sup>I]<b>3</b> and its derivatives as radiolabeled probes for the diagnosis of prostate cancer.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02451" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02451" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Prostate cancer is the most commonly diagnosed form of cancer and the second leading cause of cancer-related deaths among men worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Quantitation of concentrations of prostate specific antigen (PSA) concentrations, a serum tumor marker of prostate cancer, is effective for diagnosing prostate cancer.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a> However, an invasive biopsy is required to confirm the diagnosis when the results of PSA tests are positive because the PSA level is prone to elevation from other causes such as aging and benign prostatic hyperplasia (BPH).<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Therefore, noninvasive diagnosis of prostate cancer using imaging techniques has significant clinical benefits.</div><div class="NLM_p">Nuclear imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) are valuable for noninvasive diagnosis. Currently, 2-deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose ([<sup>18</sup>F]FDG) is widely used as a PET probe for diagnoses of various cancers. However, [<sup>18</sup>F]FDG is not suitable for diagnosis of prostate cancer because of the lack of correlation between [<sup>18</sup>F]FDG uptake and tumor incidence.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5-8)</a> Furthermore, [<sup>18</sup>F]FDG uptake into the prostate of patients with BPH is similar to that of patients with prostate cancer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Therefore, imaging probes that target prostate cancer-specific biomarkers are desired.</div><div class="NLM_p">Prostate-specific membrane antigen (PSMA) is a useful target molecule for imaging and radiotherapy of prostate cancer because of its high expression in this form of cancer and its transmembrane location.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> PSMA is expressed in normal prostate, primary prostate cancer, and lymph node metastases of prostate cancer,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> although PSMA expression in prostate cancer is 10–100-fold higher than expression in normal prostate tissue.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> PSMA expression is up-regulated in patients with hormone-refractory prostate cancer, while PSA expression is decreased in the same patient population.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Because PSA is a secretory protein, metastases of prostate cancer cannot be diagnosed by the PSA test.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> On the other hand, metastases can be diagnosed by PSMA imaging because PSMA is a membrane-anchored protein.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p"><sup>111</sup>In-labeled anti-PSMA monoclonal antibody [<sup>111</sup>In]7E11-C5, marketed as ProstaScint, is a U.S. Food and Drug Administration approved imaging agent for soft tissue metastases in patients with prostate cancer. It is not in widespread use, in part because it targets an intracellular epitope of PSMA and is believed to bind dead or dying prostate cancer cells.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> More recently, <sup>111</sup>In-labeled monoclonal antibodies that bind to the extracellular domain of PSMA have been developed and shown to accumulate in prostate cancer xenograft bearing mice.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> However, there have been limited clinical success using monoclonal antibodies because of their long circulating plasma half-life and low permeability in solid tumors, particularly for metastases to bone. Therefore, we believe that small molecule imaging agents should have a pharmacokinetic advantage.</div><div class="NLM_p">PSMA has 86% sequence homology with glutamate carboxypeptidase-II (GCP-II).<a onclick="showRef(event, 'ref9 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref9 ref15 ref16">(9, 15, 16)</a> Two structured pockets exist at the active site of GCP-II, which cleaves <i>N</i>-acetylaspartyl glutamate to <i>N</i>-acetyl aspartate.<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17-19)</a> Several asymmetric urea-based compounds (X-CO-Glu where X is an amino acid) are reported to be GCP-II inhibitors.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> The glutamate moiety of urea-based inhibitors interacts with the S1′ pocket, while the other portions interact with the S1 pocket. Because there is a funnel-shaped tunnel with a depth of approximately 20 Å and width of 8–9 Å in the S1 pocket, urea-based compounds can be radiolabeled by introducing proper linkers to the amino acid residue without loss of affinity.<a onclick="showRef(event, 'ref17 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref17 ref21 ref22 ref23 ref24 ref25 ref26">(17, 21-26)</a> Previously, PSMA probes with this motif have been reported, such as <b>23</b> ([<sup>123</sup>I]DCIT)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and <b>24</b> ([<sup>123</sup>I]MIP-1072)<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). While [<sup>123</sup>I]<b>23</b> had low affinity for PSMA and low tumor accumulation in LNCaP bearing mice, [<sup>123</sup>I]<b>24</b> had high affinity for PSMA.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Therefore [<sup>123</sup>I]<b>24</b> appeares to be a promising probe for detection, prognosis, and monitoring prostate cancer, and further improvement of [<sup>123</sup>I]<b>24</b> would be of benefit to clinical cancer research.<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28, 29)</a> However, [<sup>123</sup>I]<b>24</b> is intolerant to modification because of its simple structure, which has proven difficult to improve by derivatization. In this study, we aimed to find a new design strategy for asymmetric urea derivatives with high affinity to PSMA that were easy to design and modify.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <sup>125</sup>I-labeled probes used in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Nucleophilic conjugate addition reactions between thiols and maleimides proceed under mild conditions. Utilizing this reaction, we have previously reported the synthesis of the maleimide-based radio-iodination reagent, [<sup>123</sup>I]<b>1</b> ([<sup>123</sup>I]HML)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). [<sup>123</sup>I]<b>1</b> can be easily prepared by iododestannylation, it rapidly reacts with thiols at room temperature, is stable in human serum, and is a peptidic reagent and thus derivatives are easily prepared by replacement of specific amino acids. <b>2</b> (Cys-CO-Glu), an asymmetric urea inhibitor of PSMA,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> has a reactive thiol (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Therefore, using the reaction between <b>2</b> and derivatives of <b>1</b>, we can design and synthesize various types of PSMA probes. In this study, we prepared <b>3</b> ([<sup>123</sup>I]IGLCE) via the nucleophilic conjugate addition reaction between <b>2</b> and [<sup>123</sup>I]<b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Strategy for the design and derivatization of [<sup>123</sup>I]<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The affinity of [<sup>125</sup>I]<b>3</b> ([<sup>125</sup>I]IGLCE) for PSMA was evaluated, and a rationale for its high affinity to PSMA was investigated. We hypothesized that the high affinity of [<sup>123</sup>I]<b>3</b> for PSMA was attributable to interactions between the <b>1</b>-derived moiety and PSMA, and eight derivatives of <b>3</b> were designed (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). We focused on modifying the iodine, two amino acids (Lys and Gly), the aromatic ring, and the succinimide in the <b>1</b>-derived moiety. The moieties important for high affinity were identified through a structure–activity relationship study.</div><div class="NLM_p last">Additionally, the stability and biodistribution of [<sup>125</sup>I]<b>3</b> was assessed and SPECT/computed tomography (CT) imaging was performed to assess its utility.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28307" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28307" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry and Radiochemistry</h3><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, <b>3</b> was synthesized by a nucleophilic conjugate addition of the cysteine thiol of the asymmetric urea (<b>2</b>) with the maleimide moiety of <b>1</b>. The nonradioactive product, <b>3</b>, was analyzed by <sup>1</sup>H NMR and FAB-HRMS. Its radiolabeled form, [<sup>123</sup>I]<b>3</b>, was prepared from [<sup>123</sup>I]<b>1</b>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> This labeling reaction proceeded under mild conditions (pH 6–8, room temperature) to afford high radiochemical yields (total yields were 58–63%). [<sup>123</sup>I]<b>3</b> was prepared with a radiochemical purity greater than 95% after HPLC purification, and analysis of the purified [<sup>123</sup>I]<b>3</b> showed a single peak (<i>t</i><sub>R</sub>: 23.1 min) corresponding to the isolated <b>3</b> (<i>t</i><sub>R</sub>: 23.0 min).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of IGLCE (<b>3</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Eight derivatives of <b>3</b> were synthesized via the same conjugate addition approach (Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>) and were employed to investigate the relationship between the structure of <b>3</b> and high affinity for PSMA. The appropriate active ester and maleimide-based ammonium <b>6a</b> or <b>6b</b> known in the literature<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> were condensed to yield the maleimide-based precursors <b>10a</b>, <b>10b</b>, <b>15a</b>–<b>15b</b>, <b>17</b>, and <b>21</b>. By only selecting the active ester, we could design these precursors. Introduction of several functional groups into the maleimide-based precursors was not difficult, such as the amino group of <b>21</b>. The methylamino group of active ester <b>20</b> was protected with <i>tert</i>-butoxycarbonyl group but not with a benzyl group because maleimide was resistant to acid but not to hydrogenation. The condensation product of <b>20</b> and <b>6a</b> was deprotected with 4 N HCl/ethyl acetate to yield <b>21</b>. These maleimide-based precursors were reacted with <b>2</b> to yield the final products. All of these reactions proceeded at room temperature, and the final products were purified by reverse phase HPLC.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Type 1 and 2 Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Methylmorpholine, ClCO<sub>2</sub>CH<sub>3</sub>, ethyl acetate, 88%; (b) Boc-Lys-OH, NaHCO<sub>3</sub>, H<sub>2</sub>O, 76%; (c) BocHNC<sub>4</sub>H<sub>8</sub>NH<sub>2</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 97%; (d) HCl, ethyl acetate, 66% (<b>6a</b>), 75% (<b>6b</b>); (e) H-Gly-OPMB, WSCI, Et<sub>3</sub>N, DMF, 64% (<b>7a</b>), 57% (<b>7b</b>); (f) TFA, DCM, 97% (<b>8a</b>), 94% (<b>8b</b>); (g) NHS, DIC, DMF, 62% (<b>9a</b>), 95% (<b>9b</b>); (h) <b>6a</b>, <b>9b</b>, DIPEA, CH<sub>3</sub>CN, 32%; (i) <b>6b</b>, <b>9a</b>, DIPEA, CH<sub>3</sub>CN, 46%; (j) <b>2</b>, NaOH, H<sub>2</sub>O, CH<sub>3</sub>CN,54% (<b>11a</b>), 43% (<b>11b</b>).</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Type 3 Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) DCC, NHS 1,4-dioxane, 98%; (b) H<sub>2</sub>NC<sub>3</sub>H<sub>6</sub>COOH, DIPEA, CH<sub>3</sub>CN, 39%; (c) H<sub>2</sub>NC<sub>4</sub>H<sub>8</sub>COOH, DIPEA, CH<sub>3</sub>CN, 65%; (d) H<sub>2</sub>NC<sub>5</sub>H<sub>10</sub>COOH, DIPEA, CH<sub>3</sub>CN, 50%; (e) NHS, WSCI, DMF, 36% (<b>14a</b>), 60% (<b>14b</b>), 49% (<b>14c</b>); (f) <b>6a</b>, DIPEA, CH<sub>3</sub>CN, 14% (<b>15a</b>), 17% (<b>15b</b>), 24% (<b>15c</b>); (g) <b>2</b>, NaOH, H<sub>2</sub>O, CH<sub>3</sub>CN, 58% (<b>16a</b>), 73% (<b>16b</b>), 23% (<b>16c</b>), 43% (<b>18</b>); (h) <b>6a</b>, DIPEA, CH<sub>3</sub>CN, 26%.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Type 4 Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>2</b>, NaOH, H<sub>2</sub>O, CH<sub>3</sub>CN, 45%; (b) <i>N</i>-hydroxysuccinimide, WSCI, DMF, 63%; (c) (i) <b>6a</b>, DIPEA, CH<sub>3</sub>CN, (ii) HCl, ethyl acetate, 4% (2 steps); (d) <b>2</b>, NaOH, H<sub>2</sub>O, 52%.</p></p></figure><div class="NLM_p last">This synthetic strategy appears promising for the design of novel probes, not only for the derivatives that were synthesized but also for PET probes, which generally have a short radiochemical half-life, as this reaction proceeds rapidly at room temperature.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro Cell-Binding Assay</h3><div class="NLM_p">Using Scatchard plots, the affinity of <b>3</b> for PSMA was evaluated by obtaining a <i>K</i><sub>d</sub> value using an in vitro cell-binding saturation assay. [<sup>125</sup>I]<b>23</b> and [<sup>125</sup>I]<b>24</b> were selected as positive control compounds to evaluate binding affinity.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, [<sup>125</sup>I]<b>3</b> had a higher affinity (<i>K</i><sub>d</sub>: 7.8 ± 1.4 nM) than [<sup>125</sup>I]<b>23</b> (<i>K</i><sub>d</sub>: 143 ± 2 nM) and [<sup>125</sup>I]<b>24</b> (<i>K</i><sub>d</sub>: 20.4 ± 0.6 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Comparison of Affinities between [<sup>125</sup>I]<b>3</b> and Previously Reported Probes<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>d</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">7.8 ± 1.4*<sup>,</sup>**</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>23</b></td><td class="colsep0 rowsep0" align="char" char="±">143 ± 2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">[<sup>125</sup>I]<b>24</b></td><td class="colsep0 rowsep0" align="char" char="±">20.4 ± 0.6*</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Data are expressed as means ± standard deviation. The affinity of [<sup>125</sup>I]<b>3</b> was significantly higher than that of [<sup>125</sup>I]<b>3</b> (*<i>P</i> < 0.05) and [<sup>125</sup>I]<b>24</b> (<sup>**</sup><i>P</i> < 0.05).</p></div></div></div><div class="NLM_p">We hypothesized that the high affinity of [<sup>123</sup>I]<b>3</b> for PSMA was attributable to interactions between the <b>1</b>-derived moiety and PSMA. Eight derivatives (<b>11a</b>, <b>11b</b>, <b>16a</b>–<b>16c</b>, <b>18</b>, <b>19</b>, and <b>22</b>) of <b>3</b> were designed to further investigate the interactions between the <b>1</b>-derived moiety and PSMA and their affinities for PSMA were compared (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The design of these derivatives introduced four types of modifications into the <b>1</b>-derived moiety: substitution of the iodine for a proton (<b>11a</b>), substitution of a carboxyl group of Lys for a proton (<b>11b</b>), alteration of the carbon chain length of Gly (<b>16a</b>–<b>16c</b> and <b>18</b>), and removal of the iodobenzoyl group (aromatic group) (<b>19</b> and <b>22</b>). The affinities of these compounds for PSMA were evaluated in the binding inhibition assay.</div><div class="NLM_p">The binding inhibition assay data are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Introduction of an iodine (<b>11a</b>) or carboxyl group (<b>11b</b>) into the <b>1</b>-derived moiety did not alter the affinity for PSMA. Alteration of the carbon chain length was acceptable because elongated (<b>16a</b>–<b>16c</b>) or shortened (<b>18</b>) carbon chain lengths of the <b>1</b>-derived moiety also did not affect the affinity. On the other hand, all of these derivatives, even <b>19</b>, which had a <i>N</i>-methylsuccinimidyl group appended to <b>2</b>, showed higher affinity (2.14–94.8 nM) than <b>2</b> (376 nM). This result suggested that the succinimidyl group of the <b>1</b>-derived moiety was important for high affinity. This finding supports the efficacy of the design strategy using <b>2</b> conjugated maleimide-based reagents.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparison of Affinities among <b>3</b> and Its Derivatives<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char="±"><i>K</i><sub>i</sub> [nM]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2-PMPA</td><td class="colsep0 rowsep0" align="char" char="±">31.2 ± 7.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char="±">376 ± 195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="±">4.97 ± 2.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="char" char="±">8.06 ± 3.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="char" char="±">7.91 ± 2.67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16a</b></td><td class="colsep0 rowsep0" align="char" char="±">6.26 ± 4.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="char" char="±">2.95 ± 0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16c</b></td><td class="colsep0 rowsep0" align="char" char="±">2.14 ± 0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="char" char="±">2.79 ± 1.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char="±">62.1 ± 10.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="char" char="±">94.8 ± 1.50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Data are expressed as means ± standard deviation.</p></div></div></div><div class="NLM_p">Compounds <b>19</b> and <b>22</b> showed modest affinity (62.1–94.8 nM) compared with the other derivatives (2.14–8.06 nM). It appears that the aromatic group of the <b>1</b>-derived moiety was also important for high affinity because <b>19</b> and <b>22</b>, which did not have an aromatic group, had poorer affinity than the other derivatives (<b>3</b>, <b>11a</b>, <b>11b</b>, <b>16a</b>–<b>16c</b>, <b>18</b>), which had an aromatic group. These results suggested that both a succinimidyl group and aromatic group were important for high affinity to PSMA although the distance between these moieties was not critical for the high affinity. We assessed this seemingly contradictory result using the X-ray structure of the binding site of PSMA, which had been reported by C. Barinka et al.<a onclick="showRef(event, 'ref18 ref19 ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref36 ref37">(18, 19, 36, 37)</a> In a previous report, C. Barinka et al. suggested that the glutamate moiety of urea-based inhibitors interacts with a pharmacophore (S1′ pocket), and the remainder of the inhibitor interacts with a lipophilic pocket (S1 pocket), which had been reported as a funnel-shaped tunnel with a depth of approximately 20 Å composed of hydrophobic β-sheets. Previously, M. Eder et al. had designed <sup>68</sup>Ga-labeled PSMA probes using the lipophilic chelator <i>N</i>,<i>N</i>′-bis[2-hydroxy-5-(carboxyethyl)-benzyl]ethylenediamine-<i>N</i>,<i>N</i>′-diacetic acid (HBED-CC) that targeted this hydrophobic pocket.<a onclick="showRef(event, 'ref23 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref23 ref38 ref39">(23, 38, 39)</a> Applying the same logic to <b>3</b>, the <b>1</b>-derived moiety should interact with the S1 pocket and the aromatic ring of the <b>1</b>-derived moiety should interact with the hydrophobic β-sheets of the S1 pocket. We also believe that the carbon chain length of <b>1</b> was not critical for high affinity because of the elongated structure of the hydrophobic S1 pocket.</div><div class="NLM_p last">To investigate these hypotheses, we performed a docking simulation study. The docking models between <b>3</b> and recombinant human GCP-II (rhGCP-II: PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2c6c">2c6c</a>) are shown in <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information (SI)">Supporting Information (SI)</a>. In these models, key interactions between the asymmetric urea moiety and the S1′ pocket were examined, including the cysteine moiety and Arg534, the urea group, and Gly518, and the glutamate moiety and Asn257, Lys699, and Try700 (<a class="ref internalNav" href="#notes-1" aria-label="SI Figure S1">SI Figure S1</a>). These interactions corresponded with those identified in previous reports. In addition, interactions between the <b>1</b>-derived derived moiety and the S1 pocket were examined. As previously discussed, our results supported the importance of the succinimidyl and aromatic groups for achieving high binding affinity. In the docking simulation, the aromatic ring of the <b>1</b>-derived moiety was oriented to the hydrophobic S1 pocket and the two oxygen atoms of the succinimidyl group interacted with Arg536 and Tyr549 (<a class="ref internalNav" href="#notes-1" aria-label="SI Figure S2">SI Figure S2</a>). These interactions confirmed the importance of the aromatic and succinimidyl groups for obtaining high affinity.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Stability</h3><div class="NLM_p">We investigated the stability of [<sup>125</sup>I]<b>3</b> using mouse serum. [<sup>123</sup>I]<b>3</b> was expected to be stable because [<sup>123</sup>I]<b>1</b> had been reported to be a stable radiolabeled reagent in human serum.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> A portion of [<sup>125</sup>I]<b>3</b> was degraded in mouse serum after an 18 h incubation period (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B). This degradation product was probably <i>m</i>-[<sup>125</sup>I]iodohuppric acid, which would be produced by cleavage of the Gly-Lys peptide bond. However, this degradation was not a rapid reaction, as no degradation products of [<sup>125</sup>I]<b>3</b> were observed after a 6 h incubation period (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A,B). In accordance with this result, [<sup>125</sup>I]<b>3</b> was regarded as being stable. Indeed, long-term stability would not be required because the majority of [<sup>125</sup>I]<b>3</b> was excreted from blood 30 min after injection in the subsequent biodistribution study.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Time-dependent degradation of [<sup>125</sup>I]<b>3</b> over 6 h. No degradation products were observed over the 6 h incubation period. (B) Shown are radio-HPLC charts after 6 h (left) and 18 h (right) incubations. The intact compound peaks elute at 23.03 min. The subpeak at 21.5 min is likely 3-[<sup>125</sup>I]iodohuppric acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biodistribution and Blocking Studies</h3><div class="NLM_p">An in vivo biodistribution study of [<sup>125</sup>I]<b>3</b> was performed using LNCaP- and PC-3-bearing mouse models to confirm the viability of our design strategy. The biodistribution data of [<sup>125</sup>I]<b>3</b> and the tumor to blood or muscle ratios are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. [<sup>125</sup>I]<b>3</b> showed good tumor uptake by LNCaP tumors (9.5% ID/g at 30 min), and this accumulation was maintained for at least 6 h while low tumor uptake was observed in PC-3 tumors (0.94% ID/g at 30 min). Moreover, this high uptake in LNCaP tumors was significantly inhibited (0.55% ID/g at 30 min) by coinjection of 2-(phosphonomethyl)pentanedioic acid (2-PMPA) (50 mg/kg body weight) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). These results suggested that the tumor uptake of [<sup>125</sup>I]<b>3</b> was due to PSMA-specific binding. Although high accumulation in the kidneys was also observed (89% ID/g at 30 min), the accumulation was inhibited (3.6%ID/g at 30 min) by coinjection of 2-PMPA (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). GCP-II is expressed in mouse kidneys, which is likely responsible for the [<sup>125</sup>I]<b>3</b> accumulation in this organ. Similar results have been observed with other probes targeting PSMA.<a onclick="showRef(event, 'ref22 ref23 ref26 ref27 ref28 ref31'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref26 ref27 ref28 ref31">(22, 23, 26-28, 31)</a> [<sup>125</sup>I]<b>3</b> also showed high accumulation in the spleen of C.B.-17/Icr <i>scid</i>/<i>scid</i> Jcl mice which was blocked with 2-PMPA, indicating GCP-II expression in the spleen. [<sup>125</sup>I]<b>3</b> showed fast blood clearance (8.9% ID/g at 2 min and 1.5% ID/g at 30 min, respectively) and rapid pharmacokinetics as both the tumor/blood and tumor/muscle ratios reached high values after only 30 min (5.3 and 11.1, respectively). [<sup>125</sup>I]<b>3</b> showed little deiodination as accumulation of radioactivity in the thyroid was not observed. These results suggested the possibility of the use of [<sup>125</sup>I]<b>3</b> as a PSMA targeted probe that possesses good accumulation in PSMA-expressing prostate cancer tissue with rapid pharmacokinetics and high stability.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vivo Biodistribution of [<sup>125</sup>I]<b>3</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tissues</th><th class="colsep0 rowsep0" align="center">2 min</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">1 h</th><th class="colsep0 rowsep0" align="center">3 h</th><th class="colsep0 rowsep0" align="center">6 h</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">blood</td><td class="colsep0 rowsep0" align="center">7.4 ± 2.5</td><td class="colsep0 rowsep0" align="center">1.3 ± 0.5</td><td class="colsep0 rowsep0" align="center">1.0 ± 0.3</td><td class="colsep0 rowsep0" align="center">0.7 ± 0.3</td><td class="colsep0 rowsep0" align="center">0.5 ± 0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stomach</td><td class="colsep0 rowsep0" align="center">0.7 ± 0.3</td><td class="colsep0 rowsep0" align="center">2.2 ± 2.1</td><td class="colsep0 rowsep0" align="center">1.0 ± 0.7</td><td class="colsep0 rowsep0" align="center">1.0 ± 0.9</td><td class="colsep0 rowsep0" align="center">0.7 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">intestine</td><td class="colsep0 rowsep0" align="center">3.6 ± 0.8</td><td class="colsep0 rowsep0" align="center">11.2 ± 3.0</td><td class="colsep0 rowsep0" align="center">16.5 ± 4.0</td><td class="colsep0 rowsep0" align="center">5.8 ± 3.1</td><td class="colsep0 rowsep0" align="center">5.3 ± 1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">kidney</td><td class="colsep0 rowsep0" align="center">68.1 ± 20.1</td><td class="colsep0 rowsep0" align="center">88.8 ± 26.5</td><td class="colsep0 rowsep0" align="center">92.8 ± 13.7</td><td class="colsep0 rowsep0" align="center">110 ± 44.6</td><td class="colsep0 rowsep0" align="center">97.1 ± 30.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">liver</td><td class="colsep0 rowsep0" align="center">22.5 ± 4.7</td><td class="colsep0 rowsep0" align="center">13.7 ± 1.7</td><td class="colsep0 rowsep0" align="center">13.9 ± 3.1</td><td class="colsep0 rowsep0" align="center">9.0 ± 2.3</td><td class="colsep0 rowsep0" align="center">4.5 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">spleen</td><td class="colsep0 rowsep0" align="center">12.5 ± 5.3</td><td class="colsep0 rowsep0" align="center">43.3 ± 13.9</td><td class="colsep0 rowsep0" align="center">36.5 ± 13.9</td><td class="colsep0 rowsep0" align="center">16.1 ± 7.6</td><td class="colsep0 rowsep0" align="center">9.7 ± 7.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">heart</td><td class="colsep0 rowsep0" align="center">5.4 ± 1.3</td><td class="colsep0 rowsep0" align="center">2.1 ± 0.9</td><td class="colsep0 rowsep0" align="center">1.3 ± 0.5</td><td class="colsep0 rowsep0" align="center">0.7 ± 0.4</td><td class="colsep0 rowsep0" align="center">0.4 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lung</td><td class="colsep0 rowsep0" align="center">6.8 ± 1.8</td><td class="colsep0 rowsep0" align="center">2.9 ± 0.8</td><td class="colsep0 rowsep0" align="center">2.5 ± 0.5</td><td class="colsep0 rowsep0" align="center">1.2 ± 0.3</td><td class="colsep0 rowsep0" align="center">0.9 ± 0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">muscle</td><td class="colsep0 rowsep0" align="center">1.4 ± 0.2</td><td class="colsep0 rowsep0" align="center">0.6 ± 0.2</td><td class="colsep0 rowsep0" align="center">0.5 ± 0.2</td><td class="colsep0 rowsep0" align="center">0.2 ± 0.1</td><td class="colsep0 rowsep0" align="center">0.1 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LNCaP</td><td class="colsep0 rowsep0" align="center">4.2 ± 1.2</td><td class="colsep0 rowsep0" align="center">9.5 ± 5.9</td><td class="colsep0 rowsep0" align="center">7.0 ± 2.4</td><td class="colsep0 rowsep0" align="center">9.5 ± 3.1</td><td class="colsep0 rowsep0" align="center">6.7 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC-3</td><td class="colsep0 rowsep0" align="center">2.7 ± 0.5</td><td class="colsep0 rowsep0" align="center">0.9 ± 0.3</td><td class="colsep0 rowsep0" align="center">0.7 ± 0.1</td><td class="colsep0 rowsep0" align="center">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="center">0.2 ± 0.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">thyroid</td><td class="colsep0 rowsep0" align="center">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.00 ± 0.00</td><td class="colsep0 rowsep0" align="center">0.01 ± 0.00</td><td class="colsep0 rowsep0" align="center">0.01 ± 0.01</td><td class="colsep0 rowsep0" align="center">0.02 ± 0.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LNCaP/PC-3</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">10.1</td><td class="colsep0 rowsep0" align="center">9.6</td><td class="colsep0 rowsep0" align="center">33.9</td><td class="colsep0 rowsep0" align="center">36.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LNCaP/blood</td><td class="colsep0 rowsep0" align="center">0.6</td><td class="colsep0 rowsep0" align="center">7.2</td><td class="colsep0 rowsep0" align="center">6.9</td><td class="colsep0 rowsep0" align="center">13.8</td><td class="colsep0 rowsep0" align="center">13.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC-3/blood</td><td class="colsep0 rowsep0" align="center">0.4</td><td class="colsep0 rowsep0" align="center">0.7</td><td class="colsep0 rowsep0" align="center">0.7</td><td class="colsep0 rowsep0" align="center">0.4</td><td class="colsep0 rowsep0" align="center">0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LNCaP/muscle</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">16.5</td><td class="colsep0 rowsep0" align="center">15.5</td><td class="colsep0 rowsep0" align="center">49.4</td><td class="colsep0 rowsep0" align="center">76.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PC-3/muscle</td><td class="colsep0 rowsep0" align="center">1.9</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">2.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Accumulation in each tissue (except for stomach and thyroid, where it was evaluated as %ID) was evaluated as %ID/g. Values are expressed as means ± standard deviation. The ratios are based on the %ID/g.</p></div></div></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In the blocking study, all mice were sacrificed 30 min after injection. Data for the stomach are expressed as %ID. (A) In normal tissues, significant inhibition by 2-PMPA was observed in kidney and spleen. (B) Accumulation in LNCaP tumors was significantly inhibited by 2-PMPA. The difference between the accumulations in PC-3 tumors and blocked LNCaP tumors was not significant (*<i>P</i> < 0.05; NS, not significant).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to [<sup>125</sup>I]<b>3</b>, we prepared [<sup>125</sup>I]<b>11b</b> and evaluated it in vivo (its radiosynthesis is shown in <a class="ref internalNav" href="#notes-1" aria-label="SI">SI</a>). [<sup>125</sup>I]<b>11b</b> showed more rapid clearance from blood and slightly lower accumulation in LNCaP tumor than [<sup>125</sup>I]<b>3</b> (<a class="ref internalNav" href="#notes-1" aria-label="SI Figure S4">SI Figure S4</a>). However, [<sup>125</sup>I]<b>11b</b> showed significantly higher accumulation in liver and intestine than [<sup>125</sup>I]<b>3</b> (<a class="ref internalNav" href="#notes-1" aria-label="SI Figure S3">SI Figure S3</a>). We considered that such high hepatic and intestinal accumulations of [<sup>125</sup>I]<b>11b</b> were not preferable, and we attributed this accumulation to the lower polarity of [<sup>125</sup>I]<b>11b</b> compared with that of [<sup>125</sup>I]<b>3</b> (<a class="ref internalNav" href="#notes-1" aria-label="SI Table S1">SI Table S1</a>). This was supported by the fact that [<sup>125</sup>I]<b>11b</b> had a longer HPLC retention time, indicating it was lower in polarity than [<sup>125</sup>I]<b>3</b>. Moreover, other iodinated derivatives (<b>16a</b>–<b>16c</b> and <b>18</b>) also had longer HPLC retention times than [<sup>125</sup>I]<b>3</b> (<a class="ref internalNav" href="#notes-1" aria-label="SI Table S1">SI Table S1</a>). Therefore, we regarded [<sup>123</sup>I]<b>3</b> as the best of the tested derivatives.</div><div class="NLM_p last">Then using mice, we compared the properties [<sup>125</sup>I]<b>3</b> with the previously reported PSMA probe [<sup>125</sup>I]<b>24</b>, for which a phase I clinical trial was completed. In accordance with the previous study, high accumulation of [<sup>125</sup>I]<b>24</b> in LNCaP tumor was observed (<a class="ref internalNav" href="#notes-1" aria-label="SI Table S2">SI Table S2</a>). [<sup>125</sup>I]<b>24</b> showed higher accumulation in LNCaP tumor and kidney than [<sup>125</sup>I]<b>3</b>, although the affinity of [<sup>125</sup>I]<b>24</b> for PSMA was lower than [<sup>125</sup>I]<b>3</b>. We consider that rapid clearance of [<sup>125</sup>I]<b>3</b> from blood is the cause of this lower accumulation. [<sup>125</sup>I]<b>3</b> showed lower radioactivity than [<sup>125</sup>I]<b>24</b> in blood 30 min after injection. The differences in blood clearance may be attributed to differences in the excretion routes. [<sup>125</sup>I]<b>3</b> was excreted from both kidney and liver. [<sup>125</sup>I]<b>3</b> showed high accumulation in kidney, and accumulation in intestine was elevated over time. On the other hand, [<sup>125</sup>I]<b>24</b> was excreted from kidney but not from liver. The lower hydrophilicity of [<sup>125</sup>I]<b>11b</b> compared to [<sup>125</sup>I]<b>3</b> is likely the cause of its higher hepatic accumulation of [<sup>125</sup>I]<b>11b</b>. We also believed that lower hydrophilicity is likely the cause of the higher hepatic accumulation of [<sup>125</sup>I]<b>3</b> compared to [<sup>125</sup>I]<b>24</b>. The distribution coefficient (log <i>D</i>) of [<sup>125</sup>I]<b>3</b> and [<sup>125</sup>I]<b>24</b> is shown in <a class="ref internalNav" href="#notes-1" aria-label="SI Table S3">SI Table S3</a>. [<sup>125</sup>I]<b>3</b> had a larger log <i>D</i> value (log <i>D</i> = −1.97) than [<sup>125</sup>I]<b>24</b> (log <i>D</i> = −2.91). Therefore, an improvement of the hydrophilicity would be necessary for lowering hepatic accumulation and elevating tumor accumulation.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Small Animal SPECT/CT</h3><div class="NLM_p">A SPECT/CT study was performed on the basis of the biodistribution study results. SPECT scanning commenced 30 min after injection of [<sup>123</sup>I]<b>3</b> because the tumor/blood ratio was sufficiently high at this time point to obtain SPECT images. Although the tumor/blood ratio was higher 3 h after injection, the 30 min delay was selected as the time point for SPECT scanning in order to determine whether [<sup>123</sup>I]<b>3</b> could distinguish LNCaP tumors from PC-3 tumors immediately after injection.</div><div class="NLM_p">[<sup>123</sup>I]<b>3</b> clearly distinguished LNCaP tumors from PC-3 tumors on SPECT/CT images 30 min post injection (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A,C), and tracer accumulation was clearly absent from SPECT images when coinjected with 2-PMPA (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). These results were consistent with those from the biodistribution study and suggested that [<sup>123</sup>I]<b>3</b> would be efficient as a PSMA targeting probe.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A,B) Transaxial SPECT/CT images obtained with [<sup>123</sup>I]<b>3</b>. Mice were injected with [<sup>123</sup>I]<b>3</b> without (A) or with (B) 2-PMPA (50 mg/kg weight). [<sup>123</sup>I]<b>3</b> clearly illuminated LNCaP tumors (A), and 2-PMPA prevented this reaction (B). [<sup>123</sup>I]<b>3</b> did not accumulate in PC-3 tumors. (C) Coronal SPECT/CT images were obtained with [<sup>123</sup>I]<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The syntheses of PSMA targeting derivatives by a nucleophilic conjugate addition between the cysteine of the asymmetric urea compound (<b>2</b>) and a maleimide-based reagent were successful, and the aromatic and succinimidyl moieties of these derivatives were found to be important for high affinity. [<sup>123</sup>I]<b>3</b>, which was synthesized by this reaction, exhibited high affinity for PSMA and gave clear SPECT images with LNCaP bearing mice.</div><div class="NLM_p">This study clearly established the basis of a new design strategy for PSMA probes. Through our investigation of [<sup>125</sup>I]<b>3</b>, we clarified the importance of the aromatic ring and the succinimidyl group for high affinity. Moreover, the significance of hydrophilicity for pharmacokinetics was confirmed.</div><div class="NLM_p last">These findings warrant further evaluation of [<sup>123</sup>I]<b>3</b> as an imaging agent and support the benefit of this strategy for design of other PSMA probes.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p last">W-Prep 2XY (Yamazen Corporation, Osaka, Japan) was used for silica gel column chromatography on a Hi Flash silica gel column (40 mm, 60 Å, Yamazen). Silica gel 60 F254, 0.5 mm (Merck KGaA, Darmstadt, Germany), was used for preparative thin layer chromatography (PTLC). A LC-20AD (Shimadzu Corporation, Kyoto, Japan) equipped with a SPD-20A UV detector (ρ; 220 and 254 nm) (Shimadzu) and a NDW-351 radioisotope detector (Hitachi Aloka Medical, Ltd., Tokyo, Japan) was used for high performance liquid chromatography (HPLC). The eluent consisted of a binary mixture of 0.1% trifluoroacetic acid (TFA) in H<sub>2</sub>O (solvent A) and 0.1% TFA in methanol (solvent B). Nanopure water was prepared by MQ Integra15 (Nihon Millipore, Tokyo, Japan). Mass spectra were recorded on a LCMS-2010 EV (Shimadzu), GCMS-QP2010 Plus (Shimadzu), or JMS-SX 102A QQ (JEOL Ltd., Tokyo, Japan). <sup>1</sup>H NMR spectra were recorded on a LNM-AL500 (JEOL) using CDCl<sub>3</sub>, dimethylsulfoxide-<i>d</i><sub>6</sub> (DMSO-<i>d</i><sub>6</sub>), CD<sub>3</sub>OD, or D<sub>2</sub>O as the solvent and tetramethylsilane as an internal standard (Euriso-top, Saint-Aubin, France). All chemicals used in the syntheses were reagent grade.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Chemistry and Radiochemistry</h3><div class="NLM_p"><b>2</b> was synthesized as previously reported.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a><b>1</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>23</b>,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><b>24</b>,<a onclick="showRef(event, 'ref28 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref32">(28, 32)</a> and radioiodinated forms of these compounds were synthesized by previously reported methods. [<sup>123</sup>I]<b>3</b> was prepared by incubation of <b>2</b> with [<sup>123</sup>I]<b>1</b> at room temperature for 15 min. Each radiolabeled compound was purified by reverse-phase HPLC using a Cosmosil 5C<sub>18</sub>-AR-II 4.6 mm × 150 mm column eluted with 0.1% TFA in water (solvent A) and 0.1% TFA in methanol (solvent B). An HPLC gradient with a flow rate of 1 mL/min was initiated from an isocratic system (30% solvent B) over 10 min and adjusted to 30–60% solvent B over 10 min followed by 60% solvent B.</div><div class="NLM_p last">Compounds <b>11a</b>, <b>11b</b>, <b>16a</b>–<b>16c</b>, <b>18</b>, <b>19</b>, and <b>22</b> were synthesized to investigate the relationships between the high affinity of <b>3</b> and its structure (Schemes <a class="ref internalNav" href="#sch2" aria-label="2">2</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compounds <b>4</b>–<b>6</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>9a</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>10a</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><b>12</b>,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and <b>20</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> were synthesized by previously reported methods. All compounds tested in the inhibition assay were prepared in >95% purity as judged by HPLC. Conditions for HPLC purification are defined as follows: condition 1, YMC-Pack ODS-AQ 20 mm × 250 mm column (YMC Co. Ltd., Kyoto, Japan), 5 mL/min, 30–80% gradient of solvent B over 60 min; condition 2, YMC-Pack ODS 20 mm × 250 mm column, 5 mL/min, 40–90% gradient of solvent B over 60 min.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (2<i>S</i>)-2-(3-((1<i>R</i>)-1-Carboxy-2-((1-((<i>R</i>)-5-carboxy-5-(2-(3-iodobenzamido)acetamido)pentyl)-2,5-dioxopyrrolidin-3-yl)thio)ethyl)ureido)pentanedioic Acid (<b>3</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (6.8 mg, 0.023 mmol) in H<sub>2</sub>O (0.2 mL) was added <b>1</b> (11.9 mg, 0.023 mmol) in acetonitrile (0.15 mL). 2N NaOH was added to the mixture to adjust the pH to 7. The mixture was stirred at room temperature for 2 h. HPLC purification afforded <b>3</b> (3.8 mg, 21% yield) under the following conditions: Cosmosil 5C<sub>18</sub>-AR-II column (10 mm × 250 mm) eluted with 0.1% TFA in water (solvent A) and 0.1% TFA in methanol (solvent B), at a flow rate of 2 mL/min, and an HPLC gradient initiated from an isocratic system (30% solvent B) over 15 min, adjusted to 30–60% of solvent B over 10 min followed by 60% of solvent B. <sup>1</sup>H NMR (500 MHz, D<sub>2</sub>O): δ 8.10 (s, 1H), 7.90 (d, <i>J</i> = 8.02 Hz, 1H), 7.71 (d, <i>J</i> = 7.45 Hz, 1H), 7.21 (dd, <i>J</i> = 7.45, 8.02 Hz, 1H), 4.39 (t, <i>J</i> = 5.73 Hz, 1H), 4.28 (broad s, 1H), 4.15 (m, 1H), 3.99–4.07 (m, 2H), 3.93 (m, 1H), 3.39 (t, <i>J</i> = 6.87 Hz, 2H), 2.95–3.35 (m, 3H), 2.56 (m, 1H), 2.38 (dt, <i>J</i> = 2.86, 7.45 Hz, 2H), 2.05 (m, 1H), 1.83 (m, 2H), 1.65 (m, 1H), 1.48 (m, 2H) and 1.21 (t, <i>J</i> = 7.45 Hz, 2H). ESI-MS: 808 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>28</sub>H<sub>35</sub>N<sub>5</sub>O<sub>13</sub>SI, 808.0994 [M + H]<sup>+</sup>; found, 808.0997.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 4-Methoxybenzyl 2-(3-Iodobenzamido)acetate (<b>7a</b>)</h3><div class="NLM_p last">To a solution of 3-iodobenzoic acid (2.8 g, 11 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (25 mL) was added 4-methoxybenzyl 2-aminoacetate hydrochloride (H-Gly-OPMB·HCl) (2.6 g, 11 mmol), water-soluble carbodiimide hydrochloride (WSCI·HCl) (2.1 g, 11 mmol), and triethylamine (1.1 mL). The mixture was stirred at room temperature for 6 h. After extraction with ethyl acetate, the organic layer was washed with brine and dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>7a</b> was purified by silica gel column chromatography (hexane/ethyl acetate = 2/1, 3.0 g, 64% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.06 (m, 1H), 8.20 (m, 1H), 7.92 (m, <i>1</i>H), 7.87 (m, 1H) 7.31 (m, 2H), 6.93 (m, 2H), 5.08 (s, 2H), 4.03 (d, <i>J</i> = 5.73 Hz, 2H), and 3.75 (s, 3H). EI-MS <i>m</i>/<i>z</i>: 425 [M]<sup>+</sup>, 231 (4.7), 121 (100).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 4-Methoxybenzyl 2-Benzamidoacetate (<b>7b</b>)</h3><div class="NLM_p last">To a solution of benzoic acid (1.6 g, 13 mmol) in DMF (15 mL) was added H-Gly-OPMB·HCl (3.0 g, 13 mmol), WSCI·HCl (2.5 g, 13 mmol), and triethylamine (1.8 mL). The mixture was stirred at room temperature overnight. After extraction with ethyl acetate, the organic layer was washed with brine and dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>7b</b> was purified by silica gel column chromatography (hexane/ethyl acetate = 2/1, 2.2 g, 57% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 7.81 (d, <i>J</i> = 7.45 Hz, 2H), 7.51 (m, 2H), 7.45 (t, <i>J</i> = 7.45 Hz, 2H), 7.32 (m, 2H), 6.90 (m, 2H), 6.63 (s, 1H), 5.17 (s, 2H), 4.26 (d, <i>J</i> = 4.58 Hz, 2H), and 3.82 (s, 3H). EI-MS <i>m</i>/<i>z</i>: 299 [M]<sup>+</sup>, 162 (2.0), 137 (4.7), 134 (15.9), 121 (100), 77 (34.7).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(3-Iodobenzamido)acetic Acid (<b>8a</b>)</h3><div class="NLM_p last">To a solution of <b>7a</b> (3.0 g, 7.1 mmol) in dichloromethane (24 mL) was added TFA (5.3 mL). The mixture was stirred at room temperature for 15 min. The solvent was removed under reduced pressure, and the product <b>8a</b> was recrystallized from chloroform (2.1 g, 97% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.95 (m, 1H), 8.22 (t, <i>J</i> = 1.72 Hz, 1H), 7.92 (m, 1H), 7.88 (m, 1H), 7.30 (t, <i>J</i> = 8.02 Hz, 1H), and 3.92 (d, <i>J</i> = 5.73 Hz, 2H). ESI-MS <i>m</i>/<i>z</i>: 304 [M]<sup>−</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 2-Benzamidoacetic Acid (<b>8b</b>)</h3><div class="NLM_p last">To a solution of <b>7b</b> (2.2 g, 7.3 mmol) in dichloromethane (25 mL) was added TFA (5.5 mL). The mixture was stirred at room temperature for 15 min. The solvent was removed under reduced pressure, and the product <b>8b</b> was recrystallized from chloroform (1.2 g, 94% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 8.81 (t, <i>J</i> = 5.73 Hz, 1H), 7.87 (m, 2H), 7.55 (m, 1H), 7.48 (t, <i>J</i> = 7.45 Hz, 2H), and 3.93 (d, <i>J</i> = 5.73 Hz, 2H). EI-MS <i>m</i>/<i>z</i>: 179 [M]<sup>+</sup>, 134 (20), 105 (100), 77 (69).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 2,5-Dioxopyrrolidin-1-yl 2-Benzamidoacetate (<b>9b</b>)</h3><div class="NLM_p last">To a solution of <b>8b</b> (1.2 g, 6.7 mmol) in DMF (10 mL) was added <i>N</i>-hydroxysuccinimide (NHS) (0.78 g, 6.8 mmol) and <i>N</i>,<i>N</i>′-diisopropylcarbodiimide (DIC) (0.86 mg, 6.8 mmol). The mixture was stirred at room temperature for 14 h. After extraction with ethyl acetate, the organic layer was washed with brine and dried over sodium sulfate. The solvent was removed under reduced pressure, and the resulting white precipitate was washed with chloroform and collected (1.8 g, 95% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>): δ 9.16 (t, <i>J</i> = 5.73 Hz, 1H), 7.88 (d, <i>J</i> = 7.45 Hz, 2H), 7.58 (t, <i>J</i> = 6.87 Hz, 1H), 7.50 (t, <i>J</i> = 7.73 Hz, 2H), 4.43 (d, <i>J</i> = 5.73 Hz, 2H), 2.82 (s, 4H).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>S</i>)-2-(2-Benzamidoacetamido)-6-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)hexanoic Acid (<b>10a</b>)</h3><div class="NLM_p last">To a solution of <b>9b</b> (0.1 g, 0.36 mmol) in acetonitrile (3 mL) was added <b>6a</b> (95 mg, 0.36 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) (0.13 mL). The mixture was stirred at room temperature for 3 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>10a</b> was purified by PTLC (chloroform/methanol = 9/1) followed by HPLC using condition 1 (<i>t</i><sub>R</sub>: 44 min, 6.3 mg, 4.5% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 7.87 (m, 2H), 7.55 (t, <i>J</i> = 7.45 Hz, 1H), 7.47 (t, <i>J</i> = 7.73 Hz, 2H), 6.77 (s, 2H), 4.42 (m, 1H), 4.10 (m, 2H), 3.49 (t, <i>J</i> = 6.87 Hz, 2H), 1.90 (m, 1H), 1.74 (m, 1H), 1.60 (m, 2H), and 1.38 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 388 [M + H]<sup>+</sup>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-[2-[[5-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)pentyl]amino]-2-oxoethyl]-3-iodobenzamide (<b>10b</b>)</h3><div class="NLM_p last">To a solution of <b>9a</b> (96 mg, 0.24 mmol) in acetonitrile (3 mL) was added <b>6b</b> (52 mg, 0.24 mmol) and DIPEA (41 μL). The mixture was stirred at room temperature for 1 h. After extraction with ethyl acetate, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>10b</b> was purified by silica gel column chromatography (chloroform/methanol = 10/1, 51 mg, 46% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.18 (t, <i>J</i> = 1.72 Hz, 1H), 7.85 (m, 1H), 7.78 (dd, <i>J</i> = 1.15, 7.45 Hz, 1H), 7.19 (t, <i>J</i> = 7.73 Hz, 1H), 7.05 (s, 1H), 6.69 (s, 2H), 6.13 (s, 1H), 4.10 (d, <i>J</i> = 5.16 Hz, 2H), 3.52 (t, <i>J</i> = 6.87 Hz, 2H), 3.43 (m, 2H), 1.62 (m, 4H), and 1.32 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 470 [M + H]<sup>+</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (2<i>S</i>)-2-[3-[(1<i>R</i>)-2-[[1-[(<i>S</i>)-5-(2-Benzamidoacetamido)-5-carboxypentyl]-2,5-dioxopyrrolidin-3-yl]thio]-1-carboxyethyl]ureido]pentanedioic Acid (<b>11a</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (4.8 mg, 0.016 mmol) in H<sub>2</sub>O (0.4 mL) was added <b>10a</b> (6.3 mg 0.013 mmol) in acetonitrile (0.6 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 1 h. <b>11a</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 37 min, 5.9 mg, 54% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 7.88 (m, 2H), 7.55 (t, <i>J</i> = 7.73 Hz, 1H), 7.47 (t, <i>J</i> = 7.45 Hz, 2H), 4.61 (m, 1H), 4.42 (m, 1H), 4.32 (m, 1H), 4.11 (m, 2H), 4.01 (m, 1H), 3.50 (m, 2H), 3.19 (m, 2H), 2.48 (m, 1H), 2.40 (m, 2H), 2.14 (m, 1H), 1.89 (m, 2H), 1.73 (m, 1H), 1.61 (m, 2H), and 1.39 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 682 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>28</sub>H<sub>36</sub>N<sub>5</sub>O<sub>13</sub>S, 682.2037 [M + H]<sup>+</sup>; found, 682.2030.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (2<i>S</i>)-2-[3-[(1<i>R</i>)-1-Carboxy-2-[[1-[5-[2-(3-iodobenzamido)acetamido]pentyl]-2,5-dioxopyrrolidin-3-yl]thio]ethyl]ureido]pentanedioic Acid (<b>11b</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (14 mg, 0.048 mmol) in H<sub>2</sub>O (0.3 mL) was added <b>10b</b> (23 mg, 0.059 mmol) in acetonitrile (0.3 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 1 h. <b>11b</b> was purified by HPLC using condition 2 (<i>t</i><sub>R</sub>: 42 min, 16 mg, 43% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.26 (t, <i>J</i> = 1.72 Hz, 1H), 7.89 (m, 2H), 7.25 (t, <i>J</i> = 8.02 Hz, 1H), 4.61 (m, 1H), 4.31 (m, 1H), 3.98 (m, 3H), 3.48 (m, 3H), 3.20 (m, 4H), 2.50 (m, 1H), 2.42 (m, 2H), 2.14 (m, 1H), 1.89 (m, 1H), 1.56 (m, 4H), and 1.32 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 764 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>27</sub>H<sub>35</sub>N<sub>5</sub>O<sub>11</sub>SI, 764.1093 [M + H]<sup>+</sup>; found, 764.1099.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 3-(3-Iodobenzamido)propanoic Acid (<b>13a</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (600 mg, 1.74 mmol) in acetonitrile (6 mL) was added 3-aminopropionic acid (170 mg, 1.91 mmol) and DIPEA (0.33 mL). The mixture was stirred at room temperature for 11 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the resulting precipitate was washed with chloroform to afford <b>13a</b> (214 mg, 39% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.16 (t, <i>J</i> = 1.72 Hz, 1H), 7.88 (d, <i>J</i> = 6.87 Hz, 1H), 7.79 (m, 1H), 7.23 (t, <i>J</i> = 8.02 Hz, 1H), 3.61 (t, <i>J</i> = 6.87 Hz, 2H), and 2.62 (t, <i>J</i> = 6.87 Hz, 2H). EI-MS <i>m</i>/<i>z</i>: 319 [M]<sup>+</sup>, 231 (36), 203 (12), 76 (36).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 4-(3-Iodobenzamido)butanoic Acid (<b>13b</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (500 mg, 1.45 mmol) in acetonitrile (4 mL) was added 4-aminobutanoic acid (164 mg, 1.59 mmol) and DIPEA (0.27 mL). The mixture was stirred at room temperature overnight. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the resulting precipitate was washed with chloroform to afford <b>10b</b> (316 mg, 65% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.17 (t, <i>J</i> = 1.72 Hz, 1H), 7.88 (dt, <i>J</i> = 1.72, 8.02 Hz, 1H), 7.80 (dt, <i>J</i> = 1.72, 8.02 Hz, 1H), 7.23 (t, <i>J</i> = 8.02 Hz, 1H), 3.41 (t, <i>J</i> = 7.16 Hz, 2H), 2.38 (t, <i>J</i> = 7.16 Hz, 2H), and 1.90 (tt, <i>J</i> = 7.16, 7.16 Hz, 2H). EI-MS <i>m</i>/<i>z</i>: 333 [M]<sup>+</sup>, 274 (19), 231 (36), 102 (50), 76 (51).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 5-(3-Iodobenzamido)pentanoic Acid (<b>13c</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (500 mg, 1.45 mmol) in acetonitrile (6 mL) was added 5-aminopentanoic acid (188 mg, 1.60 mmol) and DIPEA (0.27 mL). The mixture was stirred at room temperature for 7 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the resulting precipitate was washed with chloroform to afford <b>13c</b> (252 mg, 50% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD): δ 8.17 (t, <i>J</i> = 1.72 Hz, 1H), 7.87 (dt, <i>J</i> = 1.72, 8.02 Hz, 1H), 7.80 (m, 1H), 7.23 (t, <i>J</i> = 8.02 Hz, 1H), 3.38 (t, <i>J</i> = 6.87 Hz, 2H), 2.35 (t, <i>J</i> = 6.87 Hz, 2H), and 1.66 (m, 4H). EI-MS <i>m</i>/<i>z</i>: 347 [M]<sup>+</sup>, 288 (27), 260 (12), 231 (100), 203 (23), 116 (18), 104 (14), 76 (36).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2,5-Dioxopyrrolidin-1-yl 3-(3-Iodobenzamido)propanoate (<b>14a</b>)</h3><div class="NLM_p last">To a solution of <b>13a</b> (200 mg, 0.63 mmol) in DMF (4 mL) was added NHS (72 mg, 0.63 mmol) and WSCI·HCl (120 mg, 0.63 mmol). The mixture was stirred at room temperature for 7 h. After extraction with ethyl acetate and washing with saturated aqueous sodium bicarbonate, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>14a</b> was purified by silica gel column chromatography (chloroform/methanol = 10/1, 93 mg, 36% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 8.18 (t, <i>J</i> = 1.72 Hz, 1H), 7.83 (d, <i>J</i> = 8.02 Hz, 1H), 7.76 (d, <i>J</i> = 8.02 Hz, 1H), 7.17 (t, <i>J</i> = 8.02 Hz, 1H), 6.95 (broad s, 1H), 3.88 (m, 2H), 2.94 (t, <i>J</i> = 6.30 Hz, 2H), and 2.88 (s, 4H). EI-MS <i>m</i>/<i>z</i>: 416 [M]<sup>+</sup>, 301 (41), 260 (13), 231 (100), 203 (24), 104 (12), 76 (40).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2,5-Dioxopyrrolidin-1-yl 4-(3-Iodobenzamido)butanoate (<b>14b</b>)</h3><div class="NLM_p last">To a solution of <b>13b</b> (250 mg, 0.75 mmol) in DMF (5 mL) was added NHS (86 mg, 0.75 mmol) and WSCI·HCl (144 mg, 0.75 mmol). The mixture was stirred at room temperature overnight. After extraction with ethyl acetate and washing with saturated aqueous sodium bicarbonate, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>14b</b> was purified by silica gel column chromatography (chloroform/methanol = 10/1, 195 mg, 60% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 8.10 (t, <i>J</i> = 1.72 Hz, 1H), 7.82 (d, <i>J</i> = 7.45 Hz, 1H), 7.73 (d, <i>J</i> = 7.45 Hz, 1H), 7.17 (t, <i>J</i> = 7.45 Hz, 1H), 6.51 (broad s, 1H), 3.56 (m, 2H), 2.86 (s, 4H), 2.73 (t, <i>J</i> = 6.87 Hz, 2H), and 2.12 (tt, <i>J</i> = 6.87 Hz, 6.87 Hz, 2H). EI-MS <i>m</i>/<i>z</i>: 430 [M]<sup>+</sup>, 315 (36), 274 (8), 231 (100), 203 (25), 104 (13), 84 (26), 76 (42).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 2,5-Dioxopyrrolidin-1-yl 5-(3-Iodobenzamido)pentanoate (<b>14c</b>)</h3><div class="NLM_p last">To a solution of <b>13c</b> (133 mg, 0.38 mmol) in DMF (4 mL) was added NHS (44 mg, 0.38 mmol) and WSCI·HCl (73 mg, 0.38 mmol). The mixture was stirred at room temperature for 3 h. After extraction with ethyl acetate and washing with saturated aqueous sodium bicarbonate, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>14c</b> was purified by silica gel column chromatography (chloroform/methanol = 20/1, 83 mg, 49% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 8.10 (t, <i>J</i> = 1.72 Hz, 1H), 7.81 (d, <i>J</i> = 8.02 Hz, 1H), 7.75 (d, <i>J</i> = 8.02 Hz, 1H), 7.17 (t, <i>J</i> = 8.02 Hz, 1H), 6.36 (broad s, 1H), 3.50 (m, 2H), 2.86 (s, 4H), 2.69 (t, <i>J</i> = 6.87 Hz, 2H), 1.88 (m, 2H), and 1.76 (m, 2H). EI-MS <i>m</i>/<i>z</i>: 444 [M]<sup>+</sup>, 330 (7), 288 (18), 231 (100), 203 (20), 104 (14), 98 (16), 76 (32).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-6-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)-2-(3-(3-iodobenzamido)propanamido)hexanoic Acid (<b>15a</b>)</h3><div class="NLM_p last">To a solution of <b>14a</b> (110 mg, 0.26 mmol) in acetonitrile (3 mL) was added <b>6a</b> (69 mg, 0.26 mmol) and DIPEA (91 μL). The mixture was stirred at room temperature for 4 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>15a</b> was purified by PTLC (chloroform/methanol = 10/1) followed by HPLC using condition 1 (<i>t</i><sub>R</sub>: 60 min, 19 mg, 14% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz): δ 8.17 (t, <i>J</i> = 1.72 Hz, 1H), 7.87 (d, <i>J</i> = 8.02 Hz, 1H), 7.81 (d, <i>J</i> = 8.02 Hz, 1H), 7.22 (t, <i>J</i> = 8.02 Hz, 1H), 6.78 (s, 2H), 4.36 (m, 1H), 3.64 (m, 2H), 3.44 (t, <i>J</i> = 7.16 Hz, 2H), 2.56 (m, 2H), 1.66–1.89 (m, 2H), 1.57 (m, 2H), and 1.35 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 528 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-6-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)-2-(4-(3-iodobenzamido)butanamido)hexanoic Acid (<b>15b</b>)</h3><div class="NLM_p last">To a solution of <b>14b</b> (58 mg, 0.13 mmol) in acetonitrile (2 mL) was added <b>6a</b> (35 mg, 0.13 mmol) and DIPEA (46 μL). The mixture was stirred at room temperature for 4 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>15b</b> was purified by PTLC (chloroform/methanol = 10/1) followed by HPLC using condition 1 (<i>t</i><sub>R</sub>: 62 min, 12 mg, 17% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz): δ 8.18 (t, <i>J</i> = 1.72 Hz, 1H), 7.88 (d, <i>J</i> = 8.02 Hz, 1H), 7.82 (d, <i>J</i> = 8.02 Hz, 1H), 7.24 (t, <i>J</i> = 8.02 Hz, 1H), 6.78 (s, 2H), 4.34 (m, 1H), 3.49 (t, <i>J</i> = 6.87 Hz, 2H), 3.41 (t, <i>J</i> = 6.87 Hz, 2H), 2.33 (t, <i>J</i> = 7.45 Hz, 2H), 1.92 (t, <i>J</i> = 6.87 Hz, 2H), 1.67–1.91 (m, 2H), 1.59 (m, 2H), and 1.36 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 542 [M + H]<sup>+</sup>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-6-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)-2-(5-(3-iodobenzamido)pentanamido)hexanoic Acid (<b>15c</b>)</h3><div class="NLM_p last">To a solution of <b>14c</b> (100 mg, 0.23 mmol) in acetonitrile (2 mL) was added <b>6a</b> (60 mg, 0.23 mmol) and DIPEA (77 μL). The mixture was stirred at room temperature for 2 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>15c</b> was purified by PTLC (chloroform/methanol = 10/1) followed by HPLC using condition 1 (<i>t</i><sub>R</sub>: 63 min, 30 mg, 24% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz): δ 8.17 (t, <i>J</i> = 1.72 Hz, 1H), 7.87 (d, <i>J</i> = 8.02 Hz, 1H), 7.81 (d, <i>J</i> = 8.02 Hz, 1H), 7.23 (t, <i>J</i> = 8.02 Hz, 1H), 6.78 (s, 2H), 4.35 (m, 1H), 3.48 (t, <i>J</i> = 7.16 Hz, 2H), 3.39 (m, 2H), 2.30 (t, <i>J</i> = 7.16 Hz, 2H), 1.55–1.86 (m, 8H), and 1.36 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 556 [M + H]<sup>+</sup>.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2<i>S</i>)-2-(3-(1<i>R</i>)-1-Carboxy-2-((1-(<i>S</i>)-5-carboxy-5-(3-(3-iodobenzamido)propanamido)pentyl-2,5-dioxopyrrolidin-3-yl)thio)ethyl)ureido)pentanedioic Acid (<b>16a</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (6.1 mg, 0.021 mmol) in H<sub>2</sub>O (0.6 mL) was added <b>15a</b> (11 mg, 0.021 mmol) in acetonitrile (0.4 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 2 h. The product <b>16a</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 52 min, 10 mg, 58% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz): δ 8.18 (t, <i>J</i> = 1.72 Hz, 1H), 7.87 (t, <i>J</i> = 8.02 Hz, 1H), 7.81 (d, <i>J</i> = 8.02 Hz, 1H), 7.23 (t, <i>J</i> = 8.02 Hz, 1H), 4.53 (m, 1H), 4.37 (m, 1H), 4.01 (m, 1H), 3.65 (m, 2H), 3.39 (m, 2H), 3.22 (m, 2H), 2.58 (m, 2H), 2.41 (m, 2H), 2.15 (m, 2H), 1.88 (m, 2H), 1.70 (m, 1H), 1.56 (m, 2H), and 1.35 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 822 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>29</sub>H<sub>37</sub>N<sub>5</sub>O<sub>13</sub>SI, 822.1159 [M + H]<sup>+</sup>; found, 822.1153.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>S</i>)-2-(3-(1<i>R</i>)-1-Carboxy-2-((1-(<i>S</i>)-5-carboxy-5-(4-(3-iodobenzamido)butanamido)pentyl-2,5-dioxopyrrolidin-3-yl)thio)ethyl)ureido)pentanedioic Acid (<b>16b</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (6.0 mg, 0.020 mmol) in H<sub>2</sub>O (0.9 mL) was added <b>15b</b> (11 mg, 0.020 mmol) in acetonitrile (0.9 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 1 h. The product <b>16b</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 53 min, 12 mg, 73% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz): δ 8.19 (t, <i>J</i> = 1.72 Hz, 1H), 7.88 (t, <i>J</i> = 8.02 Hz, 1H), 7.82 (d, <i>J</i> = 8.02 Hz, 1H), 7.24 (t, <i>J</i> = 8.02 Hz, 1H), 4.61 (m, 1H), 4.33 (m, 2H), 4.00 (m, 1H), 3.49 (m, 2H), 3.42 (t, <i>J</i> = 6.87 Hz, 2H), 3.35 (s, 1H), 3.19 (m, 2H), 2.40 (m, 2H), 2.34 (t, <i>J</i> = 7.45 Hz, 2H), 2.15 (m, 1H), 1.90 (m, 4H), 1.69 (m, 2H), and 1.49 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 836 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>13</sub>SI, 836.1310 [M + H]<sup>+</sup>; found, 836.1315.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>)-2-(3-(1<i>R</i>)-1-Carboxy-2-((1-(<i>S</i>)-5-carboxy-5-(5-(3-iodobenzamido)pentanamido)pentyl-2,5-dioxopyrrolidin-3-yl)thio)ethyl)ureido)pentanedioic Acid (<b>16c</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (9.0 mg, 0.031 mmol) in H<sub>2</sub>O (0.6 mL) was added <b>15c</b> (17 mg, 0.031 mmol) in acetonitrile (1 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 2 h. The product <b>16c</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 55 min, 6 mg, 23% yield). <sup>1</sup>H NMR (CD<sub>3</sub>OD, 500 MHz): δ 8.17 (t, <i>J</i> = 1.72 Hz, 1H), 7.87 (t, <i>J</i> = 8.02 Hz, 1H), 7.81 (d, <i>J</i> = 8.02 Hz, 1H), 7.23 (t, <i>J</i> = 8.02 Hz, 1H), 4.62 (m, 1H), 4.33 (m, 2H), 4.00 (m, 1H), 3.47 (m, 2H), 3.39 (m, 2H), 3.19 (m, 2H), 2.47 (m, 1H), 2.40 (m, 2H), 2.31 (t, <i>J</i> = 6.87 Hz, 2H), 2.16 (m, 1H), 1.88 (m, 2H), 1.64–1.73 (m, 5H), 1.60 (m, 2H), and 1.38 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 850 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>31</sub>H<sub>41</sub>N<sub>5</sub>O<sub>13</sub>SI, 850.1461 [M + H]<sup>+</sup>; found, 850.1466.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-6-(2,5-Dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)-2-(3-iodobenzamido)hexanoic Acid (<b>17</b>)</h3><div class="NLM_p last">To a solution of <b>12</b> (80 mg, 0.23 mmol) in acetonitrile (1.8 mL) was added <b>6a</b> (61 mg, 0.23 mmol) and DIPEA (80 μL). The mixture was stirred at room temperature for 5 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product <b>17</b> was purified by PTLC (chloroform/methanol = 9/1, 25 mg, 26% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz): δ 8.17 (s, 1H), 7.82 (t, <i>J</i> = 8.02 Hz, 1H), 7.79 (d, <i>J</i> = 8.02 Hz, 1H), 7.16 (t, <i>J</i> = 7.73 Hz, 1H), 6.96 (broad s, 1H), 6.69 (s, 2H), 4.64 (s, 1H), 3.53 (t, <i>J</i> = 6.87 Hz, 2H), 1.87–2.03 (m, 2H), 1.64 (m, 2H), and 1.33–1.42 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 457 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (2<i>S</i>)-2-(3-((1<i>R</i>)-1-Carboxy-2-((1-((<i>S</i>)-5-carboxy-5-(3-iodobenzamido)pentyl-2,5-dioxopyrrolidin-3-yl)thio)ethyl)ureido)pentanedioic Acid (<b>18</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (10 mg, 0.034 mmol) in H<sub>2</sub>O (0.7 mL) was added <b>17</b> (15.5 mg, 0.034 mmol) in acetonitrile (0.2 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 2 h. <b>18</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 53 min, 11 mg, 43% yield). <sup>1</sup>H NMR (D<sub>2</sub>O, 500 MHz): δ 8.06 (s, 1H), 7.90 (d, <i>J</i> = 8.02 Hz, 1H), 7.69 (d, <i>J</i> = 8.02 Hz, 1H), 7.21 (t, <i>J</i> = 8.02 Hz, 1H), 4.46 (m, 1H), 4.37 (m, 1H), 4.18 (m, 1H), 3.88 (m, 1H), 3.45 (t, <i>J</i> = 6.30 Hz, 2H), 2.76–3.18 (m, 3H), 2.40 (m, 2H), 2.07 (m, 1H), 1.73–1.96 (m, 3H), 1.56 (m, 2H), and 1.29 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 751 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>26</sub>H<sub>32</sub>N<sub>4</sub>O<sub>12</sub>SI, 751.0786 [M + H]<sup>+</sup>; found, 751.0782.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>2S</i>)-2-[3-[(1<i>R</i>)-1-Carboxy-2-[(1-methyl-2,5-dioxopyrrolidine-3-yl)thio]ethyl]ureido]pentanedioic acid (<b>19</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (10.6 mg, 0.036 mmol) in H<sub>2</sub>O (0.5 mL) was added <i>N</i>-methylmaleimide (4.0 mg, 0.036 mmol) in acetonitrile (0.2 mL). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 2 h. Product <b>19</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 21 min, 6.5 mg, 45% yield). <sup>1</sup>H NMR (D<sub>2</sub>O, 500 MHz): δ 4.44 (m, 1H), 4.17 (m, 1H), 3.96 (m 1H), 3.18 (m, 1H), 3.12 (m, 2H), 2.85 (s, 3H), 2.59 (m, 1H), 2.41 (t, <i>J</i> = 7.45 Hz, 2H), 2.08 (m, 1H), and 1.87 (m, 1H). FAB-MS <i>m</i>/<i>z</i>: 406 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>14</sub>H<sub>20</sub>N<sub>3</sub>O<sub>9</sub>S, 406.0924 [M + H]<sup>+</sup>; found, 406.0920.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>S</i>)-2-((1-Carboxy-5-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)pentyl)amino-<i>N</i>-methyl-2-oxoethanaminium Chloride (<b>21</b>)</h3><div class="NLM_p last">To a solution of <b>20</b> (290 mg, 1.01 mmol) in acetonitrile (4 mL) was added <b>6a</b> (277 mg, 1.05 mmol) and DIPEA (0.23 mL). The mixture was stirred at room temperature for 2 h. After extraction with ethyl acetate and washing with saturated aqueous ammonium chloride, the organic layer was dried over sodium sulfate. The solvent was removed under reduced pressure, and the product was partially purified by PTLC (chloroform/methanol = 9/1). ESI-MS <i>m</i>/<i>z</i>: 420 [M + Na]<sup>+</sup>. Next, the <i>tert</i>-butoxycarbonyl group was removed by treatment with 4 N HCl/ethyl acetate. The precipitate was washed with ethyl acetate and purified by HPLC using condition 1 to yield <b>21</b> (<i>t</i><sub>R</sub>: 22 min, 15 mg, 4% yield; 2 steps). <sup>1</sup>H NMR (D<sub>2</sub>O, 500 MHz): δ 6.80 (s, 2H), 4.43 (m, 1H), 3.83 (broad s, 2H), 3.50 (t, <i>J</i> = 6.87 Hz, 2H), 2.73 (s, 3H), 1.92 (m, 1H), 1.73 (m, 1H), 1.61 (m, 2H), and 1.38 (m, 2H). ESI-MS <i>m</i>/<i>z</i>: 298 [M + H]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (2<i>S</i>)-2-(3-((1<i>R</i>)-1-Carboxy-2-((1-((<i>S</i>)-5-carboxy-5-(2-(methylamino)acetamido)pentyl-2,5-dioxopyrrolidin-3-yl)thio)ethyl)ureido)pentanedioic Acid (<b>22</b>)</h3><div class="NLM_p last">To a solution of <b>2</b> (6.8 mg, 0.023 mmol) in H<sub>2</sub>O (0.3 mL) was added <b>21</b> (6.9 mg, 0.021 mmol). The mixture was neutralized with 2 N NaOH and stirred at room temperature for 2 h. The product <b>22</b> was purified by HPLC using condition 1 (<i>t</i><sub>R</sub>: 20 min, 7 mg, 52% yield). <sup>1</sup>H NMR (D<sub>2</sub>O, 500 MHz): δ 4.43 (m, 1H), 4.28 (dd, <i>J</i> = 5.16 Hz, 8.59 Hz, 2H), 4.17 (m, 1H), 3.95 (m, 1H), 3.82 (s, 2H), 3.40 (t, <i>J</i> = 6.87 Hz, 2H), 2.95–3.26 (m, 4H), 2.66 (s, 3H), 2.59 (m, 1H), 2.40 (t, <i>J</i> = 7.14 Hz, 2H), 2.08 (m, 1H), 1.83 (m, 2H), 1.65 (m, 1H), 1.48 (m, 2H), and 1.23 (m, 2H). FAB-MS <i>m</i>/<i>z</i>: 592 [M + H]<sup>+</sup>. HRFAB<sup>+</sup>-MS: calcd for C<sub>22</sub>H<sub>34</sub>N<sub>5</sub>O<sub>12</sub>S, 592.1929 [M + H]<sup>+</sup>; found, 592.1925.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Cell Lines and Mouse Models</h3><div class="NLM_p">Two human prostate carcinoma cell lines were purchased from DS Pharma Biomedical (Osaka, Japan): LNCaP (PSMA positive) and PC-3 (PSMA negative).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> The cells were cultured as previously reported in Roswell Park Memorial Institute 1640 (RPMI 1640) medium supplemented with 10% fetal bovine serum, glutamine, and antibiotics (penicillin/streptomycin) in a humidified CO<sub>2</sub> incubator (37 °C/5% CO<sub>2</sub>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">C.B.-17/Icr <i>+</i>/<i>+</i> Jcl mice and C.B.-17/Icr <i>scid</i>/<i>scid</i> Jcl mice were purchased from CLEA Japan (Tokyo, Japan). Animal studies were conducted in accordance with the guidelines of our institution: “Regulation on Animal Experimentation at Kyoto University”. Cultured cells were treated with 2.5 g/L trypsin/1 mM ethylenediaminetetraacetic acid and were resuspended in phosphate buffered saline. Each mouse was injected with 100 μL of a 1:1 mixture of cell suspension and BD Matrigel basement membrane matrix (1–5 × 10<sup>6</sup> cells/mouse) in the right (PC-3) or left (LNCaP) shoulder. Tumor-bearing mice were used for studies when tumors reached a diameter of approximately 5–10 mm.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> In Vitro Cell-Binding Assay (Saturation Assay)</h3><div class="NLM_p last">The affinity of [<sup>125</sup>I]<b>3</b> for PSMA was determined by an in vitro saturation assay according to previous reports with slight modifications.<a onclick="showRef(event, 'ref28 ref32'); return false;" href="javascript:void(0);" class="ref ref28 ref32">(28, 32)</a> LNCaP cells in 12-well plates (4 × 10<sup>5</sup> cells/well) were incubated for 48 h (37 °C/5% CO<sub>2</sub>). The medium was removed, and each well was washed twice with 500 μL of assay medium (RPMI 1640 supplemented with 0.5% bovine serum albumin). The <sup>125</sup>I-labeled compound (specific activity: 81.4 kBq/nmol) was added to each well, and the plates were incubated at 37 °C for 1 h. Nonspecific binding was evaluated by adding 100 μM of nonradioactive iodinated test compound. After incubation, each well was washed twice with 500 μL of fresh assay medium and the cells were lysed with 0.2 N NaOH. Radioactivity bound to cells was measured with a γ-counter. <i>K</i><sub>d</sub> values were calculated using Scatchard plots.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> In Vitro Cell-Binding Assay (Inhibition Assay)</h3><div class="NLM_p last">The affinities of the novel compounds <b>11a</b>–<b>11b</b>, <b>16a</b>–<b>16c</b>, <b>18</b>, <b>19</b>, <b>22</b>, and <b>3</b> were determined by an in vitro binding inhibition assay, as previously reported with slight modification.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> [<sup>125</sup>I]<b>23</b> was used as the radioligand for the inhibition assay. LNCaP cells in 12-well plates (4 × 10<sup>5</sup> cells/well) were incubated for 48 h (37 °C/5% CO<sub>2</sub>). The medium was removed, and then each well was washed twice with 500 μL of assay medium (RPMI 1640 supplemented with 0.5% bovine serum albumin). Then 500 μL of [<sup>125</sup>I]<b>23</b> (29.6 kBq/mL) and the test compound were added to each well, and the plates were incubated at 37 °C for 1 h. Nonspecific binding was evaluated by adding 0.5 mM 2-PMPA (Tocris Bioscience, Missouri, USA). After incubation, each well was washed twice with 500 μL of fresh assay medium, and then the cells were lysed with 0.2 N NaOH. Radioactivity bound to the cells was measured with a γ-counter. IC<sub>50</sub> values were calculated using the GraphPad Prism 5 program (GraphPad Software, Inc., San Diego, CA, USA). <i>K</i><sub>i</sub> values were calculated using the Cheng–Prusoff equation.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> In Vitro Stability</h3><div class="NLM_p last">C.B.-17/Icr <i>+/+</i> Jcl male mice weighing 20–22 g were anesthetized with isoflurane. Blood samples were collected from the hearts and were centrifuged at 1500<i>g</i>. The supernatant was collected and stored at −80 °C until use. Then 20 μL of [<sup>125</sup>I]<b>3</b> was added to 100 μL of mouse serum. The sample was incubated at 37 °C for 1, 3, or 6 h. After incubation, 150 μL of methanol was added to the sample, and it was centrifuged at 5000<i>g</i>. The supernatant was collected and filtered with a Cosmonice Filter (S) (0.45 μm, 4 mm), and the filtrate was analyzed by HPLC.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Biodistribution and Blocking Studies</h3><div class="NLM_p">[<sup>125</sup>I]<b>3</b> (100 μL) was administered by injection to tumor bearing mice weighing 22–24 g via the tail vein (<i>n</i> = 4 for each time point). Mice were sacrificed by decapitation at the following fixed time points: 2 min, 30 min, 1 h, 3 h, and 6 h. The weight and radioactivity of tissues were measured, and the uptake of [<sup>125</sup>I]<b>3</b> was evaluated as a percentage of the injected dose per gram of tissue (%ID/g).</div><div class="NLM_p last">To confirm in vivo PSMA-specific binding, a blocking study was conducted. Briefly, 100 μL of [<sup>125</sup>I]<b>3</b> was coinjected with 2-PMPA (50 mg/kg weight), a GCP-II inhibitor, to tumor-bearing mice weighing 22–24 g via the tail vein. The mice were decapitated 30 min after injection. The weight and radioactivity of each tissue were measured, and the uptake of [<sup>125</sup>I]<b>3</b> was evaluated as %ID/g.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Small-Animal SPECT/CT</h3><div class="NLM_p">SPECT/CT studies were performed using the FX3300 imager (SII NanoTechnology Inc., Northridge, CA, USA). LNCaP and PC-3 tumor-bearing mice (20–25 g) were anesthetized (2.5% isoflurane in an air mixture) and placed on a heating pad to maintain body temperature. The mice were then injected with [<sup>123</sup>I]<b>3</b> (25.9 MBq, in 0.10 mL isotonic saline) via the tail vein. A competition experiment was performed by coinjection of the radiotracer with 50 mg/kg of 2-PMPA in a total volume of 0.10 mL of isotonic saline.</div><div class="NLM_p last">SPECT scans were acquired over 30–64 min, after which CT scans were performed for anatomic reference (spatial resolution, 50 μm; 60 kV, and 310 μA). In the SPECT studies, all projection data were acquired using a 20% energy window centered at 159 keV for <sup>123</sup>I, a 35 mm radius of rotation, a 360° circular orbit, a 60 s projection time, and 32 projection angles. Single-pinhole collimators (1.0 mm diameter, 9.0 mm focal length) were used. SPECT images were reconstructed using three-dimensional ordered-subset expectation maximization, and CT images were reconstructed using a modified three-dimensional cone-beam Feldkamp algorithm resulting in a 0.177 × 0.177 × 0.177 mm<sup>3</sup> voxel size for a 512 × 512 × 512 image volume. Acquired SPECT and CT data sets were processed with AMIRA software (version 5.1) (FEI Company, Hillsboro, Oregon, USA).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Statistics</h3><div class="NLM_p last">GraphPad Prism 5 software was used for statistical analyses. The Tukey–Kramer test was used to assess statistical differences. A <i>P</i> value <0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/jm400895s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Docking simulation study, additional data of radiosynthesis and biodistribution, reverse phase HPLC retention time, and distribution coefficient.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400895s/suppl_file/jm400895s_si_001.pdf">jm400895s_si_001.pdf (493.25 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400895s" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83421" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83421" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hideo Saji</span> - <span class="hlFld-Affiliation affiliation">Department of Patho-Functional
Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#076f74666d6e47776f66756a296c7e6873682a72296664296d77"><span class="__cf_email__" data-cfemail="1f776c7e75765f6f777e6d72317466706b70326a317e7c31756f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Harada</span> - <span class="hlFld-Affiliation affiliation">Department of Patho-Functional
Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hiroyuki Kimura</span> - <span class="hlFld-Affiliation affiliation">Department of Patho-Functional
Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Masahiro Ono</span> - <span class="hlFld-Affiliation affiliation">Department of Patho-Functional
Bioanalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d468e4205-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was partly supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science and New Energy and Industrial Technology Development Organization (NEDO).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> Abbreviations Used</h2><tr><td class="NLM_term">PSMA</td><td class="NLM_def"><p class="first last">prostate-specific membrane antigen</p></td></tr><tr><td class="NLM_term">2-PMPA</td><td class="NLM_def"><p class="first last">2-(phosphonomethyl)pentanedioic acid</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">prostate specific antigen</p></td></tr><tr><td class="NLM_term">BPH</td><td class="NLM_def"><p class="first last">benign prostatic hyperplasia</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single photon emission computed tomography</p></td></tr><tr><td class="NLM_term">[<sup>18</sup>F]FDG</td><td class="NLM_def"><p class="first last">2-deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose</p></td></tr><tr><td class="NLM_term">GCP-II</td><td class="NLM_def"><p class="first last">glutamate carboxypeptidase-II</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">FAB</td><td class="NLM_def"><p class="first last">fast atom bombardment</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">log <i>D</i></td><td class="NLM_def"><p class="first last">distribution coefficient</p></td></tr><tr><td class="NLM_term">PTLC</td><td class="NLM_def"><p class="first last">preparative thin layer chromatography</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectrometry</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">H-Gly-OPMB</td><td class="NLM_def"><p class="first last">4-methoxybenzyl 2-aminoacetate hydrochloride</p></td></tr><tr><td class="NLM_term">WSCI·HCl</td><td class="NLM_def"><p class="first last">water-soluble carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">NHS</td><td class="NLM_def"><p class="first last"><i>N</i>-hydroxysuccinimide</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50342" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50342" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naishadham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer Statistics, 2012</span> <span class="citation_source-journal">CA: Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=10-29&author=R.+Siegelauthor=D.+Naishadhamauthor=A.+Jemal&title=Cancer+Statistics%2C+2012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DNaishadham%26aufirst%3DD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520Statistics%252C%25202012%26jtitle%3DCA%253A%2520Cancer%2520J.%2520Clin.%26date%3D2012%26volume%3D62%26spage%3D10%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cook, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, A.</span><span> </span><span class="NLM_article-title">Prostate Cancer Screening</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1007%2Fs11912-010-0136-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=57-62&author=E.+Cookauthor=A.+Nelson&title=Prostate+Cancer+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate Cancer Screening</span></div><div class="casAuthors">Cook, Elise D.; Nelson, Ana C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-62</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1534-6269</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Prostate cancer is the most common cancer and the second leading cause of cancer-related deaths in American men.  Although the use of the prostate-specific antigen (PSA) test for prostate cancer screening since the 1990s has led to increased early diagnoses, the most recent studies are in conflict about the risks and benefits of routine prostate cancer screening.  Recently, evidence has emerged to support the use of the PSA test to lower mortality, but there is still concern that over-diagnosis may lead to over-treatment of cancers that would not significantly affect patients' health for several years.  This article describes the results of important recent prostate cancer screening trials, the National Comprehensive Cancer Network and American Cancer Society screening guidelines, and discusses the implications for clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYhqWk_--1M7Vg90H21EOLACvtfcHk0li_m7lWWV5wYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFClsA%253D%253D&md5=2d9df49378329ae27f55200a36940b9a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11912-010-0136-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-010-0136-x%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DE.%26aulast%3DNelson%26aufirst%3DA.%26atitle%3DProstate%2520Cancer%2520Screening%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2011%26volume%3D13%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hugosson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergdahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">Mortality results from the Goteborg randomised population-based prostate-cancer screening trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1016%2FS1470-2045%2810%2970146-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BC3cjltVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=725-732&author=J.+Hugossonauthor=S.+Carlssonauthor=G.+Ausauthor=S.+Bergdahlauthor=A.+Khatamiauthor=P.+Loddingauthor=C.+Pihlauthor=J.+Stranneauthor=E.+Holmbergauthor=H.+Lilja&title=Mortality+results+from+the+Goteborg+randomised+population-based+prostate-cancer+screening+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality results from the Goteborg randomised population-based prostate-cancer screening trial</span></div><div class="casAuthors">Hugosson Jonas; Carlsson Sigrid; Aus Gunnar; Bergdahl Svante; Khatami Ali; Lodding Par; Pihl Carl-Gustaf; Stranne Johan; Holmberg Erik; Lilja Hans</div><div class="citationInfo"><span class="NLM_cas:title">The lancet oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">725-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world.  One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate.  METHODS:  In December, 1994, 20,000 men born between 1930 and 1944, randomly sampled from the population register, were randomised by computer in a 1:1 ratio to either a screening group invited for PSA testing every 2 years (n=10,000) or to a control group not invited (n=10,000).  Men in the screening group were invited up to the upper age limit (median 69, range 67-71 years) and only men with raised PSA concentrations were offered additional tests such as digital rectal examination and prostate biopsies.  The primary endpoint was prostate-cancer specific mortality, analysed according to the intention-to-screen principle.  The study is ongoing, with men who have not reached the upper age limit invited for PSA testing.  This is the first planned report on cumulative prostate-cancer incidence and mortality calculated up to Dec 31, 2008.  This study is registered as an International Standard Randomised Controlled Trial ISRCTN54449243.  FINDINGS:  In each group, 48 men were excluded from the analysis because of death or emigration before the randomisation date, or prevalent prostate cancer.  In men randomised to screening, 7578 (76%) of 9952 attended at least once.  During a median follow-up of 14 years, 1138 men in the screening group and 718 in the control group were diagnosed with prostate cancer, resulting in a cumulative prostate-cancer incidence of 12.7% in the screening group and 8.2% in the control group (hazard ratio 1.64; 95% CI 1.50-1.80; p<0.0001).  The absolute cumulative risk reduction of death from prostate cancer at 14 years was 0.40% (95% CI 0.17-0.64), from 0.90% in the control group to 0.50% in the screening group.  The rate ratio for death from prostate cancer was 0.56 (95% CI 0.39-0.82; p=0.002) in the screening compared with the control group.  The rate ratio of death from prostate cancer for attendees compared with the control group was 0.44 (95% CI 0.28-0.68; p=0.0002).  Overall, 293 (95% CI 177-799) men needed to be invited for screening and 12 to be diagnosed to prevent one prostate cancer death.  INTERPRETATION:  This study shows that prostate cancer mortality was reduced almost by half over 14 years.  However, the risk of over-diagnosis is substantial and the number needed to treat is at least as high as in breast-cancer screening programmes.  The benefit of prostate-cancer screening compares favourably to other cancer screening programs.  FUNDING:  The Swedish Cancer Society, the Swedish Research Council, and the National Cancer Institute.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyN9gpZPQ1Ehjv2lLSLOxFfW6udTcc2ebA2OUGBcSeV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjltVCrtg%253D%253D&md5=1c8d1ea5d05059690871bc6b08499330</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2810%2970146-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252810%252970146-7%26sid%3Dliteratum%253Aachs%26aulast%3DHugosson%26aufirst%3DJ.%26aulast%3DCarlsson%26aufirst%3DS.%26aulast%3DAus%26aufirst%3DG.%26aulast%3DBergdahl%26aufirst%3DS.%26aulast%3DKhatami%26aufirst%3DA.%26aulast%3DLodding%26aufirst%3DP.%26aulast%3DPihl%26aufirst%3DC.%26aulast%3DStranne%26aufirst%3DJ.%26aulast%3DHolmberg%26aufirst%3DE.%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DMortality%2520results%2520from%2520the%2520Goteborg%2520randomised%2520population-based%2520prostate-cancer%2520screening%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D725%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Stamey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcneal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freiha, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redwine, E.</span><span> </span><span class="NLM_article-title">Prostate-Specific Antigen as a Serum Marker For Adenocarcinoma Of The Prostate</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1056%2FNEJM198710083171501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=2442609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADyaL2szhsFakug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1987&pages=909-916&author=T.+Stameyauthor=N.+Yangauthor=A.+Hayauthor=J.+Mcnealauthor=F.+Freihaauthor=E.+Redwine&title=Prostate-Specific+Antigen+as+a+Serum+Marker+For+Adenocarcinoma+Of+The+Prostate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate</span></div><div class="casAuthors">Stamey T A; Yang N; Hay A R; McNeal J E; Freiha F S; Redwine E</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">909-16</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">To compare the clinical usefulness of the serum markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP), we measured them by radioimmunoassay in 2200 serum samples from 699 patients, 378 of whom had prostatic cancer.  PSA was elevated in 122 of 127 patients with newly diagnosed, untreated prostatic cancer, including 7 of 12 patients with unsuspected early disease and all of 115 with more advanced disease.  The PSA level increased with advancing clinical stage and was proportional to the estimated volume of the tumor.  The PAP concentration was elevated in only 57 of the patients with cancer and correlated less closely with tumor volume.  PSA was increased in 86 percent and PAP in 14 percent of the patients with benign prostatic hyperplasia.  After radical prostatectomy for cancer, PSA routinely fell to undetectable levels, with a half-life of 2.2 days.  If initially elevated, PAP fell to normal levels within 24 hours but always remained detectable.  In six patients followed postoperatively by means of repeated measurements, PSA--but not PAP--appeared to be useful in detecting residual and early recurrence of tumor and in monitoring responses to radiation therapy.  Prostate massage increased the levels of both PSA and PAP approximately 1.5 to 2 times.  Needle biopsy and transurethral resection increased both considerably.  We conclude that PSA is more sensitive than PAP in the detection of prostatic cancer and will probably be more useful in monitoring responses and recurrence after therapy.  However, since both PSA and PAP may be elevated in benign prostatic hyperplasia, neither marker is specific.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3KA7iei6rnMvLc4ARHEmzfW6udTcc2eaOQTxRInf-vLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szhsFakug%253D%253D&md5=7961023350b1cf31483d61ca8d80041b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJM198710083171501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198710083171501%26sid%3Dliteratum%253Aachs%26aulast%3DStamey%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DHay%26aufirst%3DA.%26aulast%3DMcneal%26aufirst%3DJ.%26aulast%3DFreiha%26aufirst%3DF.%26aulast%3DRedwine%26aufirst%3DE.%26atitle%3DProstate-Specific%2520Antigen%2520as%2520a%2520Serum%2520Marker%2520For%2520Adenocarcinoma%2520Of%2520The%2520Prostate%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D1987%26volume%3D317%26spage%3D909%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Effert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bares, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakse, G.</span><span> </span><span class="NLM_article-title">Metabolic imaging of untreated prostate cancer by positron emission tomography with (18)fluorine-labeled deoxyglucose</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1016%2FS0022-5347%2801%2966366-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADyaK287msVKnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1996&pages=994-998&author=P.+Effertauthor=R.+Baresauthor=S.+Handtauthor=J.+Wolffauthor=U.+Bullauthor=G.+Jakse&title=Metabolic+imaging+of+untreated+prostate+cancer+by+positron+emission+tomography+with+%2818%29fluorine-labeled+deoxyglucose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose</span></div><div class="casAuthors">Effert P J; Bares R; Handt S; Wolff J M; Bull U; Jakse G</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">994-8</span>
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    </div><div class="casAbstract">PURPOSE:  We evaluated positron emission tomograph (PET) with 18fluorine (18F)-labeled deoxyglucose for metabolic grading of untreated primary prostate cancer, and differentiation of benign and malignant prostatic disease.  MATERIALS AND METHODS:  A total of 48 patients with untreated prostate cancer of different stages and 16 with histologically confirmed benign prostatic hyperplasia (BPH) underwent static PET after intravenous injection of 150 to 300 MBq. 18F-deoxyglucose. 18F-deoxyglucose accumulation was quantitated by calculating differential uptake ratios and prostate-to-skeletal muscle ratios.  RESULTS:  Low 18F-deoxyglucose uptake was noted in the majority of primary tumors (81%). 18F-deoxyglucose accumulation did not correlate with increasing tumor grade or stage.  There was a significant overlap in uptake values in BPH and malignant prostatic disease.  A trend towards statistical significance was noted with lower prostate-to-skeletal muscle ratios in patients with BPH (p < 0.07).  Increased 18F-deoxyglucose accumulation was detected in some patients with BPH and malignant prostatic disease, as well as in those with lymph node and bone metastases of prostate cancer.  CONCLUSIONS:  18F-deoxyglucose PET does not allow for metabolic labeling in the majority of untreated primary prostate cancers.  BPH and primary prostate cancer cannot be reliably differentiated on the basis of PET.  Increased 18F-deoxyglucose accumulation occurs in some primary prostate tumors and in metastatic deposits of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRP14DyxVo2fwqdek-gHSrIfW6udTcc2eaOQTxRInf-vLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287msVKnug%253D%253D&md5=189d6fab95ccff0ed579278ff4f63e2e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2801%2966366-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252801%252966366-3%26sid%3Dliteratum%253Aachs%26aulast%3DEffert%26aufirst%3DP.%26aulast%3DBares%26aufirst%3DR.%26aulast%3DHandt%26aufirst%3DS.%26aulast%3DWolff%26aufirst%3DJ.%26aulast%3DBull%26aufirst%3DU.%26aulast%3DJakse%26aufirst%3DG.%26atitle%3DMetabolic%2520imaging%2520of%2520untreated%2520prostate%2520cancer%2520by%2520positron%2520emission%2520tomography%2520with%2520%252818%2529fluorine-labeled%2520deoxyglucose%26jtitle%3DJ.%2520Urol.%26date%3D1996%26volume%3D155%26spage%3D994%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Hain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisey, M.</span><span> </span><span class="NLM_article-title">Positron emission tomography for urological tumours</span> <span class="citation_source-journal">BJU Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1046%2Fj.1464-410X.2003.04284.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BD3s3psF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=159-164&author=S.+Hainauthor=M.+Maisey&title=Positron+emission+tomography+for+urological+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography for urological tumours</span></div><div class="casAuthors">Hain S F; Maisey M N</div><div class="citationInfo"><span class="NLM_cas:title">BJU international</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-64</span>
        ISSN:<span class="NLM_cas:issn">1464-4096</span>.
    </div><div class="casAbstract">For urological tumours, positron emission tomography (PET) is currently most useful in testicular cancer.  In patients with residual masses or raised marker levels after treatment, PET is both sensitive and specific for detecting recurrent disease, at suspected and unsuspected sites.  Although fewer studies are available it also appears to be useful for staging at diagnosis, although this requires further investigation.  Prostate cancer imaging has been more variable, with studies showing that PET cannot reliably differentiate between tumour and hypertrophy.  It is not as good as a bone scan for defining bone metastases.  In renal cancer, PET can be used to define the primary tumour, providing better staging of local recurrence than computed tomography (CT), and to define metastatic disease.  There are few studies in bladder cancer, and despite excretion of the tracer via the bladder in early studies, it has better results than CT or magnetic resonance imaging for local staging; again it can detect metastases.  Overall, the place of PET in urological tumours is developing, with the strongest areas undoubtedly being testicular and renal cancer.  Tracers other than fluorodeoxyglucose are being examined and are providing further information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7-To4evheSQyMywPm6HgQfW6udTcc2eaOQTxRInf-vLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3psF2muw%253D%253D&md5=e745ee72821104943fcdcb83b748c01b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1046%2Fj.1464-410X.2003.04284.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1464-410X.2003.04284.x%26sid%3Dliteratum%253Aachs%26aulast%3DHain%26aufirst%3DS.%26aulast%3DMaisey%26aufirst%3DM.%26atitle%3DPositron%2520emission%2520tomography%2520for%2520urological%2520tumours%26jtitle%3DBJU%2520Int.%26date%3D2003%26volume%3D92%26spage%3D159%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Bouchelouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkbey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choyke, P.</span><span> </span><span class="NLM_article-title">PET/CT Imaging and Radioimmunotherapy of Prostate Cancer</span> <span class="citation_source-journal">Semin. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1053%2Fj.semnuclmed.2010.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FgtFShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=29-44&author=K.+Boucheloucheauthor=S.+Tagawaauthor=S.+Goldsmithauthor=B.+Turkbeyauthor=J.+Capalaauthor=P.+Choyke&title=PET%2FCT+Imaging+and+Radioimmunotherapy+of+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PET/CT Imaging and Radioimmunotherapy of Prostate Cancer</span></div><div class="casAuthors">Bouchelouche Kirsten; Tagawa Scott T; Goldsmith Stanley J; Turkbey Baris; Capala Jacek; Choyke Peter</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Prostate cancer is a common cancer in men and continues to be a major health problem.  Imaging plays an important role in the clinical management of patients with prostate cancer.  An important goal for prostate cancer imaging is more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information.  Positron emission tomography (PET)/computed tomography (CT) in oncology is emerging as an important imaging tool.  The most common radiotracer for PET/CT in oncology, (18)F-fluorodeoxyglucose (FDG), is not very useful in the imaging of prostate cancer.  However, in recent years other PET tracers have improved the accuracy of PET/CT imaging of prostate cancer.  Among these, choline labeled with (18)F or (11)C, (11)C-acetate, and (18)F-fluoride has demonstrated promising results, and other new radiopharmaceuticals are under development and evaluation in preclinical and clinical studies.  Large prospective clinical PET/CT trials are needed to establish the role of PET/CT in prostate cancer patients.  Because there are only limited available therapeutic options for patients with advanced metastatic prostate cancer, there is an urgent need for the development of more effective treatment modalities that could improve outcome.  Prostate cancer represents an attractive target for radioimmunotherapy (RIT) for several reasons, including pattern of metastatic spread (lymph nodes and bone marrow, sites with good access to circulating antibodies) and small volume disease (ideal for antigen access and antibody delivery).  Furthermore, prostate cancer is also radiation sensitive.  Prostate-specific membrane antigen is expressed by virtually all prostate cancers, and represents an attractive target for RIT.  Antiprostate-specific membrane antigen RIT demonstrates antitumor activity and is well tolerated.  Clinical trials are underway to further improve upon treatment efficacy and patient selection.  This review focuses on the recent advances of clinical PET/CT imaging and RIT of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-K1Rm_sF4_rYtC3U5jeOifW6udTcc2ebDEKMPlb7lPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FgtFShtA%253D%253D&md5=0b61a1bca4849aa7ed3d48bcebfc9ca2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2010.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2010.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DBouchelouche%26aufirst%3DK.%26aulast%3DTagawa%26aufirst%3DS.%26aulast%3DGoldsmith%26aufirst%3DS.%26aulast%3DTurkbey%26aufirst%3DB.%26aulast%3DCapala%26aufirst%3DJ.%26aulast%3DChoyke%26aufirst%3DP.%26atitle%3DPET%252FCT%2520Imaging%2520and%2520Radioimmunotherapy%2520of%2520Prostate%2520Cancer%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D41%26spage%3D29%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terris, M.</span><span> </span><span class="NLM_article-title">Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=108-111&author=I.+Liuauthor=M.+Zafarauthor=Y.+Laiauthor=G.+Segallauthor=M.+Terris&title=Fluorodeoxyglucose+positron+emission+tomography+studies+in+diagnosis+and+staging+of+clinically+organ-confined+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DI.%26aulast%3DZafar%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DSegall%26aufirst%3DG.%26aulast%3DTerris%26aufirst%3DM.%26atitle%3DFluorodeoxyglucose%2520positron%2520emission%2520tomography%2520studies%2520in%2520diagnosis%2520and%2520staging%2520of%2520clinically%2520organ-confined%2520prostate%2520cancer%26jtitle%3DUrology%26date%3D2001%26volume%3D57%26spage%3D108%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">856</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.2174%2F092986712799034888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=22214450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=856-870&author=C.+Barinkaauthor=C.+Rojasauthor=B.+Slusherauthor=M.+Pomper&title=Glutamate+Carboxypeptidase+II+in+Diagnosis+and+Treatment+of+Neurologic+Disorders+and+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer</span></div><div class="casAuthors">Barinka, C.; Rojas, C.; Slusher, B.; Pomper, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">856-870</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate carboxypeptidase II (GCPII) is a membrane-bound binuclear zinc metallopeptidase with the highest expression levels found in the nervous and prostatic tissue.  Throughout the nervous system, glia-bound GCPII is intimately involved in the neuronneuron and neuron-glia signaling via the hydrolysis of N-acetylaspartylglutamate (NAAG), the most abundant mammalian peptidic neurotransmitter.  The inhibition of the GCPII-controlled NAAG catabolism has been shown to attenuate neurotoxicity assocd. with enhanced glutamate transmission and GCPII-specific inhibitors demonstrate efficacy in multiple preclin. models including traumatic brain injury, stroke, neuropathic and inflammatory pain, amyotrophic lateral sclerosis, and schizophrenia.  The second major area of pharmacol. interventions targeting GCPII focuses on prostate carcinoma; GCPII expression levels are highly increased in androgen-independent and metastatic disease.  Consequently, the enzyme serves as a potential target for imaging and therapy.  This review offers a summary of GCPII structure, physiol. functions in healthy tissues, and its assocn. with various pathologies.  The review also outlines the development of GCPII-specific small-mol. compds. and their use in preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyUBiL7cpnjrVg90H21EOLACvtfcHk0lgO1J0gNTb0Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D&md5=1d4a526d7ecd78b11f6b405112d6220a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F092986712799034888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799034888%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGlutamate%2520Carboxypeptidase%2520II%2520in%2520Diagnosis%2520and%2520Treatment%2520of%2520Neurologic%2520Disorders%2520and%2520Prostate%2520Cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D856%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Silver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CordonCardo, C.</span><span> </span><span class="NLM_article-title">Prostate-specific membrane antigen expression in normal and malignant human tissues</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=9815541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=81-85&author=D.+Silverauthor=I.+Pellicerauthor=W.+Fairauthor=W.+Hestonauthor=C.+CordonCardo&title=Prostate-specific+membrane+antigen+expression+in+normal+and+malignant+human+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen expression in normal and malignant human tissues</span></div><div class="casAuthors">Silver D A; Pellicer I; Fair W R; Heston W D; Cordon-Cardo C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-5</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">Prostate-specific membrane antigen is a type II membrane protein with folate hydrolase activity produced by prostatic epithelium.  The expression of this molecule has also been documented in extraprostatic tissues, including small bowel and brain.  In the present study, an extensive immunohistochemical analysis was performed on a panel of well-characterized normal and malignant human tissues to further define the pattern of prostate-specific membrane antigen (PSMA) expression.  Detectable PSMA levels were identified in prostatic epithelium, duodenal mucosa, and a subset of proximal renal tubules.  A subpopulation of neuroendocrine cells in the colonic crypts also exhibited PSMA immunoreactivity.  All other normal tissues, including cerebral cortex and cerebellum, had undetectable levels of PSMA.  Thirty-three of 35 primary prostate adenocarcinomas and 7 of 8 lymph node metastases displayed tumor cell PSMA immunostaining.  Eight of 18 prostate tumors metastatic to bone expressed PSMA.  All of the other nonprostatic primary tumors studied had undetectable PSMA levels.  However, intense staining was observed in endothelial cells of capillary vessels in peritumoral and endotumoral areas of certain malignancies, including 8 of 17 renal cell carcinomas, 7 of 13 transitional cell carcinomas, and 3 of 19 colon carcinomas.  Extraprostatic PSMA expression appears to be highly restricted.  Nevertheless, its diverse anatomical distribution implies a broader functional significance than previously suspected.  The decrease in PSMA immunoreactivity noted in advanced prostate cancer suggests that expression of this molecule may be linked to the degree of tumor differentiation.  The neoexpression of PSMA in endothelial cells of capillary beds in certain tumors may be related to tumor angiogenesis and suggests a potential mechanism for specific targeting of tumor neovasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa3hRIf6mlYUcLvDNbOD4DfW6udTcc2ebDEKMPlb7lPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D&md5=06fb3a1b21fc371a5e42843ed558e5eb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DD.%26aulast%3DPellicer%26aufirst%3DI.%26aulast%3DFair%26aufirst%3DW.%26aulast%3DHeston%26aufirst%3DW.%26aulast%3DCordonCardo%26aufirst%3DC.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520expression%2520in%2520normal%2520and%2520malignant%2520human%2520tissues%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span> </span><span class="NLM_article-title">Alternatively Spliced Variants of Prostate-Specific Membrane Antigen RNA—Ratio of Expression As a Potential Measurement of Progression</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=1441-1443&author=S.+Suauthor=I.+Huangauthor=W.+Fairauthor=C.+Powellauthor=W.+Heston&title=Alternatively+Spliced+Variants+of+Prostate-Specific+Membrane+Antigen+RNA%E2%80%94Ratio+of+Expression+As+a+Potential+Measurement+of+Progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DI.%26aulast%3DFair%26aufirst%3DW.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DHeston%26aufirst%3DW.%26atitle%3DAlternatively%2520Spliced%2520Variants%2520of%2520Prostate-Specific%2520Membrane%2520Antigen%2520RNA%25E2%2580%2594Ratio%2520of%2520Expression%2520As%2520a%2520Potential%2520Measurement%2520of%2520Progression%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D1441%26epage%3D1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Israeli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span> </span><span class="NLM_article-title">Molecular-Cloning of a Complementary-DNA Encoding a Prostate-Specific Membrane Antigen</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=227-230&author=R.+Israeliauthor=C.+Powellauthor=W.+Fairauthor=W.+Heston&title=Molecular-Cloning+of+a+Complementary-DNA+Encoding+a+Prostate-Specific+Membrane+Antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraeli%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DFair%26aufirst%3DW.%26aulast%3DHeston%26aufirst%3DW.%26atitle%3DMolecular-Cloning%2520of%2520a%2520Complementary-DNA%2520Encoding%2520a%2520Prostate-Specific%2520Membrane%2520Antigen%26jtitle%3DCancer%2520Res.%26date%3D1993%26volume%3D53%26spage%3D227%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ponsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherullo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zippe, C.</span><span> </span><span class="NLM_article-title">Evaluation of preoperative ProstaScint (TM) scans in the prediction of nodal disease</span> <span class="citation_source-journal">Prostate Cancer Prostatic Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1038%2Fsj.pcan.4500570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=12497003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BD38jjsVCluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=132-135&author=L.+Ponskyauthor=E.+Cherulloauthor=R.+Starkeyauthor=D.+Nelsonauthor=D.+Neumannauthor=C.+Zippe&title=Evaluation+of+preoperative+ProstaScint+%28TM%29+scans+in+the+prediction+of+nodal+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of preoperative ProstaScint scans in the prediction of nodal disease</span></div><div class="casAuthors">Ponsky L E; Cherullo E E; Starkey R; Nelson D; Neumann Donald; Zippe C D</div><div class="citationInfo"><span class="NLM_cas:title">Prostate cancer and prostatic diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-5</span>
        ISSN:<span class="NLM_cas:issn">1365-7852</span>.
    </div><div class="casAbstract">Diagnostic methods are limited for detecting microscopic soft tissue metastases in patients with prostate cancer.  Previous studies using (111)Indium Capromab Pendetide (ProstaScint scan) analyzed patients with extensive localized tumor (prostate specific antigen (PSA) >20 ng/ml) not optimal for surgical therapy.  We evaluated the role of the ProstaScint trade mark scan in a preoperative population to provide histological documentation and to assess its utility in a surgical population.  A total of 22 preoperative patients, underwent a ProstaScint scan.  The mean preoperative PSA was 16.0 ng/ml (range 3.9-33 ng/ml).  The mean Gleason score at biopsy was 6.9 (range 6-9).  Each patient underwent a radical retropubic prostatectomy and bilateral pelvic lymph node dissection, which included resection of both obturator and common iliac lymph nodes.  Histologic analysis of the resected lymph nodes provided the standard of comparison with the ProstaScint scan.  The results of the scan and pathology for all 22 patients were compared with the bilateral obturator and iliac nodes, creating 88 data points.  Nine areas (10%) were positive on the scan.  One of these (11%) was a true positive while the other eight (89%) were false positives.  Seventy-nine areas (90%) were negative on scan results.  Of these, five areas (6%) were false negatives and 74 areas (94%) were true negatives.  The scan yielded a sensitivity of 17%, specificity of 90%, negative predictive value (NPV) of 94% and a positive predictive value (PPV) of 11%.  The high false positive rate and low PPV of ProstaScint scans overestimates metastatic lymph nodes disease, and is not useful when used preoperatively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTetKsfJfl8G9Hxxy173TfNfW6udTcc2eYYUl_ePGzlsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jjsVCluw%253D%253D&md5=2daadb7c921218e3e5db53f1a0aa3115</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.pcan.4500570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.pcan.4500570%26sid%3Dliteratum%253Aachs%26aulast%3DPonsky%26aufirst%3DL.%26aulast%3DCherullo%26aufirst%3DE.%26aulast%3DStarkey%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DNeumann%26aufirst%3DD.%26aulast%3DZippe%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520preoperative%2520ProstaScint%2520%2528TM%2529%2520scans%2520in%2520the%2520prediction%2520of%2520nodal%2520disease%26jtitle%3DProstate%2520Cancer%2520Prostatic%2520Dis.%26date%3D2002%26volume%3D5%26spage%3D132%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajasekaran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bander, N.</span><span> </span><span class="NLM_article-title">Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3629</span><span class="NLM_x">–</span> <span class="NLM_lpage">3634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=9288760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFensbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=3629-3634&author=H.+Liuauthor=P.+Moyauthor=S.+Kimauthor=Y.+Xiaauthor=A.+Rajasekaranauthor=V.+Navarroauthor=B.+Knudsenauthor=N.+Bander&title=Monoclonal+antibodies+to+the+extracellular+domain+of+prostate-specific+membrane+antigen+also+react+with+tumor+vascular+endothelium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium</span></div><div class="casAuthors">Liu, He; Moy, Peggy; Kim, Sae; Xia, Yan; Rajasekaran, Ayyappan; Navarro, Vincent; Knudsen, Beatrice; Bander, Neil H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3629-3634</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA), initially defined by monoclonal antibody (mAb) 7E11, is a now well-characterized type 2 integral membrane glycoprotein expressed in a highly restricted manner by prostate epithelial cells.  7E11 has been shown to bind an intracellular epitope of PSMA that, in viable cells, is not available for binding.  Herein, the authors report the initial characterization of the first 4 reported IgG mAbs that bind the external domain of PSMA.  Competitive binding studies indicate these antibodies define 2 distinct, noncompeting epitopes on the extracellular domain of PSMA.  In contrast to 7E11, these mAbs bind to viable LNCaP cells in vitro.  In addn., they show strong immunohistochem. reactivity to tissue sections of prostate epithelia, including prostate cancer.  These mAbs were also strongly reactive with vascular endothelium within a wide variety of carcinomas (including lung, colon, breast, and others) but not with normal vascular endothelium.  These antibodies should prove useful for in vivo targeting to prostate cancer, as well as to the vascular compartment of a wide variety of carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnfwsJ-92adbVg90H21EOLACvtfcHk0liHXXNFuRlcrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFensbo%253D&md5=35bfbebbbca72a6d5ef3667d84a772c3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMoy%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DRajasekaran%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DV.%26aulast%3DKnudsen%26aufirst%3DB.%26aulast%3DBander%26aufirst%3DN.%26atitle%3DMonoclonal%2520antibodies%2520to%2520the%2520extracellular%2520domain%2520of%2520prostate-specific%2520membrane%2520antigen%2520also%2520react%2520with%2520tumor%2520vascular%2520endothelium%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D3629%26epage%3D3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J.</span><span> </span><span class="NLM_article-title">Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1073%2Fpnas.93.2.749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=8570628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADyaK28XnslOksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=749-753&author=R.+Carterauthor=A.+Feldmanauthor=J.+Coyle&title=Prostate-specific+membrane+antigen+is+a+hydrolase+with+substrate+and+pharmacologic+characteristics+of+a+neuropeptidase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase</span></div><div class="casAuthors">Carter, ruth E.; Feldman, Alexis R.; Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">749-53</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">This report demonstrates that the investigational prostatic carcinoma marker known as the prostate-specific membrane antigen (PSM) possesses hydrolytic activity with the substrate and pharmacol. properties of the N-acetylated α-linked acidic dipeptidase (NAALADase).  NAALADase is a membrane hydrolase that has been characterized in the mammalian nervous system on the basis of its catabolism of the neuropeptide N-acetylaspartylglutamate (NAAG) to yield glutamate and N-acetylaspartate and that has been hypothesized to influence glutamatergic signaling processes.  The immunoscreening of a rat brain cDNA expression library with anti-NAALADase antisera identified a 1428-base partial cDNA that shares 86% sequence identity with 1428 bases of the human PSM cDNA [Israeli, R. S., Powell, C. T., Fair, W. R. & Heston, W. D. W. (1993) Cancer Res. 53, 227-230].  A cDNA contg. the entire PSM open reading frame was subsequently isolated by reverse transcription-PCR from the PSM-pos. prostate carcinoma cell line LNCaP.  Transient transfection of this cDNA into two NAALADase-neg. cell lines conferred NAAG-hydrolyzing activity that was inhibited by the NAALADase inhibitors quisqualic acid and β-NAAG.  Thus we demonstrate a PSM-encoded function and identify a NAALADase-encoding cDNA.  Northern analyses identify at least six transcripts that are variably expressed in NAALADase-pos. but not in NAALADase-neg. rat tissues and human cell lines; therefore, PSM and/or related mol. species appear to account for NAAG hydrolysis in the nervous system.  These results also raise questions about the role of PSM in both normal and pathol. prostate epithelial-cell function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Bzy9_R_Aj7Vg90H21EOLACvtfcHk0liHXXNFuRlcrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnslOksA%253D%253D&md5=73d28883aed16fafc6733d33676ad0de</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.2.749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.2.749%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DR.%26aulast%3DFeldman%26aufirst%3DA.%26aulast%3DCoyle%26aufirst%3DJ.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520is%2520a%2520hydrolase%2520with%2520substrate%2520and%2520pharmacologic%2520characteristics%2520of%2520a%2520neuropeptidase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D749%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Tiffany, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapidus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span> </span><span class="NLM_article-title">Characterization of the enzymatic activity of PSM: comparison with brain NAALADase</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=28-35&author=C.+Tiffanyauthor=R.+Lapidusauthor=A.+Merionauthor=D.+Calvinauthor=B.+Slusher&title=Characterization+of+the+enzymatic+activity+of+PSM%3A+comparison+with+brain+NAALADase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiffany%26aufirst%3DC.%26aulast%3DLapidus%26aufirst%3DR.%26aulast%3DMerion%26aufirst%3DA.%26aulast%3DCalvin%26aufirst%3DD.%26aulast%3DSlusher%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520the%2520enzymatic%2520activity%2520of%2520PSM%253A%2520comparison%2520with%2520brain%2520NAALADase%26jtitle%3DProstate%26date%3D1999%26volume%3D39%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4504</span><span class="NLM_x">–</span> <span class="NLM_lpage">4517</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800111u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4504-4517&author=S.+Banerjeeauthor=C.+Fossauthor=M.+Castanaresauthor=R.+Measeauthor=Y.+Byunauthor=J.+Foxauthor=J.+Hiltonauthor=S.+Lupoldauthor=A.+Kozikowskiauthor=M.+Pomper&title=Synthesis+and+evaluation+of+technetium-99m-and+rhenium-labeled+inhibitors+of+the+prostate-specific+membrane+antigen+%28PSMA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm800111u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800111u%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DLupold%26aufirst%3DS.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520technetium-99m-and%2520rhenium-labeled%2520inhibitors%2520of%2520the%2520prostate-specific%2520membrane%2520antigen%2520%2528PSMA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4504%26epage%3D4517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovenska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mlcochova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hlouchova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plechanovova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span> </span><span class="NLM_article-title">Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3267</span><span class="NLM_x">–</span> <span class="NLM_lpage">3273</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070133w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlOmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3267-3273&author=C.+Barinkaauthor=M.+Rovenskaauthor=P.+Mlcochovaauthor=K.+Hlouchovaauthor=A.+Plechanovovaauthor=P.+Majerauthor=T.+Tsukamotoauthor=B.+Slusherauthor=J.+Konvalinkaauthor=J.+Lubkowski&title=Structural+insight+into+the+pharmacophore+pocket+of+human+glutamate+carboxypeptidase+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insight into the Pharmacophore Pocket of Human Glutamate Carboxypeptidase II</span></div><div class="casAuthors">Barinka, Cyril; Rovenska, Miroslava; Mlcochova, Petra; Hlouchova, Klara; Plechanovova, Anna; Majer, Pavel; Tsukamoto, Takashi; Slusher, Barbara S.; Konvalinka, Jan; Lubkowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3267-3273</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of glutamate carboxypeptidase II (GCPII) has been shown to be neuroprotective in multiple preclin. models in which dysregulated glutamatergic transmission is implicated.  Herein, we report crystal structures of the human GCPII complexed with three glutamate mimetics/derivs., 2-(phosphonomethyl)pentanedioic acid (2-PMPA), quisqualic acid (QA), and L-serine O-sulfate (L-SOS), at 1.72, 1.62, and 2.10 Å resoln., resp.  Despite the structural differences between the distal parts of the inhibitors, all three compds. share similar binding modes in the pharmacophore (i.e., S1') pocket of GCPII, where they are stabilized by a combination of polar and van der Waals interactions.  The structural diversity of the distal parts of the inhibitors leads to rearrangements of the S1' site that are necessary for efficient interactions between the enzyme and an inhibitor.  The set of structures presented here, in conjunction with the available biochem. data, illustrates a flexibility of the GCPII pharmacophore pocket and highlights the structural features required for potent GCPII inhibition.  These findings could facilitate the rational structure-based drug design of new GCPII inhibitors in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqR1kd5UUodrVg90H21EOLACvtfcHk0ljsAxqPHoLj4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlOmsLc%253D&md5=1b0a665eaaef88fb9f622d8ae87ef41e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm070133w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070133w%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DRovenska%26aufirst%3DM.%26aulast%3DMlcochova%26aufirst%3DP.%26aulast%3DHlouchova%26aufirst%3DK.%26aulast%3DPlechanovova%26aufirst%3DA.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DKonvalinka%26aufirst%3DJ.%26aulast%3DLubkowski%26aufirst%3DJ.%26atitle%3DStructural%2520insight%2520into%2520the%2520pharmacophore%2520pocket%2520of%2520human%2520glutamate%2520carboxypeptidase%2520II%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3267%26epage%3D3273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span> </span><span class="NLM_article-title">Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7737</span><span class="NLM_x">–</span> <span class="NLM_lpage">7743</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800765e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWksrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7737-7743&author=C.+Barinkaauthor=Y.+Byunauthor=C.+Dusichauthor=S.+Banerjeeauthor=Y.+Chenauthor=M.+Castanaresauthor=A.+Kozikowskiauthor=R.+Measeauthor=M.+Pomperauthor=J.+Lubkowski&title=Interactions+between+Human+Glutamate+Carboxypeptidase+II+and+Urea-Based+Inhibitors%3A+Structural+Characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization</span></div><div class="casAuthors">Barinka, Cyril; Byun, Youngjoo; Dusich, Crystal L.; Banerjee, Sangeeta R.; Chen, Ying; Castanares, Mark; Kozikowski, Alan P.; Mease, Ronnie C.; Pomper, Martin G.; Lubkowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7737-7743</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based, low mol. wt. ligands of glutamate carboxypeptidase II (GCPII) have demonstrated efficacy in various models of neurol. disorders and can serve as imaging agents for prostate cancer.  To enhance further development of such compds., we detd. x-ray structures of four complexes between human GCPII and urea-based inhibitors at high resoln.  All ligands demonstrate an invariant glutarate moiety within the S1' pocket of the enzyme.  The ureido linkage between P1 and P1' inhibitor sites interacts with the active-site Zn12+ ion and the side chains of Tyr-552 and His-553.  Interactions within the S1 pocket are defined primarily by a network of hydrogen bonds between the P1 carboxylate group of the inhibitors and the side chains of Arg-534, Arg-536, and Asn-519.  Importantly, we have identified a hydrophobic pocket accessory to the S1 site that can be exploited for structure-based design of novel GCPII inhibitors with increased lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCkVTUEw3n-rVg90H21EOLACvtfcHk0ljsAxqPHoLj4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWksrbI&md5=6023d910f6b69aae7c85852235004cef</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm800765e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800765e%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DDusich%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DPomper%26aufirst%3DM.%26aulast%3DLubkowski%26aufirst%3DJ.%26atitle%3DInteractions%2520between%2520Human%2520Glutamate%2520Carboxypeptidase%2520II%2520and%2520Urea-Based%2520Inhibitors%253A%2520Structural%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7737%26epage%3D7743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grajkowska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wroblewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzdega, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wroblewska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neale, J.</span><span> </span><span class="NLM_article-title">Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">–</span> <span class="NLM_lpage">1738</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1yls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1729-1738&author=A.+Kozikowskiauthor=J.+Zhangauthor=F.+Nanauthor=P.+Petukhovauthor=E.+Grajkowskaauthor=J.+Wroblewskiauthor=T.+Yamamotoauthor=T.+Bzdegaauthor=B.+Wroblewskaauthor=J.+Neale&title=Synthesis+of+urea-based+inhibitors+as+active+site+probes+of+glutamate+carboxypeptidase+II%3A+efficacy+as+analgesic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents</span></div><div class="casAuthors">Kozikowski, Alan P.; Zhang, Jiazhong; Nan, Fajun; Petukhov, Pavel A.; Grajkowska, Ewa; Wroblewski, Jarda T.; Yamamoto, Tatsuo; Bzdega, Tomasz; Wroblewska, Barbara; Neale, Joseph H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1729-1738</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neuropeptidase glutamate carboxypeptidase II (GCPII) hydrolyzes N-acetyl-L-aspartyl-L-glutamate (NAAG) to liberate N-acetylaspartate and glutamate.  GCPII was originally cloned as PSMA, an Mr 100 000 type II transmembrane glycoprotein highly expressed in prostate tissues.  PSMA/GCPII is located on the short arm of chromosome 11 and functions as both a folate hydrolase and a neuropeptidase.  Inhibition of brain GCPII may have therapeutic potential in the treatment of certain disease states arising from pathol. overactivated glutamate receptors.  Recently, the authors reported that certain urea-based structures act as potent inhibitors of GCPII (J. Med. Chem. 2001, 44, 298).  However, many of the potent GCPII inhibitors prepd. to date are highly polar compds. and therefore do not readily penetrate the blood-brain barrier.  Herein, the authors elaborate on the synthesis of a series of potent, urea-based GCPII inhibitors and provide assay data for these ligands against human GCPII.  Moreover, the authors provide data revealing the ability of one of these compds., namely, (S)-2-[3-[(S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]ureido]pentanedioic acid (I), to reduce the perception of inflammatory pain.  Within the present series, the γ-tetrazole bearing glutamate isostere is the most potent inhibitor with a Ki of 0.9 nM.  The biol. evaluation of these compds. revealed that the active site of GCPII likely comprises two regions, namely, the pharmacophore subpocket and the nonpharmacophore subpocket.  The pharmacophore subpocket is very sensitive to structural changes, and thus, it appears important to keep one of the glutamic acid moieties intact to maintain the potency of the GCPII inhibitors.  The site encompassing the nonpharmacophore subpocket that binds to glutamate's α-carboxyl group is sensitive to structural change.  However, the other region of the nonpharmacophore subpocket can accommodate both hydrophobic and hydrophilic groups.  Thus, an arom. ring can be introduced to the inhibitor thereby increasing its hydrophobicity and thus potentially its ability to cross the blood-brain barrier.  Intrathecally administered I significantly reduced pain perception in the formalin model of rat sensory nerve injury.  A maximal dose of morphine (10 mg) applied in the same exptl. paradigm provided no significant increase in analgesia in comparison to I during phase 1 of this pain study and modestly greater analgesia than I in phase 2.  These urea-based inhibitors of GCPII thus offer a novel approach to pain management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ZZS2UrE6CbVg90H21EOLACvtfcHk0ljmz_fD-Xi4bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1yls7Y%253D&md5=809ec62cf1ee52481d88596913bb145a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0306226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306226%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DNan%26aufirst%3DF.%26aulast%3DPetukhov%26aufirst%3DP.%26aulast%3DGrajkowska%26aufirst%3DE.%26aulast%3DWroblewski%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DBzdega%26aufirst%3DT.%26aulast%3DWroblewska%26aufirst%3DB.%26aulast%3DNeale%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520urea-based%2520inhibitors%2520as%2520active%2520site%2520probes%2520of%2520glutamate%2520carboxypeptidase%2520II%253A%2520efficacy%2520as%2520analgesic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1729%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Ga-68-and In-111-Labelled Small Molecule Inhibitors of PSMA for Prostate Cancer Imaging</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=S19&author=S.+Banerjeeauthor=M.+Pullambhatlaauthor=Y.+Byunauthor=G.+Greenauthor=J.+Foxauthor=A.+Hortiauthor=R.+Measeauthor=M.+Pomper&title=Ga-68-and+In-111-Labelled+Small+Molecule+Inhibitors+of+PSMA+for+Prostate+Cancer+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHorti%26aufirst%3DA.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGa-68-and%2520In-111-Labelled%2520Small%2520Molecule%2520Inhibitors%2520of%2520PSMA%2520for%2520Prostate%2520Cancer%2520Imaging%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2009%26volume%3D52%26spage%3DS19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Ga-68-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5333</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100623e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5333-5341&author=S.+Banerjeeauthor=M.+Pullambhatlaauthor=Y.+Byunauthor=S.+Nimmagaddaauthor=G.+Greenauthor=J.+Foxauthor=A.+Hortiauthor=R.+Measeauthor=M.+Pomper&title=Ga-68-Labeled+Inhibitors+of+Prostate-Specific+Membrane+Antigen+%28PSMA%29+for+Imaging+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm100623e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100623e%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHorti%26aufirst%3DA.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGa-68-Labeled%2520Inhibitors%2520of%2520Prostate-Specific%2520Membrane%2520Antigen%2520%2528PSMA%2529%2520for%2520Imaging%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5333%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauder-Wust, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span> </span><span class="NLM_article-title">Ga-68-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">697</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc200279b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=688-697&author=M.+Ederauthor=M.+Schaferauthor=U.+Bauder-Wustauthor=W.+Hullauthor=C.+Wanglerauthor=W.+Mierauthor=U.+Haberkornauthor=M.+Eisenhut&title=Ga-68-Complex+Lipophilicity+and+the+Targeting+Property+of+a+Urea-Based+PSMA+Inhibitor+for+PET+Imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span></div><div class="casAuthors">Eder, Matthias; Schaefer, Martin; Bauder-Wuest, Ulrike; Hull, William-Edmund; Waengler, Carmen; Mier, Walter; Haberkorn, Uwe; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">688-697</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors of the prostate-specific membrane antigen (PSMA) represent low-mol.-wt. pepidomimetics showing the ability to image PSMA-expressing prostate tumors.  The highly efficient, acyclic Ga(III) chelator N,N'-bis [2-hydroxy-5-(carboxyethyl)benzyl] ethylenediamine-N,N'- diacetic acid (HBED-CC) was introduced as a lipophilic side chain into the hydrophilic pharmacophore Glu-NH-CO-NH-Lys which was found favorable to interact with the PSMA "active binding site".  This report describes the syntheses, in vitro binding analyses, and biodistribution data of the radiogallium labeled PSMA inhibitor Glu-NH-CO-NH-Lys(Ahx)-HBED-CC in comparison to the corresponding DOTA conjugate.  The binding properties were analyzed using competitive cell binding and enzyme-based assays followed by internalization expts.  Compared to the DOTA-conjugate, the HBED-CC deriv. showed reduced unspecific binding and considerable higher specific internalization in LNCaP cells.  The 68Ga complex of the HBED-CC ligand exhibited higher specificity for PSMA expressing tumor cells resulting in improved in vivo properties. 68Ga labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC showed fast blood and organ clearances, low liver accumulation, and high specific uptake in PSMA expressing organs and tumor.  It could be demonstrated that the PET-imaging property of a urea-based PSMA inhibitor could significantly be improved with HBED-CC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XoCnl_RguLVg90H21EOLACvtfcHk0ljmz_fD-Xi4bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D&md5=4bb4cbba9f510ed2561b87a44bafa00a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbc200279b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200279b%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DSchafer%26aufirst%3DM.%26aulast%3DBauder-Wust%26aufirst%3DU.%26aulast%3DHull%26aufirst%3DW.%26aulast%3DWangler%26aufirst%3DC.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3DGa-68-Complex%2520Lipophilicity%2520and%2520the%2520Targeting%2520Property%2520of%2520a%2520Urea-Based%2520PSMA%2520Inhibitor%2520for%2520PET%2520Imaging%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D688%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Tc-99m/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1557-1563&author=G.+Luauthor=K.+Marescaauthor=S.+Hillierauthor=C.+Zimmermanauthor=W.+Eckelmanauthor=J.+Joyalauthor=J.+Babich&title=Synthesis+and+SAR+of+Tc-99m%2FRe-labeled+small+molecule+prostate+specific+membrane+antigen+inhibitors+with+novel+polar+chelates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DG.%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DHillier%26aufirst%3DS.%26aulast%3DZimmerman%26aufirst%3DC.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Tc-99m%252FRe-labeled%2520small%2520molecule%2520prostate%2520specific%2520membrane%2520antigen%2520inhibitors%2520with%2520novel%2520polar%2520chelates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1557%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Nedrow-Byers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benny, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkman, C.</span><span> </span><span class="NLM_article-title">PSMA-targeted SPECT agents: mode of binding effect on in vitro performance</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=355-362&author=J.+Nedrow-Byersauthor=A.+Mooreauthor=T.+Gangulyauthor=M.+Hopkinsauthor=M.+Fultonauthor=P.+Bennyauthor=C.+Berkman&title=PSMA-targeted+SPECT+agents%3A+mode+of+binding+effect+on+in+vitro+performance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNedrow-Byers%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DGanguly%26aufirst%3DT.%26aulast%3DHopkins%26aufirst%3DM.%26aulast%3DFulton%26aufirst%3DM.%26aulast%3DBenny%26aufirst%3DP.%26aulast%3DBerkman%26aufirst%3DC.%26atitle%3DPSMA-targeted%2520SPECT%2520agents%253A%2520mode%2520of%2520binding%2520effect%2520on%2520in%2520vitro%2520performance%26jtitle%3DProstate%26date%3D2013%26volume%3D73%26spage%3D355%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kularatne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted Tc-99m-Radioimaging Agents</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp9000712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsF2hs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=790-800&author=S.+Kularatneauthor=Z.+Zhouauthor=J.+Yangauthor=C.+Postauthor=P.+Low&title=Design%2C+Synthesis%2C+and+Preclinical+Evaluation+of+Prostate-Specific+Membrane+Antigen+Targeted+Tc-99m-Radioimaging+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents</span></div><div class="casAuthors">Kularatne, Sumith A.; Zhou, Zhigang; Yang, Jun; Post, Carol B.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">790-800</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The high mortality and financial burden assocd. with prostate cancer can be partly attributed to a lack of sensitive screening methods for detection and staging of the disease.  Guided by in silico docking studies using the crystal structure of PSMA, we designed and synthesized a series of PSMA-targeted 99mTc-chelate complexes for imaging PSMA-expressing human prostate cancer cells (LNCaP cell line).  Of the six targeted radioimaging agents synthesized, three were found to bind LNCaP cells with low nanomolar affinity.  Moreover, the same three PSMA-targeted imaging agents were shown to localize primarily to LNCaP tumor xenografts in nu/nu mice, with an av. of 9.8 ± 2.4% injected dose/g tissue accumulating in the tumor and only 0.11% injected dose/g tissue retained in the muscle at 4 h postinjection.  Collectively, these high affinity, PSMA-specific radioimaging agents demonstrate significant potential for use in localizing prostate cancer masses, monitoring response to therapy, detecting prostate cancer recurrence following surgery, and selecting patients for subsequent PSMA-targeted chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCrsRCzeRWhLVg90H21EOLACvtfcHk0ljDTRzgDQ_j9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsF2hs70%253D&md5=77c5b6f3776e761979de857d4299106e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fmp9000712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp9000712%26sid%3Dliteratum%253Aachs%26aulast%3DKularatne%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DPost%26aufirst%3DC.%26aulast%3DLow%26aufirst%3DP.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Preclinical%2520Evaluation%2520of%2520Prostate-Specific%2520Membrane%2520Antigen%2520Targeted%2520Tc-99m-Radioimaging%2520Agents%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D790%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszewski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4022</span><span class="NLM_x">–</span> <span class="NLM_lpage">4028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1158%2F1078-0432.CCR-04-2690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=15930336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=4022-4028&author=C.+Fossauthor=R.+Measeauthor=H.+Fanauthor=Y.+Wangauthor=H.+Ravertauthor=R.+Dannalsauthor=R.+Olszewskiauthor=W.+Hestonauthor=A.+Kozikowskiauthor=M.+Pomper&title=Radiolabeled+small-molecule+ligands+for+prostate-specific+membrane+antigen%3A+in+vivo+imaging+in+experimental+models+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer</span></div><div class="casAuthors">Foss, Catherine A.; Mease, Ronnie C.; Fan, Hong; Wang, Yuchuan; Ravert, Hayden T.; Dannals, Robert F.; Olszewski, Rafal T.; Heston, Warren D.; Kozikowski, Alan P.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4022-4028</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is overexpressed in prostate cancer, including hormone-refractory and metastatic disease.  Our goal in this study was to develop a series of PSMA-based imaging agents for clin. use.  Exptl. Design: We have synthesized and evaluated the in vivo biodistribution of two radiolabeled urea derivs. that have high affinity for PSMA in severe combined immunodeficient mice harboring MCF-7 (breast, PSMA-neg.), PC-3 (prostate, PSMA-neg.), and LNCaP (prostate, PSMA-pos.) xenografts.  Radiopharmaceutical binding selectivity and tumor uptake were also evaluated in vivo using dedicated small animal positron emission tomog., single photon emission computed tomog., and gamma scintigraphic imaging devices.  N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine ([11C]DCMC Ki, 3.1 nmol/L) and N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-[125I]iodo-L-tyrosine ([125C]DCIT Ki, 1.5 nmol/L) were synthesized using [11C]CH3I and with [125I]NaI/Iodogen, resp.  RESULTS: At 30 min postinjection, [11C]DCMC and [125I]DCIT showed tumor/muscle ratios of 10.8 and 4.7, resp., with clear delineation of LNCaP-derived tumors on imaging.  MCF-7- and PC-3-derived tumors showed significantly less uptake of [11C]DCMC or [125I]DCIT.  CONCLUSION: These results show the feasibility of imaging PSMA-pos. prostate cancer using low mol. wt. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmd1gq-93gbVg90H21EOLACvtfcHk0ljDTRzgDQ_j9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gksr0%253D&md5=da069680b889ef20e18404ac36bbb05e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2690%26sid%3Dliteratum%253Aachs%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRavert%26aufirst%3DH.%26aulast%3DDannals%26aufirst%3DR.%26aulast%3DOlszewski%26aufirst%3DR.%26aulast%3DHeston%26aufirst%3DW.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DRadiolabeled%2520small-molecule%2520ligands%2520for%2520prostate-specific%2520membrane%2520antigen%253A%2520in%2520vivo%2520imaging%2520in%2520experimental%2520models%2520of%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D4022%26epage%3D4028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Hillier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Femia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6932</span><span class="NLM_x">–</span> <span class="NLM_lpage">6940</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1158%2F0008-5472.CAN-09-1682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=19706750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6932-6940&author=S.+Hillierauthor=K.+Marescaauthor=F.+Femiaauthor=J.+Marquisauthor=C.+Fossauthor=N.+Nguyenauthor=C.+Zimmermanauthor=J.+Barrettauthor=W.+Eckelmanauthor=M.+Pomperauthor=J.+Joyalauthor=J.+Babich&title=Preclinical+Evaluation+of+Novel+Glutamate-Urea-Lysine+Analogues+That+Target+Prostate-Specific+Membrane+Antigen+as+Molecular+Imaging+Pharmaceuticals+for+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer</span></div><div class="casAuthors">Hillier, Shawn M.; Maresca, Kevin P.; Femia, Frank J.; Marquis, John C.; Foss, Catherine A.; Nguyen, Nghi; Zimmerman, Craig N.; Barrett, John A.; Eckelman, William C.; Pomper, Martin G.; Joyal, John L.; Babich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6932-6940</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA) is expressed in normal human prostate epithelium and is highly up-regulated in prostate cancer.  We previously reported a series of novel small mol. inhibitors targeting PSMA.  Two compds., MIP-1072, (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedioic acid, and MIP-1095, (S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl)ureido)pentyl)ureido)pentanedioic acid, were selected for further evaluation.  MIP-1072 and MIP-1095 potently inhibited the glutamate carboxypeptidase activity of PSMA (Ki = 4.6 ± 1.6 nM and 0.24 ± 0.14 nM, resp.) and, when radiolabeled with 123I, exhibited high affinity for PSMA on human prostate cancer LNCaP cells (Kd = 3.8 ± 1.3 nM and 0.81 ± 0.39 nM, resp.).  The assocn. of [123I]MIP-1072 and [123I]MIP-1095 with PSMA was specific; there was no binding to human prostate cancer PC3 cells, which lack PSMA, and binding was abolished by coincubation with a structurally unrelated NAALADase inhibitor, 2-(phosphonomethyl)pentanedioic acid (PMPA).  [123I]MIP-1072 and [123I]MIP-1095 internalized into LNCaP cells at 37°C.  Tissue distribution studies in mice showed 17.3 ± 6.3% (at 1 h) and 34.3 ± 12.7% (at 4 h) injected dose per g of LNCaP xenograft tissue, for [123I]MIP-1072 and [123I]MIP-1095, resp.  [123I]MIP-1095 exhibited greater tumor uptake but slower washout from blood and nontarget tissues compared with [123I]MIP-1072.  Specific binding to PSMA in vivo was shown by competition with PMPA in LNCaP xenografts, and the absence of uptake in PC3 xenografts.  The uptake of [123I]MIP-1072 and [123I]MIP-1095 in tumor-bearing mice was corroborated by single-photon emission computed tomog./computed tomog. (SPECT/CT) imaging.  PSMA-specific radiopharmaceuticals should provide a novel mol. targeting option for the detection and staging of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmETFDEvmsZLVg90H21EOLACvtfcHk0lhF8YEMAWxlWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtLzE&md5=f222208c3c3fbcaa376306c49c9ec80b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1682%26sid%3Dliteratum%253Aachs%26aulast%3DHillier%26aufirst%3DS.%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DFemia%26aufirst%3DF.%26aulast%3DMarquis%26aufirst%3DJ.%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DZimmerman%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DPomper%26aufirst%3DM.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DPreclinical%2520Evaluation%2520of%2520Novel%2520Glutamate-Urea-Lysine%2520Analogues%2520That%2520Target%2520Prostate-Specific%2520Membrane%2520Antigen%2520as%2520Molecular%2520Imaging%2520Pharmaceuticals%2520for%2520Prostate%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6932%26epage%3D6940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Barrett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallabhajosula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stabin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=380-387&author=J.+Barrettauthor=R.+Colemanauthor=S.+Goldsmithauthor=S.+Vallabhajosulaauthor=N.+Petryauthor=S.+Choauthor=T.+Armorauthor=J.+Stubbsauthor=K.+Marescaauthor=M.+Stabinauthor=J.+Joyalauthor=W.+Eckelmanauthor=J.+Babich&title=First-in-Man+Evaluation+of+2+High-Affinity+PSMA-Avid+Small+Molecules+for+Imaging+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DR.%26aulast%3DGoldsmith%26aufirst%3DS.%26aulast%3DVallabhajosula%26aufirst%3DS.%26aulast%3DPetry%26aufirst%3DN.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DArmor%26aufirst%3DT.%26aulast%3DStubbs%26aufirst%3DJ.%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DStabin%26aufirst%3DM.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DFirst-in-Man%2520Evaluation%2520of%25202%2520High-Affinity%2520PSMA-Avid%2520Small%2520Molecules%2520for%2520Imaging%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D380%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wakisaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uezono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohomomo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">A novel radioiodination reagent for protein radiopharmaceuticals with <span class="smallcaps smallerCapital">l</span>-lysine as a plasma-stable metabolizable linkage to liberate <i>m</i>-iodohippuric acid after lysosomal proteolysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2643</span><span class="NLM_x">–</span> <span class="NLM_lpage">2652</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9606397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2643-2652&author=K.+Wakisakaauthor=Y.+Aranoauthor=T.+Uezonoauthor=H.+Akizawaauthor=M.+Onoauthor=K.+Kawaiauthor=Y.+Ohomomoauthor=M.+Nakayamaauthor=H.+Saji&title=A+novel+radioiodination+reagent+for+protein+radiopharmaceuticals+with+l-lysine+as+a+plasma-stable+metabolizable+linkage+to+liberate+m-iodohippuric+acid+after+lysosomal+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm9606397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9606397%26sid%3Dliteratum%253Aachs%26aulast%3DWakisaka%26aufirst%3DK.%26aulast%3DArano%26aufirst%3DY.%26aulast%3DUezono%26aufirst%3DT.%26aulast%3DAkizawa%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DOhomomo%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DA%2520novel%2520radioiodination%2520reagent%2520for%2520protein%2520radiopharmaceuticals%2520with%2520l-lysine%2520as%2520a%2520plasma-stable%2520metabolizable%2520linkage%2520to%2520liberate%2520m-iodohippuric%2520acid%2520after%2520lysosomal%2520proteolysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2643%26epage%3D2652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prideaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgouros, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-[<i>N</i>-[(<i>S</i>)-1,3-Dicarboxypropyl]carbamoyl]-4-[F-18]fluorobenzyl-<span class="smallcaps smallerCapital">l</span>-cysteine, [F-18]DCFBC: a new imaging probe for prostate cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3036</span><span class="NLM_x">–</span> <span class="NLM_lpage">3043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1158%2F1078-0432.CCR-07-1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=18483369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVCmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3036-3043&author=R.+Measeauthor=C.+Dusichauthor=C.+Fossauthor=H.+Ravertauthor=R.+Dannalsauthor=J.+Seidelauthor=A.+Prideauxauthor=J.+Foxauthor=G.+Sgourosauthor=A.+Kozikowskiauthor=M.+Pomper&title=N-%5BN-%5B%28S%29-1%2C3-Dicarboxypropyl%5Dcarbamoyl%5D-4-%5BF-18%5Dfluorobenzyl-l-cysteine%2C+%5BF-18%5DDCFBC%3A+a+new+imaging+probe+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC:A New Imaging Probe for Prostate Cancer</span></div><div class="casAuthors">Mease, Ronnie C.; Dusich, Crystal L.; Foss, Catherine A.; Ravert, Hayden T.; Dannals, Robert F.; Seidel, Jurgen; Prideaux, Andrew; Fox, James J.; Sgouros, George; Kozikowski, Alan P.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3036-3043</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Previously, we showed successful imaging of xenografts that express the prostate-specific membrane antigen (PSMA) using small-animal positron emission tomog. (PET) and the radiolabeled PSMA inhibitor N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine.  Herein, we extend that work by prepg. and testing a PSMA inhibitor of the same class labeled with fluorine-18.  Exptl. Design: N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine ([18F]DCFBC) was prepd. by reacting 4-[18F]fluorobenzyl bromide with the precursor (S)-2-[3-[(R)-1-carboxy-2-mercaptoethyl]ureido]-pentanedioic acid in ammonia-satd. methanol at 60°C for 10 min followed by purifn. using C-18 reverse-phase semipreparative high-performance liq. chromatog.  Severe combined immunodeficient mice bearing a s.c. PSMA+ PC-3 PIP tumor behind one shoulder and a PSMA- PC-3 FLU tumor behind the other shoulder were injected via the tail vein with either 1.85 MBq (50 μCi) of [18F]DCFBC for ex vivo biodistribution or 7.4 MBq (200 μCi) for imaging.  For biodistribution, mice were sacrificed at 5, 15, 30, 60, and 120 min.  Tumor, blood, and major organs were harvested and weighed, and radioactivity was counted.  Imaging was done on the GE eXplore Vista small-animal PET scanner by collecting 12 consecutive 10-min frames.  RESULTS: Radiochem. yield for [18F]DCFBC averaged 16 ± 6% (n = 8) from 4-[18F]fluorobenzyl bromide.  Specific radioactivities ranged from 13 to 133 GBq/μmol (350-3600 Ci/mmol) with an av. of 52 GBq/μmol (1392 Ci/mmol; n = 6).  Biodistribution and imaging studies showed high uptake of [18F]DCFBC in the PIP tumors with little to no uptake in FLU tumors.  High radiopharmaceutical uptake was also seen in kidneys and bladder; however, washout of radioactivity from these organs was faster than from the PIP tumors.  The max. PIP tumor uptake was 8.16 ± 2.55% injected dose per g, achieved at 60 min after injection, which decreased to 4.69 ± 0.89 at 120 min.  The PIP tumor to muscle ratio was 20 at 120 min after injection.  Based on the mouse biodistribution, the dose-limiting organ is the kidneys (human estd. absorbed dose: 0.05 mGy/MBq; 0.2 rad/mCi).  CONCLUSION: [18F]DCFBC localizes to PSMA+-expressing tumors in mice, permitting imaging by small-animal PET.  This new radiopharmaceutical is an attractive candidate for further studies of PET imaging of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJcN5Ud7t4YrVg90H21EOLACvtfcHk0lgEjQIiYOzxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVCmtb8%253D&md5=08e8e93b4a77d04d6c8893e388ea607b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1517%26sid%3Dliteratum%253Aachs%26aulast%3DMease%26aufirst%3DR.%26aulast%3DDusich%26aufirst%3DC.%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DRavert%26aufirst%3DH.%26aulast%3DDannals%26aufirst%3DR.%26aulast%3DSeidel%26aufirst%3DJ.%26aulast%3DPrideaux%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DSgouros%26aufirst%3DG.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DN-%255BN-%255B%2528S%2529-1%252C3-Dicarboxypropyl%255Dcarbamoyl%255D-4-%255BF-18%255Dfluorobenzyl-l-cysteine%252C%2520%255BF-18%255DDCFBC%253A%2520a%2520new%2520imaging%2520probe%2520for%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D3036%26epage%3D3043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Femia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800994j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Gl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=347-357&author=K.+Marescaauthor=S.+Hillierauthor=F.+Femiaauthor=D.+Keithauthor=C.+Baroneauthor=J.+Joyalauthor=C.+Zimmermanauthor=A.+Kozikowskiauthor=J.+Barrettauthor=W.+Eckelmanauthor=J.+Babich&title=A+Series+of+Halogenated+Heterodimeric+Inhibitors+of+Prostate+Specific+Membrane+Antigen+%28PSMA%29+as+Radiolabeled+Probes+for+Targeting+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer</span></div><div class="casAuthors">Maresca, K. P.; Hillier, S. M.; Femia, F. J.; Keith, D.; Barone, C.; Joyal, J. L.; Zimmerman, C. N.; Kozikowski, A. P.; Barrett, J. A.; Eckelman, W. C.; Babich, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">347-357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate specific membrane antigen (PSMA) is a validated mol. marker for prostate cancer.  A series of glutamate-urea (Glu-urea-X) heterodimeric inhibitors of PSMA were designed and synthesized where X = .vepsiln.-N-(o-I, m-I, p-I, p-Br, o-Cl, m-Cl, p-Cl, p-F, H)-benzyl-Lys and .vepsiln.-(p-I, p-Br, p-Cl, p-F, H)-phenylureido-Lys.  The affinities for PSMA were detd. by screening in a competitive binding assay.  PSMA binding of the benzyllysine series was significantly affected by the nature of the halogen substituent (IC50 values, Cl < I = Br « F = H) and the ring position of the halogen atom (IC50 values, p-I < o-I « m-I).  The halogen atom had little affect on the binding affinity in the para substituted phenylureido-Lys series.  Two lead iodine compds. were radiolabeled with 123I and 131I and demonstrated specific PSMA binding on human prostate cancer cells, warranting evaluation as radioligands for the detection, staging, and monitoring of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ4n3KSzo2N7Vg90H21EOLACvtfcHk0lgEjQIiYOzxZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Gl&md5=8e962619d6bbfc466111dc9f2741780b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm800994j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800994j%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DHillier%26aufirst%3DS.%26aulast%3DFemia%26aufirst%3DF.%26aulast%3DKeith%26aufirst%3DD.%26aulast%3DBarone%26aufirst%3DC.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DZimmerman%26aufirst%3DC.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DA%2520Series%2520of%2520Halogenated%2520Heterodimeric%2520Inhibitors%2520of%2520Prostate%2520Specific%2520Membrane%2520Antigen%2520%2528PSMA%2529%2520as%2520Radiolabeled%2520Probes%2520for%2520Targeting%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Majumdar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haselton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinnell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocampo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G.</span><span> </span><span class="NLM_article-title">Generation of novel radiolabeled opiates through site-selective iodination</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4001</span><span class="NLM_x">–</span> <span class="NLM_lpage">4004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4001-4004&author=S.+Majumdarauthor=M.+Burgmanauthor=N.+Haseltonauthor=S.+Grinnellauthor=J.+Ocampoauthor=A.+Pasternakauthor=G.+Pasternak&title=Generation+of+novel+radiolabeled+opiates+through+site-selective+iodination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DBurgman%26aufirst%3DM.%26aulast%3DHaselton%26aufirst%3DN.%26aulast%3DGrinnell%26aufirst%3DS.%26aulast%3DOcampo%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DA.%26aulast%3DPasternak%26aufirst%3DG.%26atitle%3DGeneration%2520of%2520novel%2520radiolabeled%2520opiates%2520through%2520site-selective%2520iodination%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4001%26epage%3D4004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Camphausen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sproull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venditto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechbiel, M.</span><span> </span><span class="NLM_article-title">Evaluation of chelating agents as anti-angiogenic therapy through copper chelation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5133</span><span class="NLM_x">–</span> <span class="NLM_lpage">5140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5133-5140&author=K.+Camphausenauthor=M.+Sproullauthor=S.+Tantamaauthor=V.+Vendittoauthor=S.+Sankineniauthor=T.+Scottauthor=M.+Brechbiel&title=Evaluation+of+chelating+agents+as+anti-angiogenic+therapy+through+copper+chelation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamphausen%26aufirst%3DK.%26aulast%3DSproull%26aufirst%3DM.%26aulast%3DTantama%26aufirst%3DS.%26aulast%3DVenditto%26aufirst%3DV.%26aulast%3DSankineni%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DT.%26aulast%3DBrechbiel%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520chelating%2520agents%2520as%2520anti-angiogenic%2520therapy%2520through%2520copper%2520chelation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5133%26epage%3D5140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W.</span><span> </span><span class="NLM_article-title">Relationship Between Inhibition Constant (K1) and Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic-Reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+Prusoff&title=Relationship+Between+Inhibition+Constant+%28K1%29+and+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic-Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%26atitle%3DRelationship%2520Between%2520Inhibition%2520Constant%2520%2528K1%2529%2520and%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic-Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Mesters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenfeld, R.</span><span> </span><span class="NLM_article-title">Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1038%2Fsj.emboj.7600969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=16467855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=1375-1384&author=J.+Mestersauthor=C.+Barinkaauthor=W.+Liauthor=T.+Tsukamotoauthor=P.+Majerauthor=B.+Slusherauthor=J.+Konvalinkaauthor=R.+Hilgenfeld&title=Structure+of+glutamate+carboxypeptidase+II%2C+a+drug+target+in+neuronal+damage+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer</span></div><div class="casAuthors">Mesters, Jeroen R.; Barinka, Cyril; Li, Weixing; Tsukamoto, Takashi; Majer, Pavel; Slusher, Barbara S.; Konvalinka, Jan; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1375-1384</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Membrane-bound glutamate carboxypeptidase II (GCPII) is a zinc metalloenzyme that catalyzes the hydrolysis of the neurotransmitter N-acetyl-L-aspartyl-L-glutamate (NAAG) to N-acetyl-L-aspartate and L-glutamate (which is itself a neurotransmitter).  Potent and selective GCPII inhibitors have been shown to decrease brain glutamate and provide neuroprotection in preclin. models of stroke, amyotrophic lateral sclerosis, and neuropathic pain.  Here, we report crystal structures of the extracellular part of GCPII in complex with both potent and weak inhibitors and with glutamate, the product of the enzyme's hydrolysis reaction, at 2.0, 2.4, and 2.2 Å resoln., resp.  GCPII folds into three domains: protease-like, apical, and C-terminal.  All three participate in substrate binding, with two of them directly involved in C-terminal glutamate recognition.  One of the carbohydrate moieties of the enzyme is essential for homodimer formation of GCPII.  The three-dimensional structures presented here reveal an induced-fit substrate-binding mode of this key enzyme and provide essential information for the design of GCPII inhibitors useful in the treatment of neuronal diseases and prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ej_7P55ksrVg90H21EOLACvtfcHk0ljQknSErEQO2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gkurw%253D&md5=438416f784240c8974f0df12cb1f1fc7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600969%26sid%3Dliteratum%253Aachs%26aulast%3DMesters%26aufirst%3DJ.%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DKonvalinka%26aufirst%3DJ.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DStructure%2520of%2520glutamate%2520carboxypeptidase%2520II%252C%2520a%2520drug%2520target%2520in%2520neuronal%2520damage%2520and%2520prostate%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D1375%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span> </span><span class="NLM_article-title">A high-resolution structure of ligand-free human glutamate carboxypeptidase II</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=150-153&author=C.+Barinkaauthor=J.+Starkovaauthor=J.+Konvalinkaauthor=J.+Lubkowski&title=A+high-resolution+structure+of+ligand-free+human+glutamate+carboxypeptidase+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DStarkova%26aufirst%3DJ.%26aulast%3DKonvalinka%26aufirst%3DJ.%26aulast%3DLubkowski%26aufirst%3DJ.%26atitle%3DA%2520high-resolution%2520structure%2520of%2520ligand-free%2520human%2520glutamate%2520carboxypeptidase%2520II%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2007%26volume%3D63%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Afshar-Oromieh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zechmann, C.</span><span> </span><span class="NLM_article-title">[Ga-68]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with F-18-FECH</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1007%2Fs00259-012-2069-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BC38vit1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=1085-1086&author=A.+Afshar-Oromiehauthor=U.+Haberkornauthor=M.+Ederauthor=M.+Eisenhutauthor=C.+Zechmann&title=%5BGa-68%5DGallium-labelled+PSMA+ligand+as+superior+PET+tracer+for+the+diagnosis+of+prostate+cancer%3A+comparison+with+F-18-FECH"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH</span></div><div class="casAuthors">Afshar-Oromieh A; Haberkorn U; Eder M; Eisenhut M; Zechmann C M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1085-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3JpjC7vm3gwpJitSxOdIlfW6udTcc2eZcUewfFsi0erntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vit1ajsw%253D%253D&md5=68d829df054642abaf31cc2813c970f1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2069-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2069-0%26sid%3Dliteratum%253Aachs%26aulast%3DAfshar-Oromieh%26aufirst%3DA.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DZechmann%26aufirst%3DC.%26atitle%3D%255BGa-68%255DGallium-labelled%2520PSMA%2520ligand%2520as%2520superior%2520PET%2520tracer%2520for%2520the%2520diagnosis%2520of%2520prostate%2520cancer%253A%2520comparison%2520with%2520F-18-FECH%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2012%26volume%3D39%26spage%3D1085%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Afshar-Oromieh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhart, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadaschik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland-Letz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giesel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zechmann, C.</span><span> </span><span class="NLM_article-title">PET imaging with a [Ga-68]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1007%2Fs00259-012-2298-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=23179945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=486-495&author=A.+Afshar-Oromiehauthor=A.+Malcherauthor=M.+Ederauthor=M.+Eisenhutauthor=H.+Linhartauthor=B.+Hadaschikauthor=T.+Holland-Letzauthor=F.+Gieselauthor=C.+Kratochwilauthor=S.+Haufeauthor=U.+Haberkornauthor=C.+Zechmann&title=PET+imaging+with+a+%5BGa-68%5Dgallium-labelled+PSMA+ligand+for+the+diagnosis+of+prostate+cancer%3A+biodistribution+in+humans+and+first+evaluation+of+tumour+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumor lesions</span></div><div class="casAuthors">Afshar-Oromieh, A.; Malcher, A.; Eder, M.; Eisenhut, M.; Linhart, H. G.; Hadaschik, B. A.; Holland-Letz, T.; Giesel, F. L.; Kratochwil, C.; Haufe, S.; Haberkorn, U.; Zechmann, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-495</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein with high expression in prostate carcinoma (PC) cells.  Recently, procedures have been developed to label PSMA ligands with 68Ga, 99mTc and 123/124/131I.  Our initial experience with Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)](68Ga-PSMA) suggests that this novel tracer can detect PC relapses and metastases with high contrast.  The aim of this study was to investigate its biodistribution in normal tissues and tumor lesions.  Methods: A total of 37 patients with PC and rising prostate-specific antigen (PSA) levels were subjected to 68Ga-PSMA positron emission tomog. (PET)/CT.  Quant. assessment of tracer uptake was performed 1 and 3 h post-injection (p.i.) by anal. of mean and max. standardized uptake values (SUVmean/max) of several organs and 65 tumor lesions.  Subsequently, tumor to background ratios were calcd.  Results: The PET/CT images showed intense tracer uptake in both kidneys and salivary glands.  Moderate uptake was seen in lacrimal glands, liver, spleen and in small and large bowel.  Quant. assessment revealed excellent contrast between tumor lesions and most normal tissues.  Of 37 patients, 31 (83.8 %) showed at least one lesion suspicious for cancer at a detection rate of 60 % at PSA <2.2 ng/mL and 100 % at PSA >2.2 ng/mL.  Median tumor to background ratios were 18.8 (2.4-158.3) in early images and 28.3 (2.9-224.0) in late images.  Conclusion: The biodistribution of the novel 68Ga-PSMA tracer and its ability to detect PC lesions was analyzed in 37 patients.  Within healthy organs, kidneys and salivary glands demonstrated the highest radiotracer uptake.  Lesions suspicious for PC presented with excellent contrast as early as 1 h p.i. with high detection rates even at low PSA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHzN95PUT36rVg90H21EOLACvtfcHk0ljQknSErEQO2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslOgsL0%253D&md5=259104a7ea6bb216c156f8a3b1ccd6c6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2298-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2298-2%26sid%3Dliteratum%253Aachs%26aulast%3DAfshar-Oromieh%26aufirst%3DA.%26aulast%3DMalcher%26aufirst%3DA.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DLinhart%26aufirst%3DH.%26aulast%3DHadaschik%26aufirst%3DB.%26aulast%3DHolland-Letz%26aufirst%3DT.%26aulast%3DGiesel%26aufirst%3DF.%26aulast%3DKratochwil%26aufirst%3DC.%26aulast%3DHaufe%26aufirst%3DS.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DZechmann%26aufirst%3DC.%26atitle%3DPET%2520imaging%2520with%2520a%2520%255BGa-68%255Dgallium-labelled%2520PSMA%2520ligand%2520for%2520the%2520diagnosis%2520of%2520prostate%2520cancer%253A%2520biodistribution%2520in%2520humans%2520and%2520first%2520evaluation%2520of%2520tumour%2520lesions%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26spage%3D486%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 23 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xiaojiang Duan, Futao Liu, Hongmok Kwon, Youngjoo Byun, Il Minn, Xuekang Cai, Jingming Zhang, Martin G. Pomper, Zhi Yang, Zhen Xi, <span class="NLM_string-name hlFld-ContribAuthor">Xing Yang</span>. </span><span class="cited-content_cbyCitation_article-title">(S)-3-(Carboxyformamido)-2-(3-(carboxymethyl)ureido)propanoic Acid as a Novel PSMA Targeting Scaffold for Prostate Cancer Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (7)
                                     , 3563-3576. <a href="https://doi.org/10.1021/acs.jmedchem.9b02031" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02031%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D%252528S%252529-3-%252528Carboxyformamido%252529-2-%2525283-%252528carboxymethyl%252529ureido%252529propanoic%252BAcid%252Bas%252Ba%252BNovel%252BPSMA%252BTargeting%252BScaffold%252Bfor%252BProstate%252BCancer%252BImaging%26aulast%3DDuan%26aufirst%3DXiaojiang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D08122019%26date%3D30032020%26date%3D24032020%26volume%3D63%26issue%3D7%26spage%3D3563%26epage%3D3576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Arun K. Ghosh, <span class="NLM_string-name hlFld-ContribAuthor">Margherita Brindisi</span>. </span><span class="cited-content_cbyCitation_article-title">Urea Derivatives in Modern Drug Discovery and Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2751-2788. <a href="https://doi.org/10.1021/acs.jmedchem.9b01541" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01541</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01541&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01541%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUrea%252BDerivatives%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BMedicinal%252BChemistry%26aulast%3DGhosh%26aufirst%3DArun%2BK.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D16092019%26date%3D02122019%26volume%3D63%26issue%3D6%26spage%3D2751%26epage%3D2788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Young-Do Kwon, Jung-Mi Oh, Minh Thanh La, Hea-Jong Chung, Sun Joo Lee, Sungkun Chun, Sun-Hwa Lee, Byung-Hoon Jeong, <span class="NLM_string-name hlFld-ContribAuthor">Hee-Kwon Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Multifunctional Fluorescent Inhibitors with Synergistic Interaction of Prostate-Specific Membrane Antigen and Hypoxia for Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2019,</strong> <em>30 </em>
                                    (1)
                                     , 90-100. <a href="https://doi.org/10.1021/acs.bioconjchem.8b00767" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.8b00767</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.8b00767&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.8b00767%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BMultifunctional%252BFluorescent%252BInhibitors%252Bwith%252BSynergistic%252BInteraction%252Bof%252BProstate-Specific%252BMembrane%252BAntigen%252Band%252BHypoxia%252Bfor%252BProstate%252BCancer%26aulast%3DKwon%26aufirst%3DYoung-Do%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D23102018%26date%3D27112018%26date%3D11122018%26date%3D28112018%26volume%3D30%26issue%3D1%26spage%3D90%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin  Zhao</span>, <span class="hlFld-ContribAuthor ">Zongyang  Li</span>, <span class="hlFld-ContribAuthor ">Shuaihu  Yan</span>, <span class="hlFld-ContribAuthor ">Shiyang  Xu</span>, <span class="hlFld-ContribAuthor ">Ming-An  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Fu</span>, and <span class="hlFld-ContribAuthor ">Zhenhua  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Pd/C Catalyzed Carbonylation of Azides in the Presence of Amines. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (8)
                                     , 1736-1739. <a href="https://doi.org/10.1021/acs.orglett.6b00381" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b00381</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b00381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b00381%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DPd%25252FC%252BCatalyzed%252BCarbonylation%252Bof%252BAzides%252Bin%252Bthe%252BPresence%252Bof%252BAmines%26aulast%3DZhao%26aufirst%3DJin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06022016%26date%3D25032016%26date%3D15042016%26volume%3D18%26issue%3D8%26spage%3D1736%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lital  Cohen</span>, <span class="hlFld-ContribAuthor ">Yoav D.  Livney</span>, <span class="hlFld-ContribAuthor ">Yehuda G.  Assaraf</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted nanomedicine modalities for prostate cancer treatment. </span><span class="cited-content_cbyCitation_journal-name">Drug Resistance Updates</span><span> <strong>2021,</strong> <em>56 </em>, 100762. <a href="https://doi.org/10.1016/j.drup.2021.100762" title="DOI URL">https://doi.org/10.1016/j.drup.2021.100762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drup.2021.100762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drup.2021.100762%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Resistance%2520Updates%26atitle%3DTargeted%252Bnanomedicine%252Bmodalities%252Bfor%252Bprostate%252Bcancer%252Btreatment%26aulast%3DCohen%26aufirst%3DLital%26date%3D2021%26volume%3D56%26spage%3D100762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zheng‐Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Liang</span>, <span class="hlFld-ContribAuthor ">Zhuo  Chen</span>, <span class="hlFld-ContribAuthor ">Lin  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Phase‐Transfer Catalytic Strategy: Rapid Synthesis of Spiro‐Fused Heterocycles, Integrated with Four Pharmacophores‐Succinimide, Pyrrolidine, Oxindole, and Trifluoromethyl Group. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (5)
                                     , 788-793. <a href="https://doi.org/10.1002/ejoc.202001409" title="DOI URL">https://doi.org/10.1002/ejoc.202001409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001409%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPhase%2525E2%252580%252590Transfer%252BCatalytic%252BStrategy%25253A%252BRapid%252BSynthesis%252Bof%252BSpiro%2525E2%252580%252590Fused%252BHeterocycles%25252C%252BIntegrated%252Bwith%252BFour%252BPharmacophores%2525E2%252580%252590Succinimide%25252C%252BPyrrolidine%25252C%252BOxindole%25252C%252Band%252BTrifluoromethyl%252BGroup%26aulast%3DChen%26aufirst%3DZheng%25E2%2580%2590Jun%26date%3D2021%26date%3D2020%26volume%3D2021%26issue%3D5%26spage%3D788%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Afsharzadeh</span>, <span class="hlFld-ContribAuthor ">Maryam  Hashemi</span>, <span class="hlFld-ContribAuthor ">Maryam  Babaei</span>, <span class="hlFld-ContribAuthor ">Khalil  Abnous</span>, <span class="hlFld-ContribAuthor ">Mohammad  Ramezani</span>. </span><span class="cited-content_cbyCitation_article-title">PEG‐PLA nanoparticles decorated with small‐molecule PSMA ligand for targeted delivery of galbanic acid and docetaxel to prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2020,</strong> <em>235 </em>
                                    (5)
                                     , 4618-4630. <a href="https://doi.org/10.1002/jcp.29339" title="DOI URL">https://doi.org/10.1002/jcp.29339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.29339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.29339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DPEG%2525E2%252580%252590PLA%252Bnanoparticles%252Bdecorated%252Bwith%252Bsmall%2525E2%252580%252590molecule%252BPSMA%252Bligand%252Bfor%252Btargeted%252Bdelivery%252Bof%252Bgalbanic%252Bacid%252Band%252Bdocetaxel%252Bto%252Bprostate%252Bcancer%252Bcells%26aulast%3DAfsharzadeh%26aufirst%3DMaryam%26date%3D2020%26date%3D2019%26volume%3D235%26issue%3D5%26spage%3D4618%26epage%3D4630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinyue  Yao</span>, <span class="hlFld-ContribAuthor ">Zhihao  Zha</span>, <span class="hlFld-ContribAuthor ">Karl  Ploessl</span>, <span class="hlFld-ContribAuthor ">Seok Rye  Choi</span>, <span class="hlFld-ContribAuthor ">Ruiyue  Zhao</span>, <span class="hlFld-ContribAuthor ">David  Alexoff</span>, <span class="hlFld-ContribAuthor ">Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Hank F.  Kung</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of novel radioiodinated PSMA targeting ligands for potential radiotherapy of prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (5)
                                     , 115319. <a href="https://doi.org/10.1016/j.bmc.2020.115319" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115319%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252Bradioiodinated%252BPSMA%252Btargeting%252Bligands%252Bfor%252Bpotential%252Bradiotherapy%252Bof%252Bprostate%252Bcancer%26aulast%3DYao%26aufirst%3DXinyue%26date%3D2020%26volume%3D28%26issue%3D5%26spage%3D115319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongmok  Kwon</span>, <span class="hlFld-ContribAuthor ">Sang‐Hyun  Son</span>, <span class="hlFld-ContribAuthor ">Youngjoo  Byun</span>. </span><span class="cited-content_cbyCitation_article-title">Prostate‐Specific Membrane Antigen (PSMA)‐Targeted Radionuclide Probes for Imaging and Therapy of Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>8 </em>
                                    (9)
                                     , 1588-1600. <a href="https://doi.org/10.1002/ajoc.201900329" title="DOI URL">https://doi.org/10.1002/ajoc.201900329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201900329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201900329%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DProstate%2525E2%252580%252590Specific%252BMembrane%252BAntigen%252B%252528PSMA%252529%2525E2%252580%252590Targeted%252BRadionuclide%252BProbes%252Bfor%252BImaging%252Band%252BTherapy%252Bof%252BProstate%252BCancer%26aulast%3DKwon%26aufirst%3DHongmok%26date%3D2019%26date%3D2019%26volume%3D8%26issue%3D9%26spage%3D1588%26epage%3D1600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sagnik  Sengupta</span>, <span class="hlFld-ContribAuthor ">Mena  Asha Krishnan</span>, <span class="hlFld-ContribAuthor ">Sudeshna  Chattopadhyay</span>, <span class="hlFld-ContribAuthor ">Venkatesh  Chelvam</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of prostate‐specific membrane antigen ligands in clinical translation research for diagnosis of prostate cancer. </span><span class="cited-content_cbyCitation_journal-name">CANCER REPORTS</span><span> <strong>2019,</strong> <em>59 </em>, e1169. <a href="https://doi.org/10.1002/cnr2.1169" title="DOI URL">https://doi.org/10.1002/cnr2.1169</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cnr2.1169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcnr2.1169%26sid%3Dliteratum%253Aachs%26jtitle%3DCANCER%2520REPORTS%26atitle%3DComparison%252Bof%252Bprostate%2525E2%252580%252590specific%252Bmembrane%252Bantigen%252Bligands%252Bin%252Bclinical%252Btranslation%252Bresearch%252Bfor%252Bdiagnosis%252Bof%252Bprostate%252Bcancer%26aulast%3DSengupta%26aufirst%3DSagnik%26date%3D2019%26date%3D2019%26volume%3D59%26spage%3De1169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tsuneo  Saga</span>, <span class="hlFld-ContribAuthor ">Yuji  Nakamoto</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Ishimori</span>, <span class="hlFld-ContribAuthor ">Takahiro  Inoue</span>, <span class="hlFld-ContribAuthor ">Yoichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Shusuke  Akamatsu</span>, <span class="hlFld-ContribAuthor ">Takayuki  Goto</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kosuke  Kitaguchi</span>, <span class="hlFld-ContribAuthor ">Masao  Watanabe</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>, <span class="hlFld-ContribAuthor ">Osamu  Ogawa</span>, <span class="hlFld-ContribAuthor ">Kaori  Togashi</span>. </span><span class="cited-content_cbyCitation_article-title">Initial evaluation of
              PET
              /
              CT
              with
              18
              F‐
              FSU
              ‐880 targeting prostate‐specific membrane antigen in prostate cancer patients. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2019,</strong> <em>110 </em>
                                    (2)
                                     , 742-750. <a href="https://doi.org/10.1111/cas.13911" title="DOI URL">https://doi.org/10.1111/cas.13911</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.13911&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.13911%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DInitial%252Bevaluation%252Bof%252BPET%252B%25252F%252BCT%252Bwith%252B18%252BF%2525E2%252580%252590%252BFSU%252B%2525E2%252580%252590880%252Btargeting%252Bprostate%2525E2%252580%252590specific%252Bmembrane%252Bantigen%252Bin%252Bprostate%252Bcancer%252Bpatients%26aulast%3DSaga%26aufirst%3DTsuneo%26date%3D2019%26date%3D2019%26volume%3D110%26issue%3D2%26spage%3D742%26epage%3D750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Till  Wüstemann</span>, <span class="hlFld-ContribAuthor ">Uwe  Haberkorn</span>, <span class="hlFld-ContribAuthor ">John  Babich</span>, <span class="hlFld-ContribAuthor ">Walter  Mier</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (1)
                                     , 40-69. <a href="https://doi.org/10.1002/med.21508" title="DOI URL">https://doi.org/10.1002/med.21508</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21508%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252Bprostate%252Bcancer%25253A%252BProstate-specific%252Bmembrane%252Bantigen%252Bbased%252Bdiagnosis%252Band%252Btherapy%26aulast%3DW%25C3%25BCstemann%26aufirst%3DTill%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D1%26spage%3D40%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ganesan  Vaidyanathan</span>, <span class="hlFld-ContribAuthor ">Choong Mo  Kang</span>, <span class="hlFld-ContribAuthor ">Darryl  McDougald</span>, <span class="hlFld-ContribAuthor ">Il  Minn</span>, <span class="hlFld-ContribAuthor ">Mary  Brummet</span>, <span class="hlFld-ContribAuthor ">Martin G.  Pomper</span>, <span class="hlFld-ContribAuthor ">Michael R.  Zalutsky</span>. </span><span class="cited-content_cbyCitation_article-title">Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2018,</strong> <em>62-63 </em>, 18-30. <a href="https://doi.org/10.1016/j.nucmedbio.2018.05.002" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2018.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2018.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2018.05.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DBrush%252Bborder%252Benzyme-cleavable%252Blinkers%25253A%252BEvaluation%252Bfor%252Breducing%252Brenal%252Buptake%252Bof%252Bradiolabeled%252Bprostate-specific%252Bmembrane%252Bantigen%252Binhibitors%26aulast%3DVaidyanathan%26aufirst%3DGanesan%26date%3D2018%26volume%3D62-63%26spage%3D18%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daiko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yoichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Yusuke  Yagi</span>, <span class="hlFld-ContribAuthor ">Ryoko  Kawai</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of succinimidyl-Cys-C(O)-Glu derivatives with different near-infrared fluorophores as optical imaging probes for prostate-specific membrane antigen. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2291-2301. <a href="https://doi.org/10.1016/j.bmc.2018.03.015" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bsuccinimidyl-Cys-C%252528O%252529-Glu%252Bderivatives%252Bwith%252Bdifferent%252Bnear-infrared%252Bfluorophores%252Bas%252Boptical%252Bimaging%252Bprobes%252Bfor%252Bprostate-specific%252Bmembrane%252Bantigen%26aulast%3DMatsuoka%26aufirst%3DDaiko%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2291%26epage%3D2301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhihao  Zha</span>, <span class="hlFld-ContribAuthor ">Karl  Ploessl</span>, <span class="hlFld-ContribAuthor ">Seok Rye  Choi</span>, <span class="hlFld-ContribAuthor ">Zehui  Wu</span>, <span class="hlFld-ContribAuthor ">Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Hank F.  Kung</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of a novel urea-based  68 Ga-complex for imaging PSMA binding in tumor. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2018,</strong> <em>59 </em>, 36-47. <a href="https://doi.org/10.1016/j.nucmedbio.2017.12.007" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2017.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2017.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2017.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Burea-based%252B68%252BGa-complex%252Bfor%252Bimaging%252BPSMA%252Bbinding%252Bin%252Btumor%26aulast%3DZha%26aufirst%3DZhihao%26date%3D2018%26volume%3D59%26spage%3D36%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daiko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yoichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of a novel near-infrared fluorescent probe based on succinimidyl-Cys-C(O)-Glu that targets prostate-specific membrane antigen for optical imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (21)
                                     , 4876-4880. <a href="https://doi.org/10.1016/j.bmcl.2017.09.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.09.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.09.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.09.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bnovel%252Bnear-infrared%252Bfluorescent%252Bprobe%252Bbased%252Bon%252Bsuccinimidyl-Cys-C%252528O%252529-Glu%252Bthat%252Btargets%252Bprostate-specific%252Bmembrane%252Bantigen%252Bfor%252Boptical%252Bimaging%26aulast%3DMatsuoka%26aufirst%3DDaiko%26date%3D2017%26volume%3D27%26issue%3D21%26spage%3D4876%26epage%3D4880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Molecular Imaging. </span><span class="cited-content_cbyCitation_journal-name">Biological & Pharmaceutical Bulletin</span><span> <strong>2017,</strong> <em>40 </em>
                                    (10)
                                     , 1605-1615. <a href="https://doi.org/10.1248/bpb.b17-00505" title="DOI URL">https://doi.org/10.1248/bpb.b17-00505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/bpb.b17-00505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fbpb.b17-00505%26sid%3Dliteratum%253Aachs%26jtitle%3DBiological%2520%2526%2520Pharmaceutical%2520Bulletin%26atitle%3DIn%252BVivo%252BMolecular%252BImaging%26aulast%3DSaji%26aufirst%3DHideo%26date%3D2017%26volume%3D40%26issue%3D10%26spage%3D1605%26epage%3D1615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoya  Harada</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Satoru  Onoe</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Daiko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Kenji  Arimitsu</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biologic Evaluation of Novel
              18
              F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2016,</strong> <em>57 </em>
                                    (12)
                                     , 1978-1984. <a href="https://doi.org/10.2967/jnumed.116.175810" title="DOI URL">https://doi.org/10.2967/jnumed.116.175810</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.116.175810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.116.175810%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DSynthesis%252Band%252BBiologic%252BEvaluation%252Bof%252BNovel%252B18%252BF-Labeled%252BProbes%252BTargeting%252BProstate-Specific%252BMembrane%252BAntigen%252Bfor%252BPET%252Bof%252BProstate%252BCancer%26aulast%3DHarada%26aufirst%3DNaoya%26date%3D2016%26date%3D2016%26volume%3D57%26issue%3D12%26spage%3D1978%26epage%3D1984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elena  Dolci</span>, <span class="hlFld-ContribAuthor ">Vincent  Froidevaux</span>, <span class="hlFld-ContribAuthor ">Christine  Joly-Duhamel</span>, <span class="hlFld-ContribAuthor ">Rémi  Auvergne</span>, <span class="hlFld-ContribAuthor ">Bernard  Boutevin</span>, <span class="hlFld-ContribAuthor ">Sylvain  Caillol</span>. </span><span class="cited-content_cbyCitation_article-title">Maleimides As a Building Block for the Synthesis of High Performance Polymers. </span><span class="cited-content_cbyCitation_journal-name">Polymer Reviews</span><span> <strong>2016,</strong> <em>56 </em>
                                    (3)
                                     , 512-556. <a href="https://doi.org/10.1080/15583724.2015.1116094" title="DOI URL">https://doi.org/10.1080/15583724.2015.1116094</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/15583724.2015.1116094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F15583724.2015.1116094%26sid%3Dliteratum%253Aachs%26jtitle%3DPolymer%2520Reviews%26atitle%3DMaleimides%252BAs%252Ba%252BBuilding%252BBlock%252Bfor%252Bthe%252BSynthesis%252Bof%252BHigh%252BPerformance%252BPolymers%26aulast%3DDolci%26aufirst%3DElena%26date%3D2016%26date%3D2016%26volume%3D56%26issue%3D3%26spage%3D512%26epage%3D556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun-Ha  Cho</span>, <span class="hlFld-ContribAuthor ">Jae Cheong  Lim</span>, <span class="hlFld-ContribAuthor ">So-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Sung-Hee  Jung</span>. </span><span class="cited-content_cbyCitation_article-title">An assessment tumor targeting ability of 177Lu labeled cyclic CCK analogue peptide by binding with cholecystokinin receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacological Sciences</span><span> <strong>2016,</strong> <em>131 </em>
                                    (3)
                                     , 209-214. <a href="https://doi.org/10.1016/j.jphs.2016.06.006" title="DOI URL">https://doi.org/10.1016/j.jphs.2016.06.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphs.2016.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphs.2016.06.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacological%2520Sciences%26atitle%3DAn%252Bassessment%252Btumor%252Btargeting%252Bability%252Bof%252B177Lu%252Blabeled%252Bcyclic%252BCCK%252Banalogue%252Bpeptide%252Bby%252Bbinding%252Bwith%252Bcholecystokinin%252Breceptor%26aulast%3DCho%26aufirst%3DEun-Ha%26date%3D2016%26volume%3D131%26issue%3D3%26spage%3D209%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Sotaro  Sampei</span>, <span class="hlFld-ContribAuthor ">Daiko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Naoya  Harada</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kenji  Arimitsu</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 99mTc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (10)
                                     , 2251-2256. <a href="https://doi.org/10.1016/j.bmc.2016.03.051" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.051</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.051%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252B99mTc-labeled%252Basymmetric%252Burea%252Bderivatives%252Bthat%252Btarget%252Bprostate-specific%252Bmembrane%252Bantigen%252Bfor%252Bsingle-photon%252Bemission%252Bcomputed%252Btomography%252Bimaging%26aulast%3DKimura%26aufirst%3DHiroyuki%26date%3D2016%26volume%3D24%26issue%3D10%26spage%3D2251%26epage%3D2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jessica K.  Simmons</span>, <span class="hlFld-ContribAuthor ">Wessel P.  Dirksen</span>, <span class="hlFld-ContribAuthor ">Blake E.  Hildreth</span>, <span class="hlFld-ContribAuthor ">Carlee  Dorr</span>, <span class="hlFld-ContribAuthor ">Christina  Williams</span>, <span class="hlFld-ContribAuthor ">Rachael  Thomas</span>, <span class="hlFld-ContribAuthor ">Matthew  Breen</span>, <span class="hlFld-ContribAuthor ">Ramiro E.  Toribio</span>, <span class="hlFld-ContribAuthor ">Thomas J.  Rosol</span>. </span><span class="cited-content_cbyCitation_article-title">Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivo. </span><span class="cited-content_cbyCitation_journal-name">The Prostate</span><span> <strong>2014,</strong> <em>74 </em>
                                    (13)
                                     , 1251-1265. <a href="https://doi.org/10.1002/pros.22838" title="DOI URL">https://doi.org/10.1002/pros.22838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pros.22838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpros.22838%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Prostate%26atitle%3DCanine%252Bprostate%252Bcancer%252Bcell%252Bline%252B%252528Probasco%252529%252Bproduces%252Bosteoblastic%252Bmetastases%252Bin%252Bvivo%26aulast%3DSimmons%26aufirst%3DJessica%2BK.%26date%3D2014%26date%3D2014%26volume%3D74%26issue%3D13%26spage%3D1251%26epage%3D1265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masashi  Ueda</span>, <span class="hlFld-ContribAuthor ">Takahiro  Fukushima</span>, <span class="hlFld-ContribAuthor ">Kei  Ogawa</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Takashi  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Yuzuru  Ikehara</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of a radioiodinated peptide probe targeting αvβ6 integrin for the detection of pancreatic ductal adenocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2014,</strong> <em>445 </em>
                                    (3)
                                     , 661-666. <a href="https://doi.org/10.1016/j.bbrc.2014.02.086" title="DOI URL">https://doi.org/10.1016/j.bbrc.2014.02.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2014.02.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2014.02.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Ba%252Bradioiodinated%252Bpeptide%252Bprobe%252Btargeting%252B%2525CE%2525B1v%2525CE%2525B26%252Bintegrin%252Bfor%252Bthe%252Bdetection%252Bof%252Bpancreatic%252Bductal%252Badenocarcinoma%26aulast%3DUeda%26aufirst%3DMasashi%26date%3D2014%26volume%3D445%26issue%3D3%26spage%3D661%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of <sup>125</sup>I-labeled probes used in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Strategy for the design and derivatization of [<sup>123</sup>I]<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of IGLCE (<b>3</b>)</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Type 1 and 2 Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Methylmorpholine, ClCO<sub>2</sub>CH<sub>3</sub>, ethyl acetate, 88%; (b) Boc-Lys-OH, NaHCO<sub>3</sub>, H<sub>2</sub>O, 76%; (c) BocHNC<sub>4</sub>H<sub>8</sub>NH<sub>2</sub>, NaHCO<sub>3</sub>, H<sub>2</sub>O, 1,4-dioxane, 97%; (d) HCl, ethyl acetate, 66% (<b>6a</b>), 75% (<b>6b</b>); (e) H-Gly-OPMB, WSCI, Et<sub>3</sub>N, DMF, 64% (<b>7a</b>), 57% (<b>7b</b>); (f) TFA, DCM, 97% (<b>8a</b>), 94% (<b>8b</b>); (g) NHS, DIC, DMF, 62% (<b>9a</b>), 95% (<b>9b</b>); (h) <b>6a</b>, <b>9b</b>, DIPEA, CH<sub>3</sub>CN, 32%; (i) <b>6b</b>, <b>9a</b>, DIPEA, CH<sub>3</sub>CN, 46%; (j) <b>2</b>, NaOH, H<sub>2</sub>O, CH<sub>3</sub>CN,54% (<b>11a</b>), 43% (<b>11b</b>).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Type 3 Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) DCC, NHS 1,4-dioxane, 98%; (b) H<sub>2</sub>NC<sub>3</sub>H<sub>6</sub>COOH, DIPEA, CH<sub>3</sub>CN, 39%; (c) H<sub>2</sub>NC<sub>4</sub>H<sub>8</sub>COOH, DIPEA, CH<sub>3</sub>CN, 65%; (d) H<sub>2</sub>NC<sub>5</sub>H<sub>10</sub>COOH, DIPEA, CH<sub>3</sub>CN, 50%; (e) NHS, WSCI, DMF, 36% (<b>14a</b>), 60% (<b>14b</b>), 49% (<b>14c</b>); (f) <b>6a</b>, DIPEA, CH<sub>3</sub>CN, 14% (<b>15a</b>), 17% (<b>15b</b>), 24% (<b>15c</b>); (g) <b>2</b>, NaOH, H<sub>2</sub>O, CH<sub>3</sub>CN, 58% (<b>16a</b>), 73% (<b>16b</b>), 23% (<b>16c</b>), 43% (<b>18</b>); (h) <b>6a</b>, DIPEA, CH<sub>3</sub>CN, 26%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Type 4 Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <b>2</b>, NaOH, H<sub>2</sub>O, CH<sub>3</sub>CN, 45%; (b) <i>N</i>-hydroxysuccinimide, WSCI, DMF, 63%; (c) (i) <b>6a</b>, DIPEA, CH<sub>3</sub>CN, (ii) HCl, ethyl acetate, 4% (2 steps); (d) <b>2</b>, NaOH, H<sub>2</sub>O, 52%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Time-dependent degradation of [<sup>125</sup>I]<b>3</b> over 6 h. No degradation products were observed over the 6 h incubation period. (B) Shown are radio-HPLC charts after 6 h (left) and 18 h (right) incubations. The intact compound peaks elute at 23.03 min. The subpeak at 21.5 min is likely 3-[<sup>125</sup>I]iodohuppric acid.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. In the blocking study, all mice were sacrificed 30 min after injection. Data for the stomach are expressed as %ID. (A) In normal tissues, significant inhibition by 2-PMPA was observed in kidney and spleen. (B) Accumulation in LNCaP tumors was significantly inhibited by 2-PMPA. The difference between the accumulations in PC-3 tumors and blocked LNCaP tumors was not significant (*<i>P</i> < 0.05; NS, not significant).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/medium/jm-2013-00895s_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A,B) Transaxial SPECT/CT images obtained with [<sup>123</sup>I]<b>3</b>. Mice were injected with [<sup>123</sup>I]<b>3</b> without (A) or with (B) 2-PMPA (50 mg/kg weight). [<sup>123</sup>I]<b>3</b> clearly illuminated LNCaP tumors (A), and 2-PMPA prevented this reaction (B). [<sup>123</sup>I]<b>3</b> did not accumulate in PC-3 tumors. (C) Coronal SPECT/CT images were obtained with [<sup>123</sup>I]<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-20/jm400895s/production/images/large/jm-2013-00895s_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400895s&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26474" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26474" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Siegel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naishadham, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jemal, A.</span><span> </span><span class="NLM_article-title">Cancer Statistics, 2012</span> <span class="citation_source-journal">CA: Cancer J. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">10</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=10-29&author=R.+Siegelauthor=D.+Naishadhamauthor=A.+Jemal&title=Cancer+Statistics%2C+2012"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%26aulast%3DNaishadham%26aufirst%3DD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520Statistics%252C%25202012%26jtitle%3DCA%253A%2520Cancer%2520J.%2520Clin.%26date%3D2012%26volume%3D62%26spage%3D10%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cook, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, A.</span><span> </span><span class="NLM_article-title">Prostate Cancer Screening</span> <span class="citation_source-journal">Curr. Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1007%2Fs11912-010-0136-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivFClsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2011&pages=57-62&author=E.+Cookauthor=A.+Nelson&title=Prostate+Cancer+Screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate Cancer Screening</span></div><div class="casAuthors">Cook, Elise D.; Nelson, Ana C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Oncology Reports</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-62</span>CODEN:
                <span class="NLM_cas:coden">CORUAT</span>;
        ISSN:<span class="NLM_cas:issn">1534-6269</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Prostate cancer is the most common cancer and the second leading cause of cancer-related deaths in American men.  Although the use of the prostate-specific antigen (PSA) test for prostate cancer screening since the 1990s has led to increased early diagnoses, the most recent studies are in conflict about the risks and benefits of routine prostate cancer screening.  Recently, evidence has emerged to support the use of the PSA test to lower mortality, but there is still concern that over-diagnosis may lead to over-treatment of cancers that would not significantly affect patients' health for several years.  This article describes the results of important recent prostate cancer screening trials, the National Comprehensive Cancer Network and American Cancer Society screening guidelines, and discusses the implications for clin. practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYhqWk_--1M7Vg90H21EOLACvtfcHk0liKR_Gj8MxX1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivFClsA%253D%253D&md5=2d9df49378329ae27f55200a36940b9a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs11912-010-0136-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11912-010-0136-x%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DE.%26aulast%3DNelson%26aufirst%3DA.%26atitle%3DProstate%2520Cancer%2520Screening%26jtitle%3DCurr.%2520Oncol.%2520Rep.%26date%3D2011%26volume%3D13%26spage%3D57%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hugosson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aus, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergdahl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khatami, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pihl, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stranne, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmberg, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilja, H.</span><span> </span><span class="NLM_article-title">Mortality results from the Goteborg randomised population-based prostate-cancer screening trial</span> <span class="citation_source-journal">Lancet Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">725</span><span class="NLM_x">–</span> <span class="NLM_lpage">732</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1016%2FS1470-2045%2810%2970146-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BC3cjltVCrtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=725-732&author=J.+Hugossonauthor=S.+Carlssonauthor=G.+Ausauthor=S.+Bergdahlauthor=A.+Khatamiauthor=P.+Loddingauthor=C.+Pihlauthor=J.+Stranneauthor=E.+Holmbergauthor=H.+Lilja&title=Mortality+results+from+the+Goteborg+randomised+population-based+prostate-cancer+screening+trial"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Mortality results from the Goteborg randomised population-based prostate-cancer screening trial</span></div><div class="casAuthors">Hugosson Jonas; Carlsson Sigrid; Aus Gunnar; Bergdahl Svante; Khatami Ali; Lodding Par; Pihl Carl-Gustaf; Stranne Johan; Holmberg Erik; Lilja Hans</div><div class="citationInfo"><span class="NLM_cas:title">The lancet oncology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">725-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world.  One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate.  METHODS:  In December, 1994, 20,000 men born between 1930 and 1944, randomly sampled from the population register, were randomised by computer in a 1:1 ratio to either a screening group invited for PSA testing every 2 years (n=10,000) or to a control group not invited (n=10,000).  Men in the screening group were invited up to the upper age limit (median 69, range 67-71 years) and only men with raised PSA concentrations were offered additional tests such as digital rectal examination and prostate biopsies.  The primary endpoint was prostate-cancer specific mortality, analysed according to the intention-to-screen principle.  The study is ongoing, with men who have not reached the upper age limit invited for PSA testing.  This is the first planned report on cumulative prostate-cancer incidence and mortality calculated up to Dec 31, 2008.  This study is registered as an International Standard Randomised Controlled Trial ISRCTN54449243.  FINDINGS:  In each group, 48 men were excluded from the analysis because of death or emigration before the randomisation date, or prevalent prostate cancer.  In men randomised to screening, 7578 (76%) of 9952 attended at least once.  During a median follow-up of 14 years, 1138 men in the screening group and 718 in the control group were diagnosed with prostate cancer, resulting in a cumulative prostate-cancer incidence of 12.7% in the screening group and 8.2% in the control group (hazard ratio 1.64; 95% CI 1.50-1.80; p<0.0001).  The absolute cumulative risk reduction of death from prostate cancer at 14 years was 0.40% (95% CI 0.17-0.64), from 0.90% in the control group to 0.50% in the screening group.  The rate ratio for death from prostate cancer was 0.56 (95% CI 0.39-0.82; p=0.002) in the screening compared with the control group.  The rate ratio of death from prostate cancer for attendees compared with the control group was 0.44 (95% CI 0.28-0.68; p=0.0002).  Overall, 293 (95% CI 177-799) men needed to be invited for screening and 12 to be diagnosed to prevent one prostate cancer death.  INTERPRETATION:  This study shows that prostate cancer mortality was reduced almost by half over 14 years.  However, the risk of over-diagnosis is substantial and the number needed to treat is at least as high as in breast-cancer screening programmes.  The benefit of prostate-cancer screening compares favourably to other cancer screening programs.  FUNDING:  The Swedish Cancer Society, the Swedish Research Council, and the National Cancer Institute.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRyN9gpZPQ1Ehjv2lLSLOxFfW6udTcc2eYvdWL5yTo7ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cjltVCrtg%253D%253D&md5=1c8d1ea5d05059690871bc6b08499330</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2810%2970146-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252810%252970146-7%26sid%3Dliteratum%253Aachs%26aulast%3DHugosson%26aufirst%3DJ.%26aulast%3DCarlsson%26aufirst%3DS.%26aulast%3DAus%26aufirst%3DG.%26aulast%3DBergdahl%26aufirst%3DS.%26aulast%3DKhatami%26aufirst%3DA.%26aulast%3DLodding%26aufirst%3DP.%26aulast%3DPihl%26aufirst%3DC.%26aulast%3DStranne%26aufirst%3DJ.%26aulast%3DHolmberg%26aufirst%3DE.%26aulast%3DLilja%26aufirst%3DH.%26atitle%3DMortality%2520results%2520from%2520the%2520Goteborg%2520randomised%2520population-based%2520prostate-cancer%2520screening%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2010%26volume%3D11%26spage%3D725%26epage%3D732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Stamey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcneal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freiha, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redwine, E.</span><span> </span><span class="NLM_article-title">Prostate-Specific Antigen as a Serum Marker For Adenocarcinoma Of The Prostate</span> <span class="citation_source-journal">New Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span><span class="NLM_x">–</span> <span class="NLM_lpage">916</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1056%2FNEJM198710083171501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=2442609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADyaL2szhsFakug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=1987&pages=909-916&author=T.+Stameyauthor=N.+Yangauthor=A.+Hayauthor=J.+Mcnealauthor=F.+Freihaauthor=E.+Redwine&title=Prostate-Specific+Antigen+as+a+Serum+Marker+For+Adenocarcinoma+Of+The+Prostate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate</span></div><div class="casAuthors">Stamey T A; Yang N; Hay A R; McNeal J E; Freiha F S; Redwine E</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">909-16</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">To compare the clinical usefulness of the serum markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP), we measured them by radioimmunoassay in 2200 serum samples from 699 patients, 378 of whom had prostatic cancer.  PSA was elevated in 122 of 127 patients with newly diagnosed, untreated prostatic cancer, including 7 of 12 patients with unsuspected early disease and all of 115 with more advanced disease.  The PSA level increased with advancing clinical stage and was proportional to the estimated volume of the tumor.  The PAP concentration was elevated in only 57 of the patients with cancer and correlated less closely with tumor volume.  PSA was increased in 86 percent and PAP in 14 percent of the patients with benign prostatic hyperplasia.  After radical prostatectomy for cancer, PSA routinely fell to undetectable levels, with a half-life of 2.2 days.  If initially elevated, PAP fell to normal levels within 24 hours but always remained detectable.  In six patients followed postoperatively by means of repeated measurements, PSA--but not PAP--appeared to be useful in detecting residual and early recurrence of tumor and in monitoring responses to radiation therapy.  Prostate massage increased the levels of both PSA and PAP approximately 1.5 to 2 times.  Needle biopsy and transurethral resection increased both considerably.  We conclude that PSA is more sensitive than PAP in the detection of prostatic cancer and will probably be more useful in monitoring responses and recurrence after therapy.  However, since both PSA and PAP may be elevated in benign prostatic hyperplasia, neither marker is specific.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR3KA7iei6rnMvLc4ARHEmzfW6udTcc2eYvdWL5yTo7ybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2szhsFakug%253D%253D&md5=7961023350b1cf31483d61ca8d80041b</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJM198710083171501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM198710083171501%26sid%3Dliteratum%253Aachs%26aulast%3DStamey%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DN.%26aulast%3DHay%26aufirst%3DA.%26aulast%3DMcneal%26aufirst%3DJ.%26aulast%3DFreiha%26aufirst%3DF.%26aulast%3DRedwine%26aufirst%3DE.%26atitle%3DProstate-Specific%2520Antigen%2520as%2520a%2520Serum%2520Marker%2520For%2520Adenocarcinoma%2520Of%2520The%2520Prostate%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D1987%26volume%3D317%26spage%3D909%26epage%3D916" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Effert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bares, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Handt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakse, G.</span><span> </span><span class="NLM_article-title">Metabolic imaging of untreated prostate cancer by positron emission tomography with (18)fluorine-labeled deoxyglucose</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">155</span><span class="NLM_x">, </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1016%2FS0022-5347%2801%2966366-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADyaK287msVKnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=155&publication_year=1996&pages=994-998&author=P.+Effertauthor=R.+Baresauthor=S.+Handtauthor=J.+Wolffauthor=U.+Bullauthor=G.+Jakse&title=Metabolic+imaging+of+untreated+prostate+cancer+by+positron+emission+tomography+with+%2818%29fluorine-labeled+deoxyglucose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose</span></div><div class="casAuthors">Effert P J; Bares R; Handt S; Wolff J M; Bull U; Jakse G</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of urology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">155</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">994-8</span>
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    </div><div class="casAbstract">PURPOSE:  We evaluated positron emission tomograph (PET) with 18fluorine (18F)-labeled deoxyglucose for metabolic grading of untreated primary prostate cancer, and differentiation of benign and malignant prostatic disease.  MATERIALS AND METHODS:  A total of 48 patients with untreated prostate cancer of different stages and 16 with histologically confirmed benign prostatic hyperplasia (BPH) underwent static PET after intravenous injection of 150 to 300 MBq. 18F-deoxyglucose. 18F-deoxyglucose accumulation was quantitated by calculating differential uptake ratios and prostate-to-skeletal muscle ratios.  RESULTS:  Low 18F-deoxyglucose uptake was noted in the majority of primary tumors (81%). 18F-deoxyglucose accumulation did not correlate with increasing tumor grade or stage.  There was a significant overlap in uptake values in BPH and malignant prostatic disease.  A trend towards statistical significance was noted with lower prostate-to-skeletal muscle ratios in patients with BPH (p < 0.07).  Increased 18F-deoxyglucose accumulation was detected in some patients with BPH and malignant prostatic disease, as well as in those with lymph node and bone metastases of prostate cancer.  CONCLUSIONS:  18F-deoxyglucose PET does not allow for metabolic labeling in the majority of untreated primary prostate cancers.  BPH and primary prostate cancer cannot be reliably differentiated on the basis of PET.  Increased 18F-deoxyglucose accumulation occurs in some primary prostate tumors and in metastatic deposits of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRP14DyxVo2fwqdek-gHSrIfW6udTcc2eZm1MnrsFpi1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK287msVKnug%253D%253D&md5=189d6fab95ccff0ed579278ff4f63e2e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0022-5347%2801%2966366-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-5347%252801%252966366-3%26sid%3Dliteratum%253Aachs%26aulast%3DEffert%26aufirst%3DP.%26aulast%3DBares%26aufirst%3DR.%26aulast%3DHandt%26aufirst%3DS.%26aulast%3DWolff%26aufirst%3DJ.%26aulast%3DBull%26aufirst%3DU.%26aulast%3DJakse%26aufirst%3DG.%26atitle%3DMetabolic%2520imaging%2520of%2520untreated%2520prostate%2520cancer%2520by%2520positron%2520emission%2520tomography%2520with%2520%252818%2529fluorine-labeled%2520deoxyglucose%26jtitle%3DJ.%2520Urol.%26date%3D1996%26volume%3D155%26spage%3D994%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Hain, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maisey, M.</span><span> </span><span class="NLM_article-title">Positron emission tomography for urological tumours</span> <span class="citation_source-journal">BJU Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">159</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1046%2Fj.1464-410X.2003.04284.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BD3s3psF2muw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=159-164&author=S.+Hainauthor=M.+Maisey&title=Positron+emission+tomography+for+urological+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography for urological tumours</span></div><div class="casAuthors">Hain S F; Maisey M N</div><div class="citationInfo"><span class="NLM_cas:title">BJU international</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-64</span>
        ISSN:<span class="NLM_cas:issn">1464-4096</span>.
    </div><div class="casAbstract">For urological tumours, positron emission tomography (PET) is currently most useful in testicular cancer.  In patients with residual masses or raised marker levels after treatment, PET is both sensitive and specific for detecting recurrent disease, at suspected and unsuspected sites.  Although fewer studies are available it also appears to be useful for staging at diagnosis, although this requires further investigation.  Prostate cancer imaging has been more variable, with studies showing that PET cannot reliably differentiate between tumour and hypertrophy.  It is not as good as a bone scan for defining bone metastases.  In renal cancer, PET can be used to define the primary tumour, providing better staging of local recurrence than computed tomography (CT), and to define metastatic disease.  There are few studies in bladder cancer, and despite excretion of the tracer via the bladder in early studies, it has better results than CT or magnetic resonance imaging for local staging; again it can detect metastases.  Overall, the place of PET in urological tumours is developing, with the strongest areas undoubtedly being testicular and renal cancer.  Tracers other than fluorodeoxyglucose are being examined and are providing further information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT7-To4evheSQyMywPm6HgQfW6udTcc2eZm1MnrsFpi1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3psF2muw%253D%253D&md5=e745ee72821104943fcdcb83b748c01b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1046%2Fj.1464-410X.2003.04284.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1464-410X.2003.04284.x%26sid%3Dliteratum%253Aachs%26aulast%3DHain%26aufirst%3DS.%26aulast%3DMaisey%26aufirst%3DM.%26atitle%3DPositron%2520emission%2520tomography%2520for%2520urological%2520tumours%26jtitle%3DBJU%2520Int.%26date%3D2003%26volume%3D92%26spage%3D159%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Bouchelouche, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkbey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capala, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choyke, P.</span><span> </span><span class="NLM_article-title">PET/CT Imaging and Radioimmunotherapy of Prostate Cancer</span> <span class="citation_source-journal">Semin. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1053%2Fj.semnuclmed.2010.08.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FgtFShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2011&pages=29-44&author=K.+Boucheloucheauthor=S.+Tagawaauthor=S.+Goldsmithauthor=B.+Turkbeyauthor=J.+Capalaauthor=P.+Choyke&title=PET%2FCT+Imaging+and+Radioimmunotherapy+of+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PET/CT Imaging and Radioimmunotherapy of Prostate Cancer</span></div><div class="casAuthors">Bouchelouche Kirsten; Tagawa Scott T; Goldsmith Stanley J; Turkbey Baris; Capala Jacek; Choyke Peter</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Prostate cancer is a common cancer in men and continues to be a major health problem.  Imaging plays an important role in the clinical management of patients with prostate cancer.  An important goal for prostate cancer imaging is more accurate disease characterization through the synthesis of anatomic, functional, and molecular imaging information.  Positron emission tomography (PET)/computed tomography (CT) in oncology is emerging as an important imaging tool.  The most common radiotracer for PET/CT in oncology, (18)F-fluorodeoxyglucose (FDG), is not very useful in the imaging of prostate cancer.  However, in recent years other PET tracers have improved the accuracy of PET/CT imaging of prostate cancer.  Among these, choline labeled with (18)F or (11)C, (11)C-acetate, and (18)F-fluoride has demonstrated promising results, and other new radiopharmaceuticals are under development and evaluation in preclinical and clinical studies.  Large prospective clinical PET/CT trials are needed to establish the role of PET/CT in prostate cancer patients.  Because there are only limited available therapeutic options for patients with advanced metastatic prostate cancer, there is an urgent need for the development of more effective treatment modalities that could improve outcome.  Prostate cancer represents an attractive target for radioimmunotherapy (RIT) for several reasons, including pattern of metastatic spread (lymph nodes and bone marrow, sites with good access to circulating antibodies) and small volume disease (ideal for antigen access and antibody delivery).  Furthermore, prostate cancer is also radiation sensitive.  Prostate-specific membrane antigen is expressed by virtually all prostate cancers, and represents an attractive target for RIT.  Antiprostate-specific membrane antigen RIT demonstrates antitumor activity and is well tolerated.  Clinical trials are underway to further improve upon treatment efficacy and patient selection.  This review focuses on the recent advances of clinical PET/CT imaging and RIT of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS-K1Rm_sF4_rYtC3U5jeOifW6udTcc2ebA6Pk5CyHcFLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FgtFShtA%253D%253D&md5=0b61a1bca4849aa7ed3d48bcebfc9ca2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2010.08.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2010.08.005%26sid%3Dliteratum%253Aachs%26aulast%3DBouchelouche%26aufirst%3DK.%26aulast%3DTagawa%26aufirst%3DS.%26aulast%3DGoldsmith%26aufirst%3DS.%26aulast%3DTurkbey%26aufirst%3DB.%26aulast%3DCapala%26aufirst%3DJ.%26aulast%3DChoyke%26aufirst%3DP.%26atitle%3DPET%252FCT%2520Imaging%2520and%2520Radioimmunotherapy%2520of%2520Prostate%2520Cancer%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D41%26spage%3D29%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zafar, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terris, M.</span><span> </span><span class="NLM_article-title">Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer</span> <span class="citation_source-journal">Urology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">108</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2001&pages=108-111&author=I.+Liuauthor=M.+Zafarauthor=Y.+Laiauthor=G.+Segallauthor=M.+Terris&title=Fluorodeoxyglucose+positron+emission+tomography+studies+in+diagnosis+and+staging+of+clinically+organ-confined+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DI.%26aulast%3DZafar%26aufirst%3DM.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DSegall%26aufirst%3DG.%26aulast%3DTerris%26aufirst%3DM.%26atitle%3DFluorodeoxyglucose%2520positron%2520emission%2520tomography%2520studies%2520in%2520diagnosis%2520and%2520staging%2520of%2520clinically%2520organ-confined%2520prostate%2520cancer%26jtitle%3DUrology%26date%3D2001%26volume%3D57%26spage%3D108%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rojas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">856</span><span class="NLM_x">–</span> <span class="NLM_lpage">870</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.2174%2F092986712799034888" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=22214450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=856-870&author=C.+Barinkaauthor=C.+Rojasauthor=B.+Slusherauthor=M.+Pomper&title=Glutamate+Carboxypeptidase+II+in+Diagnosis+and+Treatment+of+Neurologic+Disorders+and+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer</span></div><div class="casAuthors">Barinka, C.; Rojas, C.; Slusher, B.; Pomper, M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">856-870</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate carboxypeptidase II (GCPII) is a membrane-bound binuclear zinc metallopeptidase with the highest expression levels found in the nervous and prostatic tissue.  Throughout the nervous system, glia-bound GCPII is intimately involved in the neuronneuron and neuron-glia signaling via the hydrolysis of N-acetylaspartylglutamate (NAAG), the most abundant mammalian peptidic neurotransmitter.  The inhibition of the GCPII-controlled NAAG catabolism has been shown to attenuate neurotoxicity assocd. with enhanced glutamate transmission and GCPII-specific inhibitors demonstrate efficacy in multiple preclin. models including traumatic brain injury, stroke, neuropathic and inflammatory pain, amyotrophic lateral sclerosis, and schizophrenia.  The second major area of pharmacol. interventions targeting GCPII focuses on prostate carcinoma; GCPII expression levels are highly increased in androgen-independent and metastatic disease.  Consequently, the enzyme serves as a potential target for imaging and therapy.  This review offers a summary of GCPII structure, physiol. functions in healthy tissues, and its assocn. with various pathologies.  The review also outlines the development of GCPII-specific small-mol. compds. and their use in preclin. and clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyUBiL7cpnjrVg90H21EOLACvtfcHk0liHXmiJ57x7wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xisleksr4%253D&md5=1d4a526d7ecd78b11f6b405112d6220a</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2174%2F092986712799034888&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986712799034888%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DRojas%26aufirst%3DC.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGlutamate%2520Carboxypeptidase%2520II%2520in%2520Diagnosis%2520and%2520Treatment%2520of%2520Neurologic%2520Disorders%2520and%2520Prostate%2520Cancer%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2012%26volume%3D19%26spage%3D856%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Silver, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CordonCardo, C.</span><span> </span><span class="NLM_article-title">Prostate-specific membrane antigen expression in normal and malignant human tissues</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=9815541" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1997&pages=81-85&author=D.+Silverauthor=I.+Pellicerauthor=W.+Fairauthor=W.+Hestonauthor=C.+CordonCardo&title=Prostate-specific+membrane+antigen+expression+in+normal+and+malignant+human+tissues"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen expression in normal and malignant human tissues</span></div><div class="casAuthors">Silver D A; Pellicer I; Fair W R; Heston W D; Cordon-Cardo C</div><div class="citationInfo"><span class="NLM_cas:title">Clinical cancer research : an official journal of the American Association for Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-5</span>
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    </div><div class="casAbstract">Prostate-specific membrane antigen is a type II membrane protein with folate hydrolase activity produced by prostatic epithelium.  The expression of this molecule has also been documented in extraprostatic tissues, including small bowel and brain.  In the present study, an extensive immunohistochemical analysis was performed on a panel of well-characterized normal and malignant human tissues to further define the pattern of prostate-specific membrane antigen (PSMA) expression.  Detectable PSMA levels were identified in prostatic epithelium, duodenal mucosa, and a subset of proximal renal tubules.  A subpopulation of neuroendocrine cells in the colonic crypts also exhibited PSMA immunoreactivity.  All other normal tissues, including cerebral cortex and cerebellum, had undetectable levels of PSMA.  Thirty-three of 35 primary prostate adenocarcinomas and 7 of 8 lymph node metastases displayed tumor cell PSMA immunostaining.  Eight of 18 prostate tumors metastatic to bone expressed PSMA.  All of the other nonprostatic primary tumors studied had undetectable PSMA levels.  However, intense staining was observed in endothelial cells of capillary vessels in peritumoral and endotumoral areas of certain malignancies, including 8 of 17 renal cell carcinomas, 7 of 13 transitional cell carcinomas, and 3 of 19 colon carcinomas.  Extraprostatic PSMA expression appears to be highly restricted.  Nevertheless, its diverse anatomical distribution implies a broader functional significance than previously suspected.  The decrease in PSMA immunoreactivity noted in advanced prostate cancer suggests that expression of this molecule may be linked to the degree of tumor differentiation.  The neoexpression of PSMA in endothelial cells of capillary beds in certain tumors may be related to tumor angiogenesis and suggests a potential mechanism for specific targeting of tumor neovasculature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQa3hRIf6mlYUcLvDNbOD4DfW6udTcc2eadenhKMO6u_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M%252FjsFamtA%253D%253D&md5=06fb3a1b21fc371a5e42843ed558e5eb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilver%26aufirst%3DD.%26aulast%3DPellicer%26aufirst%3DI.%26aulast%3DFair%26aufirst%3DW.%26aulast%3DHeston%26aufirst%3DW.%26aulast%3DCordonCardo%26aufirst%3DC.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520expression%2520in%2520normal%2520and%2520malignant%2520human%2520tissues%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D1997%26volume%3D3%26spage%3D81%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span> </span><span class="NLM_article-title">Alternatively Spliced Variants of Prostate-Specific Membrane Antigen RNA—Ratio of Expression As a Potential Measurement of Progression</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1441</span><span class="NLM_x">–</span> <span class="NLM_lpage">1443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=1441-1443&author=S.+Suauthor=I.+Huangauthor=W.+Fairauthor=C.+Powellauthor=W.+Heston&title=Alternatively+Spliced+Variants+of+Prostate-Specific+Membrane+Antigen+RNA%E2%80%94Ratio+of+Expression+As+a+Potential+Measurement+of+Progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DI.%26aulast%3DFair%26aufirst%3DW.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DHeston%26aufirst%3DW.%26atitle%3DAlternatively%2520Spliced%2520Variants%2520of%2520Prostate-Specific%2520Membrane%2520Antigen%2520RNA%25E2%2580%2594Ratio%2520of%2520Expression%2520As%2520a%2520Potential%2520Measurement%2520of%2520Progression%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D1441%26epage%3D1443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Israeli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span> </span><span class="NLM_article-title">Molecular-Cloning of a Complementary-DNA Encoding a Prostate-Specific Membrane Antigen</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1993&pages=227-230&author=R.+Israeliauthor=C.+Powellauthor=W.+Fairauthor=W.+Heston&title=Molecular-Cloning+of+a+Complementary-DNA+Encoding+a+Prostate-Specific+Membrane+Antigen"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIsraeli%26aufirst%3DR.%26aulast%3DPowell%26aufirst%3DC.%26aulast%3DFair%26aufirst%3DW.%26aulast%3DHeston%26aufirst%3DW.%26atitle%3DMolecular-Cloning%2520of%2520a%2520Complementary-DNA%2520Encoding%2520a%2520Prostate-Specific%2520Membrane%2520Antigen%26jtitle%3DCancer%2520Res.%26date%3D1993%26volume%3D53%26spage%3D227%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ponsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherullo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zippe, C.</span><span> </span><span class="NLM_article-title">Evaluation of preoperative ProstaScint (TM) scans in the prediction of nodal disease</span> <span class="citation_source-journal">Prostate Cancer Prostatic Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">135</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1038%2Fsj.pcan.4500570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=12497003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BD38jjsVCluw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=132-135&author=L.+Ponskyauthor=E.+Cherulloauthor=R.+Starkeyauthor=D.+Nelsonauthor=D.+Neumannauthor=C.+Zippe&title=Evaluation+of+preoperative+ProstaScint+%28TM%29+scans+in+the+prediction+of+nodal+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of preoperative ProstaScint scans in the prediction of nodal disease</span></div><div class="casAuthors">Ponsky L E; Cherullo E E; Starkey R; Nelson D; Neumann Donald; Zippe C D</div><div class="citationInfo"><span class="NLM_cas:title">Prostate cancer and prostatic diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-5</span>
        ISSN:<span class="NLM_cas:issn">1365-7852</span>.
    </div><div class="casAbstract">Diagnostic methods are limited for detecting microscopic soft tissue metastases in patients with prostate cancer.  Previous studies using (111)Indium Capromab Pendetide (ProstaScint scan) analyzed patients with extensive localized tumor (prostate specific antigen (PSA) >20 ng/ml) not optimal for surgical therapy.  We evaluated the role of the ProstaScint trade mark scan in a preoperative population to provide histological documentation and to assess its utility in a surgical population.  A total of 22 preoperative patients, underwent a ProstaScint scan.  The mean preoperative PSA was 16.0 ng/ml (range 3.9-33 ng/ml).  The mean Gleason score at biopsy was 6.9 (range 6-9).  Each patient underwent a radical retropubic prostatectomy and bilateral pelvic lymph node dissection, which included resection of both obturator and common iliac lymph nodes.  Histologic analysis of the resected lymph nodes provided the standard of comparison with the ProstaScint scan.  The results of the scan and pathology for all 22 patients were compared with the bilateral obturator and iliac nodes, creating 88 data points.  Nine areas (10%) were positive on the scan.  One of these (11%) was a true positive while the other eight (89%) were false positives.  Seventy-nine areas (90%) were negative on scan results.  Of these, five areas (6%) were false negatives and 74 areas (94%) were true negatives.  The scan yielded a sensitivity of 17%, specificity of 90%, negative predictive value (NPV) of 94% and a positive predictive value (PPV) of 11%.  The high false positive rate and low PPV of ProstaScint scans overestimates metastatic lymph nodes disease, and is not useful when used preoperatively.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTetKsfJfl8G9Hxxy173TfNfW6udTcc2eadenhKMO6u_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38jjsVCluw%253D%253D&md5=2daadb7c921218e3e5db53f1a0aa3115</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.pcan.4500570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.pcan.4500570%26sid%3Dliteratum%253Aachs%26aulast%3DPonsky%26aufirst%3DL.%26aulast%3DCherullo%26aufirst%3DE.%26aulast%3DStarkey%26aufirst%3DR.%26aulast%3DNelson%26aufirst%3DD.%26aulast%3DNeumann%26aufirst%3DD.%26aulast%3DZippe%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520preoperative%2520ProstaScint%2520%2528TM%2529%2520scans%2520in%2520the%2520prediction%2520of%2520nodal%2520disease%26jtitle%3DProstate%2520Cancer%2520Prostatic%2520Dis.%26date%3D2002%26volume%3D5%26spage%3D132%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moy, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajasekaran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarro, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bander, N.</span><span> </span><span class="NLM_article-title">Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3629</span><span class="NLM_x">–</span> <span class="NLM_lpage">3634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=9288760" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADyaK2sXlvFensbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1997&pages=3629-3634&author=H.+Liuauthor=P.+Moyauthor=S.+Kimauthor=Y.+Xiaauthor=A.+Rajasekaranauthor=V.+Navarroauthor=B.+Knudsenauthor=N.+Bander&title=Monoclonal+antibodies+to+the+extracellular+domain+of+prostate-specific+membrane+antigen+also+react+with+tumor+vascular+endothelium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Monoclonal antibodies to the extracellular domain of prostate-specific membrane antigen also react with tumor vascular endothelium</span></div><div class="casAuthors">Liu, He; Moy, Peggy; Kim, Sae; Xia, Yan; Rajasekaran, Ayyappan; Navarro, Vincent; Knudsen, Beatrice; Bander, Neil H.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3629-3634</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA), initially defined by monoclonal antibody (mAb) 7E11, is a now well-characterized type 2 integral membrane glycoprotein expressed in a highly restricted manner by prostate epithelial cells.  7E11 has been shown to bind an intracellular epitope of PSMA that, in viable cells, is not available for binding.  Herein, the authors report the initial characterization of the first 4 reported IgG mAbs that bind the external domain of PSMA.  Competitive binding studies indicate these antibodies define 2 distinct, noncompeting epitopes on the extracellular domain of PSMA.  In contrast to 7E11, these mAbs bind to viable LNCaP cells in vitro.  In addn., they show strong immunohistochem. reactivity to tissue sections of prostate epithelia, including prostate cancer.  These mAbs were also strongly reactive with vascular endothelium within a wide variety of carcinomas (including lung, colon, breast, and others) but not with normal vascular endothelium.  These antibodies should prove useful for in vivo targeting to prostate cancer, as well as to the vascular compartment of a wide variety of carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnfwsJ-92adbVg90H21EOLACvtfcHk0lhv2lHTM1ha3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvFensbo%253D&md5=35bfbebbbca72a6d5ef3667d84a772c3</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DMoy%26aufirst%3DP.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DY.%26aulast%3DRajasekaran%26aufirst%3DA.%26aulast%3DNavarro%26aufirst%3DV.%26aulast%3DKnudsen%26aufirst%3DB.%26aulast%3DBander%26aufirst%3DN.%26atitle%3DMonoclonal%2520antibodies%2520to%2520the%2520extracellular%2520domain%2520of%2520prostate-specific%2520membrane%2520antigen%2520also%2520react%2520with%2520tumor%2520vascular%2520endothelium%26jtitle%3DCancer%2520Res.%26date%3D1997%26volume%3D57%26spage%3D3629%26epage%3D3634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Carter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J.</span><span> </span><span class="NLM_article-title">Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x">, </span> <span class="NLM_fpage">749</span><span class="NLM_x">–</span> <span class="NLM_lpage">753</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1073%2Fpnas.93.2.749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=8570628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADyaK28XnslOksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=749-753&author=R.+Carterauthor=A.+Feldmanauthor=J.+Coyle&title=Prostate-specific+membrane+antigen+is+a+hydrolase+with+substrate+and+pharmacologic+characteristics+of+a+neuropeptidase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase</span></div><div class="casAuthors">Carter, ruth E.; Feldman, Alexis R.; Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">93</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">749-53</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">This report demonstrates that the investigational prostatic carcinoma marker known as the prostate-specific membrane antigen (PSM) possesses hydrolytic activity with the substrate and pharmacol. properties of the N-acetylated α-linked acidic dipeptidase (NAALADase).  NAALADase is a membrane hydrolase that has been characterized in the mammalian nervous system on the basis of its catabolism of the neuropeptide N-acetylaspartylglutamate (NAAG) to yield glutamate and N-acetylaspartate and that has been hypothesized to influence glutamatergic signaling processes.  The immunoscreening of a rat brain cDNA expression library with anti-NAALADase antisera identified a 1428-base partial cDNA that shares 86% sequence identity with 1428 bases of the human PSM cDNA [Israeli, R. S., Powell, C. T., Fair, W. R. & Heston, W. D. W. (1993) Cancer Res. 53, 227-230].  A cDNA contg. the entire PSM open reading frame was subsequently isolated by reverse transcription-PCR from the PSM-pos. prostate carcinoma cell line LNCaP.  Transient transfection of this cDNA into two NAALADase-neg. cell lines conferred NAAG-hydrolyzing activity that was inhibited by the NAALADase inhibitors quisqualic acid and β-NAAG.  Thus we demonstrate a PSM-encoded function and identify a NAALADase-encoding cDNA.  Northern analyses identify at least six transcripts that are variably expressed in NAALADase-pos. but not in NAALADase-neg. rat tissues and human cell lines; therefore, PSM and/or related mol. species appear to account for NAAG hydrolysis in the nervous system.  These results also raise questions about the role of PSM in both normal and pathol. prostate epithelial-cell function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3Bzy9_R_Aj7Vg90H21EOLACvtfcHk0lhv2lHTM1ha3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XnslOksA%253D%253D&md5=73d28883aed16fafc6733d33676ad0de</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.2.749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.2.749%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DR.%26aulast%3DFeldman%26aufirst%3DA.%26aulast%3DCoyle%26aufirst%3DJ.%26atitle%3DProstate-specific%2520membrane%2520antigen%2520is%2520a%2520hydrolase%2520with%2520substrate%2520and%2520pharmacologic%2520characteristics%2520of%2520a%2520neuropeptidase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26spage%3D749%26epage%3D753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Tiffany, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapidus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span> </span><span class="NLM_article-title">Characterization of the enzymatic activity of PSM: comparison with brain NAALADase</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1999&pages=28-35&author=C.+Tiffanyauthor=R.+Lapidusauthor=A.+Merionauthor=D.+Calvinauthor=B.+Slusher&title=Characterization+of+the+enzymatic+activity+of+PSM%3A+comparison+with+brain+NAALADase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTiffany%26aufirst%3DC.%26aulast%3DLapidus%26aufirst%3DR.%26aulast%3DMerion%26aufirst%3DA.%26aulast%3DCalvin%26aufirst%3DD.%26aulast%3DSlusher%26aufirst%3DB.%26atitle%3DCharacterization%2520of%2520the%2520enzymatic%2520activity%2520of%2520PSM%253A%2520comparison%2520with%2520brain%2520NAALADase%26jtitle%3DProstate%26date%3D1999%26volume%3D39%26spage%3D28%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4504</span><span class="NLM_x">–</span> <span class="NLM_lpage">4517</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800111u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4504-4517&author=S.+Banerjeeauthor=C.+Fossauthor=M.+Castanaresauthor=R.+Measeauthor=Y.+Byunauthor=J.+Foxauthor=J.+Hiltonauthor=S.+Lupoldauthor=A.+Kozikowskiauthor=M.+Pomper&title=Synthesis+and+evaluation+of+technetium-99m-and+rhenium-labeled+inhibitors+of+the+prostate-specific+membrane+antigen+%28PSMA%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm800111u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800111u%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DLupold%26aufirst%3DS.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520technetium-99m-and%2520rhenium-labeled%2520inhibitors%2520of%2520the%2520prostate-specific%2520membrane%2520antigen%2520%2528PSMA%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4504%26epage%3D4517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovenska, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mlcochova, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hlouchova, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plechanovova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span> </span><span class="NLM_article-title">Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3267</span><span class="NLM_x">–</span> <span class="NLM_lpage">3273</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070133w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtlOmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3267-3273&author=C.+Barinkaauthor=M.+Rovenskaauthor=P.+Mlcochovaauthor=K.+Hlouchovaauthor=A.+Plechanovovaauthor=P.+Majerauthor=T.+Tsukamotoauthor=B.+Slusherauthor=J.+Konvalinkaauthor=J.+Lubkowski&title=Structural+insight+into+the+pharmacophore+pocket+of+human+glutamate+carboxypeptidase+II"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Insight into the Pharmacophore Pocket of Human Glutamate Carboxypeptidase II</span></div><div class="casAuthors">Barinka, Cyril; Rovenska, Miroslava; Mlcochova, Petra; Hlouchova, Klara; Plechanovova, Anna; Majer, Pavel; Tsukamoto, Takashi; Slusher, Barbara S.; Konvalinka, Jan; Lubkowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3267-3273</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibition of glutamate carboxypeptidase II (GCPII) has been shown to be neuroprotective in multiple preclin. models in which dysregulated glutamatergic transmission is implicated.  Herein, we report crystal structures of the human GCPII complexed with three glutamate mimetics/derivs., 2-(phosphonomethyl)pentanedioic acid (2-PMPA), quisqualic acid (QA), and L-serine O-sulfate (L-SOS), at 1.72, 1.62, and 2.10 Å resoln., resp.  Despite the structural differences between the distal parts of the inhibitors, all three compds. share similar binding modes in the pharmacophore (i.e., S1') pocket of GCPII, where they are stabilized by a combination of polar and van der Waals interactions.  The structural diversity of the distal parts of the inhibitors leads to rearrangements of the S1' site that are necessary for efficient interactions between the enzyme and an inhibitor.  The set of structures presented here, in conjunction with the available biochem. data, illustrates a flexibility of the GCPII pharmacophore pocket and highlights the structural features required for potent GCPII inhibition.  These findings could facilitate the rational structure-based drug design of new GCPII inhibitors in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqR1kd5UUodrVg90H21EOLACvtfcHk0lhv2lHTM1ha3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtlOmsLc%253D&md5=1b0a665eaaef88fb9f622d8ae87ef41e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm070133w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070133w%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DRovenska%26aufirst%3DM.%26aulast%3DMlcochova%26aufirst%3DP.%26aulast%3DHlouchova%26aufirst%3DK.%26aulast%3DPlechanovova%26aufirst%3DA.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DKonvalinka%26aufirst%3DJ.%26aulast%3DLubkowski%26aufirst%3DJ.%26atitle%3DStructural%2520insight%2520into%2520the%2520pharmacophore%2520pocket%2520of%2520human%2520glutamate%2520carboxypeptidase%2520II%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3267%26epage%3D3273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castanares, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span> </span><span class="NLM_article-title">Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7737</span><span class="NLM_x">–</span> <span class="NLM_lpage">7743</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800765e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWksrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7737-7743&author=C.+Barinkaauthor=Y.+Byunauthor=C.+Dusichauthor=S.+Banerjeeauthor=Y.+Chenauthor=M.+Castanaresauthor=A.+Kozikowskiauthor=R.+Measeauthor=M.+Pomperauthor=J.+Lubkowski&title=Interactions+between+Human+Glutamate+Carboxypeptidase+II+and+Urea-Based+Inhibitors%3A+Structural+Characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization</span></div><div class="casAuthors">Barinka, Cyril; Byun, Youngjoo; Dusich, Crystal L.; Banerjee, Sangeeta R.; Chen, Ying; Castanares, Mark; Kozikowski, Alan P.; Mease, Ronnie C.; Pomper, Martin G.; Lubkowski, Jacek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7737-7743</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based, low mol. wt. ligands of glutamate carboxypeptidase II (GCPII) have demonstrated efficacy in various models of neurol. disorders and can serve as imaging agents for prostate cancer.  To enhance further development of such compds., we detd. x-ray structures of four complexes between human GCPII and urea-based inhibitors at high resoln.  All ligands demonstrate an invariant glutarate moiety within the S1' pocket of the enzyme.  The ureido linkage between P1 and P1' inhibitor sites interacts with the active-site Zn12+ ion and the side chains of Tyr-552 and His-553.  Interactions within the S1 pocket are defined primarily by a network of hydrogen bonds between the P1 carboxylate group of the inhibitors and the side chains of Arg-534, Arg-536, and Asn-519.  Importantly, we have identified a hydrophobic pocket accessory to the S1 site that can be exploited for structure-based design of novel GCPII inhibitors with increased lipophilicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCkVTUEw3n-rVg90H21EOLACvtfcHk0ljKfF7Z43dziA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWksrbI&md5=6023d910f6b69aae7c85852235004cef</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm800765e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800765e%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DDusich%26aufirst%3DC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCastanares%26aufirst%3DM.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DPomper%26aufirst%3DM.%26aulast%3DLubkowski%26aufirst%3DJ.%26atitle%3DInteractions%2520between%2520Human%2520Glutamate%2520Carboxypeptidase%2520II%2520and%2520Urea-Based%2520Inhibitors%253A%2520Structural%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7737%26epage%3D7743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grajkowska, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wroblewski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bzdega, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wroblewska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neale, J.</span><span> </span><span class="NLM_article-title">Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1729</span><span class="NLM_x">–</span> <span class="NLM_lpage">1738</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0306226" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhs1yls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1729-1738&author=A.+Kozikowskiauthor=J.+Zhangauthor=F.+Nanauthor=P.+Petukhovauthor=E.+Grajkowskaauthor=J.+Wroblewskiauthor=T.+Yamamotoauthor=T.+Bzdegaauthor=B.+Wroblewskaauthor=J.+Neale&title=Synthesis+of+urea-based+inhibitors+as+active+site+probes+of+glutamate+carboxypeptidase+II%3A+efficacy+as+analgesic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Urea-Based Inhibitors as Active Site Probes of Glutamate Carboxypeptidase II: Efficacy as Analgesic Agents</span></div><div class="casAuthors">Kozikowski, Alan P.; Zhang, Jiazhong; Nan, Fajun; Petukhov, Pavel A.; Grajkowska, Ewa; Wroblewski, Jarda T.; Yamamoto, Tatsuo; Bzdega, Tomasz; Wroblewska, Barbara; Neale, Joseph H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1729-1738</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neuropeptidase glutamate carboxypeptidase II (GCPII) hydrolyzes N-acetyl-L-aspartyl-L-glutamate (NAAG) to liberate N-acetylaspartate and glutamate.  GCPII was originally cloned as PSMA, an Mr 100 000 type II transmembrane glycoprotein highly expressed in prostate tissues.  PSMA/GCPII is located on the short arm of chromosome 11 and functions as both a folate hydrolase and a neuropeptidase.  Inhibition of brain GCPII may have therapeutic potential in the treatment of certain disease states arising from pathol. overactivated glutamate receptors.  Recently, the authors reported that certain urea-based structures act as potent inhibitors of GCPII (J. Med. Chem. 2001, 44, 298).  However, many of the potent GCPII inhibitors prepd. to date are highly polar compds. and therefore do not readily penetrate the blood-brain barrier.  Herein, the authors elaborate on the synthesis of a series of potent, urea-based GCPII inhibitors and provide assay data for these ligands against human GCPII.  Moreover, the authors provide data revealing the ability of one of these compds., namely, (S)-2-[3-[(S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]ureido]pentanedioic acid (I), to reduce the perception of inflammatory pain.  Within the present series, the γ-tetrazole bearing glutamate isostere is the most potent inhibitor with a Ki of 0.9 nM.  The biol. evaluation of these compds. revealed that the active site of GCPII likely comprises two regions, namely, the pharmacophore subpocket and the nonpharmacophore subpocket.  The pharmacophore subpocket is very sensitive to structural changes, and thus, it appears important to keep one of the glutamic acid moieties intact to maintain the potency of the GCPII inhibitors.  The site encompassing the nonpharmacophore subpocket that binds to glutamate's α-carboxyl group is sensitive to structural change.  However, the other region of the nonpharmacophore subpocket can accommodate both hydrophobic and hydrophilic groups.  Thus, an arom. ring can be introduced to the inhibitor thereby increasing its hydrophobicity and thus potentially its ability to cross the blood-brain barrier.  Intrathecally administered I significantly reduced pain perception in the formalin model of rat sensory nerve injury.  A maximal dose of morphine (10 mg) applied in the same exptl. paradigm provided no significant increase in analgesia in comparison to I during phase 1 of this pain study and modestly greater analgesia than I in phase 2.  These urea-based inhibitors of GCPII thus offer a novel approach to pain management.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ZZS2UrE6CbVg90H21EOLACvtfcHk0ljKfF7Z43dziA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhs1yls7Y%253D&md5=809ec62cf1ee52481d88596913bb145a</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm0306226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0306226%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DNan%26aufirst%3DF.%26aulast%3DPetukhov%26aufirst%3DP.%26aulast%3DGrajkowska%26aufirst%3DE.%26aulast%3DWroblewski%26aufirst%3DJ.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DBzdega%26aufirst%3DT.%26aulast%3DWroblewska%26aufirst%3DB.%26aulast%3DNeale%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520urea-based%2520inhibitors%2520as%2520active%2520site%2520probes%2520of%2520glutamate%2520carboxypeptidase%2520II%253A%2520efficacy%2520as%2520analgesic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1729%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Ga-68-and In-111-Labelled Small Molecule Inhibitors of PSMA for Prostate Cancer Imaging</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">S19</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=S19&author=S.+Banerjeeauthor=M.+Pullambhatlaauthor=Y.+Byunauthor=G.+Greenauthor=J.+Foxauthor=A.+Hortiauthor=R.+Measeauthor=M.+Pomper&title=Ga-68-and+In-111-Labelled+Small+Molecule+Inhibitors+of+PSMA+for+Prostate+Cancer+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DGreen%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHorti%26aufirst%3DA.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGa-68-and%2520In-111-Labelled%2520Small%2520Molecule%2520Inhibitors%2520of%2520PSMA%2520for%2520Prostate%2520Cancer%2520Imaging%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2009%26volume%3D52%26spage%3DS19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pullambhatla, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmagadda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Ga-68-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5333</span><span class="NLM_x">–</span> <span class="NLM_lpage">5341</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100623e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5333-5341&author=S.+Banerjeeauthor=M.+Pullambhatlaauthor=Y.+Byunauthor=S.+Nimmagaddaauthor=G.+Greenauthor=J.+Foxauthor=A.+Hortiauthor=R.+Measeauthor=M.+Pomper&title=Ga-68-Labeled+Inhibitors+of+Prostate-Specific+Membrane+Antigen+%28PSMA%29+for+Imaging+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm100623e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100623e%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DPullambhatla%26aufirst%3DM.%26aulast%3DByun%26aufirst%3DY.%26aulast%3DNimmagadda%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DG.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DHorti%26aufirst%3DA.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DGa-68-Labeled%2520Inhibitors%2520of%2520Prostate-Specific%2520Membrane%2520Antigen%2520%2528PSMA%2529%2520for%2520Imaging%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5333%26epage%3D5341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauder-Wust, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wangler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mier, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span> </span><span class="NLM_article-title">Ga-68-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">688</span><span class="NLM_x">–</span> <span class="NLM_lpage">697</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc200279b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=688-697&author=M.+Ederauthor=M.+Schaferauthor=U.+Bauder-Wustauthor=W.+Hullauthor=C.+Wanglerauthor=W.+Mierauthor=U.+Haberkornauthor=M.+Eisenhut&title=Ga-68-Complex+Lipophilicity+and+the+Targeting+Property+of+a+Urea-Based+PSMA+Inhibitor+for+PET+Imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span></div><div class="casAuthors">Eder, Matthias; Schaefer, Martin; Bauder-Wuest, Ulrike; Hull, William-Edmund; Waengler, Carmen; Mier, Walter; Haberkorn, Uwe; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">688-697</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors of the prostate-specific membrane antigen (PSMA) represent low-mol.-wt. pepidomimetics showing the ability to image PSMA-expressing prostate tumors.  The highly efficient, acyclic Ga(III) chelator N,N'-bis [2-hydroxy-5-(carboxyethyl)benzyl] ethylenediamine-N,N'- diacetic acid (HBED-CC) was introduced as a lipophilic side chain into the hydrophilic pharmacophore Glu-NH-CO-NH-Lys which was found favorable to interact with the PSMA "active binding site".  This report describes the syntheses, in vitro binding analyses, and biodistribution data of the radiogallium labeled PSMA inhibitor Glu-NH-CO-NH-Lys(Ahx)-HBED-CC in comparison to the corresponding DOTA conjugate.  The binding properties were analyzed using competitive cell binding and enzyme-based assays followed by internalization expts.  Compared to the DOTA-conjugate, the HBED-CC deriv. showed reduced unspecific binding and considerable higher specific internalization in LNCaP cells.  The 68Ga complex of the HBED-CC ligand exhibited higher specificity for PSMA expressing tumor cells resulting in improved in vivo properties. 68Ga labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC showed fast blood and organ clearances, low liver accumulation, and high specific uptake in PSMA expressing organs and tumor.  It could be demonstrated that the PET-imaging property of a urea-based PSMA inhibitor could significantly be improved with HBED-CC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XoCnl_RguLVg90H21EOLACvtfcHk0ljtISpQDrdmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D&md5=4bb4cbba9f510ed2561b87a44bafa00a</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbc200279b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200279b%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DSchafer%26aufirst%3DM.%26aulast%3DBauder-Wust%26aufirst%3DU.%26aulast%3DHull%26aufirst%3DW.%26aulast%3DWangler%26aufirst%3DC.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3DGa-68-Complex%2520Lipophilicity%2520and%2520the%2520Targeting%2520Property%2520of%2520a%2520Urea-Based%2520PSMA%2520Inhibitor%2520for%2520PET%2520Imaging%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26spage%3D688%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of Tc-99m/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">1557</span><span class="NLM_x">–</span> <span class="NLM_lpage">1563</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=1557-1563&author=G.+Luauthor=K.+Marescaauthor=S.+Hillierauthor=C.+Zimmermanauthor=W.+Eckelmanauthor=J.+Joyalauthor=J.+Babich&title=Synthesis+and+SAR+of+Tc-99m%2FRe-labeled+small+molecule+prostate+specific+membrane+antigen+inhibitors+with+novel+polar+chelates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DG.%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DHillier%26aufirst%3DS.%26aulast%3DZimmerman%26aufirst%3DC.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520Tc-99m%252FRe-labeled%2520small%2520molecule%2520prostate%2520specific%2520membrane%2520antigen%2520inhibitors%2520with%2520novel%2520polar%2520chelates%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D1557%26epage%3D1563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Nedrow-Byers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benny, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkman, C.</span><span> </span><span class="NLM_article-title">PSMA-targeted SPECT agents: mode of binding effect on in vitro performance</span> <span class="citation_source-journal">Prostate</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2013&pages=355-362&author=J.+Nedrow-Byersauthor=A.+Mooreauthor=T.+Gangulyauthor=M.+Hopkinsauthor=M.+Fultonauthor=P.+Bennyauthor=C.+Berkman&title=PSMA-targeted+SPECT+agents%3A+mode+of+binding+effect+on+in+vitro+performance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNedrow-Byers%26aufirst%3DJ.%26aulast%3DMoore%26aufirst%3DA.%26aulast%3DGanguly%26aufirst%3DT.%26aulast%3DHopkins%26aufirst%3DM.%26aulast%3DFulton%26aufirst%3DM.%26aulast%3DBenny%26aufirst%3DP.%26aulast%3DBerkman%26aufirst%3DC.%26atitle%3DPSMA-targeted%2520SPECT%2520agents%253A%2520mode%2520of%2520binding%2520effect%2520on%2520in%2520vitro%2520performance%26jtitle%3DProstate%26date%3D2013%26volume%3D73%26spage%3D355%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kularatne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Post, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Low, P.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted Tc-99m-Radioimaging Agents</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp9000712" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlsF2hs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=790-800&author=S.+Kularatneauthor=Z.+Zhouauthor=J.+Yangauthor=C.+Postauthor=P.+Low&title=Design%2C+Synthesis%2C+and+Preclinical+Evaluation+of+Prostate-Specific+Membrane+Antigen+Targeted+Tc-99m-Radioimaging+Agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted 99mTc-Radioimaging Agents</span></div><div class="casAuthors">Kularatne, Sumith A.; Zhou, Zhigang; Yang, Jun; Post, Carol B.; Low, Philip S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">790-800</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The high mortality and financial burden assocd. with prostate cancer can be partly attributed to a lack of sensitive screening methods for detection and staging of the disease.  Guided by in silico docking studies using the crystal structure of PSMA, we designed and synthesized a series of PSMA-targeted 99mTc-chelate complexes for imaging PSMA-expressing human prostate cancer cells (LNCaP cell line).  Of the six targeted radioimaging agents synthesized, three were found to bind LNCaP cells with low nanomolar affinity.  Moreover, the same three PSMA-targeted imaging agents were shown to localize primarily to LNCaP tumor xenografts in nu/nu mice, with an av. of 9.8 ± 2.4% injected dose/g tissue accumulating in the tumor and only 0.11% injected dose/g tissue retained in the muscle at 4 h postinjection.  Collectively, these high affinity, PSMA-specific radioimaging agents demonstrate significant potential for use in localizing prostate cancer masses, monitoring response to therapy, detecting prostate cancer recurrence following surgery, and selecting patients for subsequent PSMA-targeted chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCrsRCzeRWhLVg90H21EOLACvtfcHk0ljtISpQDrdmNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlsF2hs70%253D&md5=77c5b6f3776e761979de857d4299106e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fmp9000712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp9000712%26sid%3Dliteratum%253Aachs%26aulast%3DKularatne%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DPost%26aufirst%3DC.%26aulast%3DLow%26aufirst%3DP.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Preclinical%2520Evaluation%2520of%2520Prostate-Specific%2520Membrane%2520Antigen%2520Targeted%2520Tc-99m-Radioimaging%2520Agents%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2009%26volume%3D6%26spage%3D790%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olszewski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heston, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title">Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">4022</span><span class="NLM_x">–</span> <span class="NLM_lpage">4028</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1158%2F1078-0432.CCR-04-2690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=15930336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Gksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=4022-4028&author=C.+Fossauthor=R.+Measeauthor=H.+Fanauthor=Y.+Wangauthor=H.+Ravertauthor=R.+Dannalsauthor=R.+Olszewskiauthor=W.+Hestonauthor=A.+Kozikowskiauthor=M.+Pomper&title=Radiolabeled+small-molecule+ligands+for+prostate-specific+membrane+antigen%3A+in+vivo+imaging+in+experimental+models+of+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Radiolabeled Small-Molecule Ligands for Prostate-Specific Membrane Antigen: In vivo Imaging in Experimental Models of Prostate Cancer</span></div><div class="casAuthors">Foss, Catherine A.; Mease, Ronnie C.; Fan, Hong; Wang, Yuchuan; Ravert, Hayden T.; Dannals, Robert F.; Olszewski, Rafal T.; Heston, Warren D.; Kozikowski, Alan P.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4022-4028</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Prostate-specific membrane antigen (PSMA) is a cell surface protein that is overexpressed in prostate cancer, including hormone-refractory and metastatic disease.  Our goal in this study was to develop a series of PSMA-based imaging agents for clin. use.  Exptl. Design: We have synthesized and evaluated the in vivo biodistribution of two radiolabeled urea derivs. that have high affinity for PSMA in severe combined immunodeficient mice harboring MCF-7 (breast, PSMA-neg.), PC-3 (prostate, PSMA-neg.), and LNCaP (prostate, PSMA-pos.) xenografts.  Radiopharmaceutical binding selectivity and tumor uptake were also evaluated in vivo using dedicated small animal positron emission tomog., single photon emission computed tomog., and gamma scintigraphic imaging devices.  N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine ([11C]DCMC Ki, 3.1 nmol/L) and N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-3-[125I]iodo-L-tyrosine ([125C]DCIT Ki, 1.5 nmol/L) were synthesized using [11C]CH3I and with [125I]NaI/Iodogen, resp.  RESULTS: At 30 min postinjection, [11C]DCMC and [125I]DCIT showed tumor/muscle ratios of 10.8 and 4.7, resp., with clear delineation of LNCaP-derived tumors on imaging.  MCF-7- and PC-3-derived tumors showed significantly less uptake of [11C]DCMC or [125I]DCIT.  CONCLUSION: These results show the feasibility of imaging PSMA-pos. prostate cancer using low mol. wt. agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmmd1gq-93gbVg90H21EOLACvtfcHk0liSLDTcBtjFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Gksr0%253D&md5=da069680b889ef20e18404ac36bbb05e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2690%26sid%3Dliteratum%253Aachs%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DMease%26aufirst%3DR.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DRavert%26aufirst%3DH.%26aulast%3DDannals%26aufirst%3DR.%26aulast%3DOlszewski%26aufirst%3DR.%26aulast%3DHeston%26aufirst%3DW.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DRadiolabeled%2520small-molecule%2520ligands%2520for%2520prostate-specific%2520membrane%2520antigen%253A%2520in%2520vivo%2520imaging%2520in%2520experimental%2520models%2520of%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D4022%26epage%3D4028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Hillier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Femia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">6932</span><span class="NLM_x">–</span> <span class="NLM_lpage">6940</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1158%2F0008-5472.CAN-09-1682" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=19706750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=6932-6940&author=S.+Hillierauthor=K.+Marescaauthor=F.+Femiaauthor=J.+Marquisauthor=C.+Fossauthor=N.+Nguyenauthor=C.+Zimmermanauthor=J.+Barrettauthor=W.+Eckelmanauthor=M.+Pomperauthor=J.+Joyalauthor=J.+Babich&title=Preclinical+Evaluation+of+Novel+Glutamate-Urea-Lysine+Analogues+That+Target+Prostate-Specific+Membrane+Antigen+as+Molecular+Imaging+Pharmaceuticals+for+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer</span></div><div class="casAuthors">Hillier, Shawn M.; Maresca, Kevin P.; Femia, Frank J.; Marquis, John C.; Foss, Catherine A.; Nguyen, Nghi; Zimmerman, Craig N.; Barrett, John A.; Eckelman, William C.; Pomper, Martin G.; Joyal, John L.; Babich, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6932-6940</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Prostate-specific membrane antigen (PSMA) is expressed in normal human prostate epithelium and is highly up-regulated in prostate cancer.  We previously reported a series of novel small mol. inhibitors targeting PSMA.  Two compds., MIP-1072, (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedioic acid, and MIP-1095, (S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl)ureido)pentyl)ureido)pentanedioic acid, were selected for further evaluation.  MIP-1072 and MIP-1095 potently inhibited the glutamate carboxypeptidase activity of PSMA (Ki = 4.6 ± 1.6 nM and 0.24 ± 0.14 nM, resp.) and, when radiolabeled with 123I, exhibited high affinity for PSMA on human prostate cancer LNCaP cells (Kd = 3.8 ± 1.3 nM and 0.81 ± 0.39 nM, resp.).  The assocn. of [123I]MIP-1072 and [123I]MIP-1095 with PSMA was specific; there was no binding to human prostate cancer PC3 cells, which lack PSMA, and binding was abolished by coincubation with a structurally unrelated NAALADase inhibitor, 2-(phosphonomethyl)pentanedioic acid (PMPA).  [123I]MIP-1072 and [123I]MIP-1095 internalized into LNCaP cells at 37°C.  Tissue distribution studies in mice showed 17.3 ± 6.3% (at 1 h) and 34.3 ± 12.7% (at 4 h) injected dose per g of LNCaP xenograft tissue, for [123I]MIP-1072 and [123I]MIP-1095, resp.  [123I]MIP-1095 exhibited greater tumor uptake but slower washout from blood and nontarget tissues compared with [123I]MIP-1072.  Specific binding to PSMA in vivo was shown by competition with PMPA in LNCaP xenografts, and the absence of uptake in PC3 xenografts.  The uptake of [123I]MIP-1072 and [123I]MIP-1095 in tumor-bearing mice was corroborated by single-photon emission computed tomog./computed tomog. (SPECT/CT) imaging.  PSMA-specific radiopharmaceuticals should provide a novel mol. targeting option for the detection and staging of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmETFDEvmsZLVg90H21EOLACvtfcHk0liSLDTcBtjFMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVOmtLzE&md5=f222208c3c3fbcaa376306c49c9ec80b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-1682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-1682%26sid%3Dliteratum%253Aachs%26aulast%3DHillier%26aufirst%3DS.%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DFemia%26aufirst%3DF.%26aulast%3DMarquis%26aufirst%3DJ.%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DNguyen%26aufirst%3DN.%26aulast%3DZimmerman%26aufirst%3DC.%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DPomper%26aufirst%3DM.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DPreclinical%2520Evaluation%2520of%2520Novel%2520Glutamate-Urea-Lysine%2520Analogues%2520That%2520Target%2520Prostate-Specific%2520Membrane%2520Antigen%2520as%2520Molecular%2520Imaging%2520Pharmaceuticals%2520for%2520Prostate%2520Cancer%26jtitle%3DCancer%2520Res.%26date%3D2009%26volume%3D69%26spage%3D6932%26epage%3D6940" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Barrett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coleman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldsmith, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vallabhajosula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petry, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armor, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubbs, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stabin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">380</span><span class="NLM_x">–</span> <span class="NLM_lpage">387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=380-387&author=J.+Barrettauthor=R.+Colemanauthor=S.+Goldsmithauthor=S.+Vallabhajosulaauthor=N.+Petryauthor=S.+Choauthor=T.+Armorauthor=J.+Stubbsauthor=K.+Marescaauthor=M.+Stabinauthor=J.+Joyalauthor=W.+Eckelmanauthor=J.+Babich&title=First-in-Man+Evaluation+of+2+High-Affinity+PSMA-Avid+Small+Molecules+for+Imaging+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DColeman%26aufirst%3DR.%26aulast%3DGoldsmith%26aufirst%3DS.%26aulast%3DVallabhajosula%26aufirst%3DS.%26aulast%3DPetry%26aufirst%3DN.%26aulast%3DCho%26aufirst%3DS.%26aulast%3DArmor%26aufirst%3DT.%26aulast%3DStubbs%26aufirst%3DJ.%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DStabin%26aufirst%3DM.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DFirst-in-Man%2520Evaluation%2520of%25202%2520High-Affinity%2520PSMA-Avid%2520Small%2520Molecules%2520for%2520Imaging%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D380%26epage%3D387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wakisaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uezono, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohomomo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">A novel radioiodination reagent for protein radiopharmaceuticals with <span class="smallcaps smallerCapital">l</span>-lysine as a plasma-stable metabolizable linkage to liberate <i>m</i>-iodohippuric acid after lysosomal proteolysis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2643</span><span class="NLM_x">–</span> <span class="NLM_lpage">2652</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9606397" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2643-2652&author=K.+Wakisakaauthor=Y.+Aranoauthor=T.+Uezonoauthor=H.+Akizawaauthor=M.+Onoauthor=K.+Kawaiauthor=Y.+Ohomomoauthor=M.+Nakayamaauthor=H.+Saji&title=A+novel+radioiodination+reagent+for+protein+radiopharmaceuticals+with+l-lysine+as+a+plasma-stable+metabolizable+linkage+to+liberate+m-iodohippuric+acid+after+lysosomal+proteolysis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm9606397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9606397%26sid%3Dliteratum%253Aachs%26aulast%3DWakisaka%26aufirst%3DK.%26aulast%3DArano%26aufirst%3DY.%26aulast%3DUezono%26aufirst%3DT.%26aulast%3DAkizawa%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DOhomomo%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DM.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DA%2520novel%2520radioiodination%2520reagent%2520for%2520protein%2520radiopharmaceuticals%2520with%2520l-lysine%2520as%2520a%2520plasma-stable%2520metabolizable%2520linkage%2520to%2520liberate%2520m-iodohippuric%2520acid%2520after%2520lysosomal%2520proteolysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2643%26epage%3D2652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mease, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dusich, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prideaux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgouros, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomper, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-[<i>N</i>-[(<i>S</i>)-1,3-Dicarboxypropyl]carbamoyl]-4-[F-18]fluorobenzyl-<span class="smallcaps smallerCapital">l</span>-cysteine, [F-18]DCFBC: a new imaging probe for prostate cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3036</span><span class="NLM_x">–</span> <span class="NLM_lpage">3043</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1158%2F1078-0432.CCR-07-1517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=18483369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmtVCmtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=3036-3043&author=R.+Measeauthor=C.+Dusichauthor=C.+Fossauthor=H.+Ravertauthor=R.+Dannalsauthor=J.+Seidelauthor=A.+Prideauxauthor=J.+Foxauthor=G.+Sgourosauthor=A.+Kozikowskiauthor=M.+Pomper&title=N-%5BN-%5B%28S%29-1%2C3-Dicarboxypropyl%5Dcarbamoyl%5D-4-%5BF-18%5Dfluorobenzyl-l-cysteine%2C+%5BF-18%5DDCFBC%3A+a+new+imaging+probe+for+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC:A New Imaging Probe for Prostate Cancer</span></div><div class="casAuthors">Mease, Ronnie C.; Dusich, Crystal L.; Foss, Catherine A.; Ravert, Hayden T.; Dannals, Robert F.; Seidel, Jurgen; Prideaux, Andrew; Fox, James J.; Sgouros, George; Kozikowski, Alan P.; Pomper, Martin G.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3036-3043</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Previously, we showed successful imaging of xenografts that express the prostate-specific membrane antigen (PSMA) using small-animal positron emission tomog. (PET) and the radiolabeled PSMA inhibitor N-[N-[(S)-1,3-dicarboxypropyl]carbamoyl]-S-[11C]methyl-L-cysteine.  Herein, we extend that work by prepg. and testing a PSMA inhibitor of the same class labeled with fluorine-18.  Exptl. Design: N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine ([18F]DCFBC) was prepd. by reacting 4-[18F]fluorobenzyl bromide with the precursor (S)-2-[3-[(R)-1-carboxy-2-mercaptoethyl]ureido]-pentanedioic acid in ammonia-satd. methanol at 60°C for 10 min followed by purifn. using C-18 reverse-phase semipreparative high-performance liq. chromatog.  Severe combined immunodeficient mice bearing a s.c. PSMA+ PC-3 PIP tumor behind one shoulder and a PSMA- PC-3 FLU tumor behind the other shoulder were injected via the tail vein with either 1.85 MBq (50 μCi) of [18F]DCFBC for ex vivo biodistribution or 7.4 MBq (200 μCi) for imaging.  For biodistribution, mice were sacrificed at 5, 15, 30, 60, and 120 min.  Tumor, blood, and major organs were harvested and weighed, and radioactivity was counted.  Imaging was done on the GE eXplore Vista small-animal PET scanner by collecting 12 consecutive 10-min frames.  RESULTS: Radiochem. yield for [18F]DCFBC averaged 16 ± 6% (n = 8) from 4-[18F]fluorobenzyl bromide.  Specific radioactivities ranged from 13 to 133 GBq/μmol (350-3600 Ci/mmol) with an av. of 52 GBq/μmol (1392 Ci/mmol; n = 6).  Biodistribution and imaging studies showed high uptake of [18F]DCFBC in the PIP tumors with little to no uptake in FLU tumors.  High radiopharmaceutical uptake was also seen in kidneys and bladder; however, washout of radioactivity from these organs was faster than from the PIP tumors.  The max. PIP tumor uptake was 8.16 ± 2.55% injected dose per g, achieved at 60 min after injection, which decreased to 4.69 ± 0.89 at 120 min.  The PIP tumor to muscle ratio was 20 at 120 min after injection.  Based on the mouse biodistribution, the dose-limiting organ is the kidneys (human estd. absorbed dose: 0.05 mGy/MBq; 0.2 rad/mCi).  CONCLUSION: [18F]DCFBC localizes to PSMA+-expressing tumors in mice, permitting imaging by small-animal PET.  This new radiopharmaceutical is an attractive candidate for further studies of PET imaging of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJcN5Ud7t4YrVg90H21EOLACvtfcHk0lhDFtc36c6gUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmtVCmtb8%253D&md5=08e8e93b4a77d04d6c8893e388ea607b</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-1517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-1517%26sid%3Dliteratum%253Aachs%26aulast%3DMease%26aufirst%3DR.%26aulast%3DDusich%26aufirst%3DC.%26aulast%3DFoss%26aufirst%3DC.%26aulast%3DRavert%26aufirst%3DH.%26aulast%3DDannals%26aufirst%3DR.%26aulast%3DSeidel%26aufirst%3DJ.%26aulast%3DPrideaux%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DSgouros%26aufirst%3DG.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DPomper%26aufirst%3DM.%26atitle%3DN-%255BN-%255B%2528S%2529-1%252C3-Dicarboxypropyl%255Dcarbamoyl%255D-4-%255BF-18%255Dfluorobenzyl-l-cysteine%252C%2520%255BF-18%255DDCFBC%253A%2520a%2520new%2520imaging%2520probe%2520for%2520prostate%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D3036%26epage%3D3043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Maresca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Femia, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckelman, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babich, J.</span><span> </span><span class="NLM_article-title">A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800994j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Gl" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=347-357&author=K.+Marescaauthor=S.+Hillierauthor=F.+Femiaauthor=D.+Keithauthor=C.+Baroneauthor=J.+Joyalauthor=C.+Zimmermanauthor=A.+Kozikowskiauthor=J.+Barrettauthor=W.+Eckelmanauthor=J.+Babich&title=A+Series+of+Halogenated+Heterodimeric+Inhibitors+of+Prostate+Specific+Membrane+Antigen+%28PSMA%29+as+Radiolabeled+Probes+for+Targeting+Prostate+Cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer</span></div><div class="casAuthors">Maresca, K. P.; Hillier, S. M.; Femia, F. J.; Keith, D.; Barone, C.; Joyal, J. L.; Zimmerman, C. N.; Kozikowski, A. P.; Barrett, J. A.; Eckelman, W. C.; Babich, J. W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">347-357</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prostate specific membrane antigen (PSMA) is a validated mol. marker for prostate cancer.  A series of glutamate-urea (Glu-urea-X) heterodimeric inhibitors of PSMA were designed and synthesized where X = .vepsiln.-N-(o-I, m-I, p-I, p-Br, o-Cl, m-Cl, p-Cl, p-F, H)-benzyl-Lys and .vepsiln.-(p-I, p-Br, p-Cl, p-F, H)-phenylureido-Lys.  The affinities for PSMA were detd. by screening in a competitive binding assay.  PSMA binding of the benzyllysine series was significantly affected by the nature of the halogen substituent (IC50 values, Cl < I = Br « F = H) and the ring position of the halogen atom (IC50 values, p-I < o-I « m-I).  The halogen atom had little affect on the binding affinity in the para substituted phenylureido-Lys series.  Two lead iodine compds. were radiolabeled with 123I and 131I and demonstrated specific PSMA binding on human prostate cancer cells, warranting evaluation as radioligands for the detection, staging, and monitoring of prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ4n3KSzo2N7Vg90H21EOLACvtfcHk0lhDFtc36c6gUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Gl&md5=8e962619d6bbfc466111dc9f2741780b</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm800994j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800994j%26sid%3Dliteratum%253Aachs%26aulast%3DMaresca%26aufirst%3DK.%26aulast%3DHillier%26aufirst%3DS.%26aulast%3DFemia%26aufirst%3DF.%26aulast%3DKeith%26aufirst%3DD.%26aulast%3DBarone%26aufirst%3DC.%26aulast%3DJoyal%26aufirst%3DJ.%26aulast%3DZimmerman%26aufirst%3DC.%26aulast%3DKozikowski%26aufirst%3DA.%26aulast%3DBarrett%26aufirst%3DJ.%26aulast%3DEckelman%26aufirst%3DW.%26aulast%3DBabich%26aufirst%3DJ.%26atitle%3DA%2520Series%2520of%2520Halogenated%2520Heterodimeric%2520Inhibitors%2520of%2520Prostate%2520Specific%2520Membrane%2520Antigen%2520%2528PSMA%2529%2520as%2520Radiolabeled%2520Probes%2520for%2520Targeting%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D347%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Majumdar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haselton, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grinnell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ocampo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasternak, G.</span><span> </span><span class="NLM_article-title">Generation of novel radiolabeled opiates through site-selective iodination</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4001</span><span class="NLM_x">–</span> <span class="NLM_lpage">4004</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4001-4004&author=S.+Majumdarauthor=M.+Burgmanauthor=N.+Haseltonauthor=S.+Grinnellauthor=J.+Ocampoauthor=A.+Pasternakauthor=G.+Pasternak&title=Generation+of+novel+radiolabeled+opiates+through+site-selective+iodination"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMajumdar%26aufirst%3DS.%26aulast%3DBurgman%26aufirst%3DM.%26aulast%3DHaselton%26aufirst%3DN.%26aulast%3DGrinnell%26aufirst%3DS.%26aulast%3DOcampo%26aufirst%3DJ.%26aulast%3DPasternak%26aufirst%3DA.%26aulast%3DPasternak%26aufirst%3DG.%26atitle%3DGeneration%2520of%2520novel%2520radiolabeled%2520opiates%2520through%2520site-selective%2520iodination%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4001%26epage%3D4004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Camphausen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sproull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tantama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venditto, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankineni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brechbiel, M.</span><span> </span><span class="NLM_article-title">Evaluation of chelating agents as anti-angiogenic therapy through copper chelation</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">5133</span><span class="NLM_x">–</span> <span class="NLM_lpage">5140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=5133-5140&author=K.+Camphausenauthor=M.+Sproullauthor=S.+Tantamaauthor=V.+Vendittoauthor=S.+Sankineniauthor=T.+Scottauthor=M.+Brechbiel&title=Evaluation+of+chelating+agents+as+anti-angiogenic+therapy+through+copper+chelation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCamphausen%26aufirst%3DK.%26aulast%3DSproull%26aufirst%3DM.%26aulast%3DTantama%26aufirst%3DS.%26aulast%3DVenditto%26aufirst%3DV.%26aulast%3DSankineni%26aufirst%3DS.%26aulast%3DScott%26aufirst%3DT.%26aulast%3DBrechbiel%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520chelating%2520agents%2520as%2520anti-angiogenic%2520therapy%2520through%2520copper%2520chelation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D5133%26epage%3D5140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prusoff, W.</span><span> </span><span class="NLM_article-title">Relationship Between Inhibition Constant (K1) and Concentration of Inhibitor Which Causes 50 Per Cent Inhibition (I50) of an Enzymatic-Reaction</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">3099</span><span class="NLM_x">–</span> <span class="NLM_lpage">3108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1973&pages=3099-3108&author=Y.+Chengauthor=W.+Prusoff&title=Relationship+Between+Inhibition+Constant+%28K1%29+and+Concentration+of+Inhibitor+Which+Causes+50+Per+Cent+Inhibition+%28I50%29+of+an+Enzymatic-Reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DPrusoff%26aufirst%3DW.%26atitle%3DRelationship%2520Between%2520Inhibition%2520Constant%2520%2528K1%2529%2520and%2520Concentration%2520of%2520Inhibitor%2520Which%2520Causes%252050%2520Per%2520Cent%2520Inhibition%2520%2528I50%2529%2520of%2520an%2520Enzymatic-Reaction%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1973%26volume%3D22%26spage%3D3099%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Mesters, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgenfeld, R.</span><span> </span><span class="NLM_article-title">Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1375</span><span class="NLM_x">–</span> <span class="NLM_lpage">1384</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1038%2Fsj.emboj.7600969" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=16467855" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2006&pages=1375-1384&author=J.+Mestersauthor=C.+Barinkaauthor=W.+Liauthor=T.+Tsukamotoauthor=P.+Majerauthor=B.+Slusherauthor=J.+Konvalinkaauthor=R.+Hilgenfeld&title=Structure+of+glutamate+carboxypeptidase+II%2C+a+drug+target+in+neuronal+damage+and+prostate+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer</span></div><div class="casAuthors">Mesters, Jeroen R.; Barinka, Cyril; Li, Weixing; Tsukamoto, Takashi; Majer, Pavel; Slusher, Barbara S.; Konvalinka, Jan; Hilgenfeld, Rolf</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1375-1384</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Membrane-bound glutamate carboxypeptidase II (GCPII) is a zinc metalloenzyme that catalyzes the hydrolysis of the neurotransmitter N-acetyl-L-aspartyl-L-glutamate (NAAG) to N-acetyl-L-aspartate and L-glutamate (which is itself a neurotransmitter).  Potent and selective GCPII inhibitors have been shown to decrease brain glutamate and provide neuroprotection in preclin. models of stroke, amyotrophic lateral sclerosis, and neuropathic pain.  Here, we report crystal structures of the extracellular part of GCPII in complex with both potent and weak inhibitors and with glutamate, the product of the enzyme's hydrolysis reaction, at 2.0, 2.4, and 2.2 Å resoln., resp.  GCPII folds into three domains: protease-like, apical, and C-terminal.  All three participate in substrate binding, with two of them directly involved in C-terminal glutamate recognition.  One of the carbohydrate moieties of the enzyme is essential for homodimer formation of GCPII.  The three-dimensional structures presented here reveal an induced-fit substrate-binding mode of this key enzyme and provide essential information for the design of GCPII inhibitors useful in the treatment of neuronal diseases and prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0ej_7P55ksrVg90H21EOLACvtfcHk0liKDWwiS0Yf2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gkurw%253D&md5=438416f784240c8974f0df12cb1f1fc7</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsj.emboj.7600969&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.emboj.7600969%26sid%3Dliteratum%253Aachs%26aulast%3DMesters%26aufirst%3DJ.%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DMajer%26aufirst%3DP.%26aulast%3DSlusher%26aufirst%3DB.%26aulast%3DKonvalinka%26aufirst%3DJ.%26aulast%3DHilgenfeld%26aufirst%3DR.%26atitle%3DStructure%2520of%2520glutamate%2520carboxypeptidase%2520II%252C%2520a%2520drug%2520target%2520in%2520neuronal%2520damage%2520and%2520prostate%2520cancer%26jtitle%3DEMBO%2520J.%26date%3D2006%26volume%3D25%26spage%3D1375%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Barinka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starkova, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konvalinka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lubkowski, J.</span><span> </span><span class="NLM_article-title">A high-resolution structure of ligand-free human glutamate carboxypeptidase II</span> <span class="citation_source-journal">Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">150</span><span class="NLM_x">–</span> <span class="NLM_lpage">153</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2007&pages=150-153&author=C.+Barinkaauthor=J.+Starkovaauthor=J.+Konvalinkaauthor=J.+Lubkowski&title=A+high-resolution+structure+of+ligand-free+human+glutamate+carboxypeptidase+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarinka%26aufirst%3DC.%26aulast%3DStarkova%26aufirst%3DJ.%26aulast%3DKonvalinka%26aufirst%3DJ.%26aulast%3DLubkowski%26aufirst%3DJ.%26atitle%3DA%2520high-resolution%2520structure%2520of%2520ligand-free%2520human%2520glutamate%2520carboxypeptidase%2520II%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520F%253A%2520Struct.%2520Biol.%2520Cryst.%2520Commun.%26date%3D2007%26volume%3D63%26spage%3D150%26epage%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Afshar-Oromieh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zechmann, C.</span><span> </span><span class="NLM_article-title">[Ga-68]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with F-18-FECH</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">1085</span><span class="NLM_x">–</span> <span class="NLM_lpage">1086</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1007%2Fs00259-012-2069-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A280%3ADC%252BC38vit1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=1085-1086&author=A.+Afshar-Oromiehauthor=U.+Haberkornauthor=M.+Ederauthor=M.+Eisenhutauthor=C.+Zechmann&title=%5BGa-68%5DGallium-labelled+PSMA+ligand+as+superior+PET+tracer+for+the+diagnosis+of+prostate+cancer%3A+comparison+with+F-18-FECH"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH</span></div><div class="casAuthors">Afshar-Oromieh A; Haberkorn U; Eder M; Eisenhut M; Zechmann C M</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1085-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ3JpjC7vm3gwpJitSxOdIlfW6udTcc2ebKwwtK34JyRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vit1ajsw%253D%253D&md5=68d829df054642abaf31cc2813c970f1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2069-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2069-0%26sid%3Dliteratum%253Aachs%26aulast%3DAfshar-Oromieh%26aufirst%3DA.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DZechmann%26aufirst%3DC.%26atitle%3D%255BGa-68%255DGallium-labelled%2520PSMA%2520ligand%2520as%2520superior%2520PET%2520tracer%2520for%2520the%2520diagnosis%2520of%2520prostate%2520cancer%253A%2520comparison%2520with%2520F-18-FECH%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2012%26volume%3D39%26spage%3D1085%26epage%3D1086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Afshar-Oromieh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eder, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linhart, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hadaschik, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland-Letz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giesel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kratochwil, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haufe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haberkorn, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zechmann, C.</span><span> </span><span class="NLM_article-title">PET imaging with a [Ga-68]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">495</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm400895s&amp;key=10.1007%2Fs00259-012-2298-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm400895s&amp;key=23179945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm400895s&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslOgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=486-495&author=A.+Afshar-Oromiehauthor=A.+Malcherauthor=M.+Ederauthor=M.+Eisenhutauthor=H.+Linhartauthor=B.+Hadaschikauthor=T.+Holland-Letzauthor=F.+Gieselauthor=C.+Kratochwilauthor=S.+Haufeauthor=U.+Haberkornauthor=C.+Zechmann&title=PET+imaging+with+a+%5BGa-68%5Dgallium-labelled+PSMA+ligand+for+the+diagnosis+of+prostate+cancer%3A+biodistribution+in+humans+and+first+evaluation+of+tumour+lesions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumor lesions</span></div><div class="casAuthors">Afshar-Oromieh, A.; Malcher, A.; Eder, M.; Eisenhut, M.; Linhart, H. G.; Hadaschik, B. A.; Holland-Letz, T.; Giesel, F. L.; Kratochwil, C.; Haufe, S.; Haberkorn, U.; Zechmann, C. M.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-495</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Prostate-specific membrane antigen (PSMA) is a cell surface protein with high expression in prostate carcinoma (PC) cells.  Recently, procedures have been developed to label PSMA ligands with 68Ga, 99mTc and 123/124/131I.  Our initial experience with Glu-NH-CO-NH-Lys-(Ahx)-[68Ga(HBED-CC)](68Ga-PSMA) suggests that this novel tracer can detect PC relapses and metastases with high contrast.  The aim of this study was to investigate its biodistribution in normal tissues and tumor lesions.  Methods: A total of 37 patients with PC and rising prostate-specific antigen (PSA) levels were subjected to 68Ga-PSMA positron emission tomog. (PET)/CT.  Quant. assessment of tracer uptake was performed 1 and 3 h post-injection (p.i.) by anal. of mean and max. standardized uptake values (SUVmean/max) of several organs and 65 tumor lesions.  Subsequently, tumor to background ratios were calcd.  Results: The PET/CT images showed intense tracer uptake in both kidneys and salivary glands.  Moderate uptake was seen in lacrimal glands, liver, spleen and in small and large bowel.  Quant. assessment revealed excellent contrast between tumor lesions and most normal tissues.  Of 37 patients, 31 (83.8 %) showed at least one lesion suspicious for cancer at a detection rate of 60 % at PSA <2.2 ng/mL and 100 % at PSA >2.2 ng/mL.  Median tumor to background ratios were 18.8 (2.4-158.3) in early images and 28.3 (2.9-224.0) in late images.  Conclusion: The biodistribution of the novel 68Ga-PSMA tracer and its ability to detect PC lesions was analyzed in 37 patients.  Within healthy organs, kidneys and salivary glands demonstrated the highest radiotracer uptake.  Lesions suspicious for PC presented with excellent contrast as early as 1 h p.i. with high detection rates even at low PSA levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHzN95PUT36rVg90H21EOLACvtfcHk0lhICOb8zqslxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslOgsL0%253D&md5=259104a7ea6bb216c156f8a3b1ccd6c6</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2298-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2298-2%26sid%3Dliteratum%253Aachs%26aulast%3DAfshar-Oromieh%26aufirst%3DA.%26aulast%3DMalcher%26aufirst%3DA.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DLinhart%26aufirst%3DH.%26aulast%3DHadaschik%26aufirst%3DB.%26aulast%3DHolland-Letz%26aufirst%3DT.%26aulast%3DGiesel%26aufirst%3DF.%26aulast%3DKratochwil%26aufirst%3DC.%26aulast%3DHaufe%26aufirst%3DS.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DZechmann%26aufirst%3DC.%26atitle%3DPET%2520imaging%2520with%2520a%2520%255BGa-68%255Dgallium-labelled%2520PSMA%2520ligand%2520for%2520the%2520diagnosis%2520of%2520prostate%2520cancer%253A%2520biodistribution%2520in%2520humans%2520and%2520first%2520evaluation%2520of%2520tumour%2520lesions%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26spage%3D486%26epage%3D495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2c6c" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2c6c','PDB','2c6c'); return false;">PDB: 2c6c</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a href="/doi/suppl/10.1021/jm400895s">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_28452"></div></div></div></div></div><hr /></hr><p class="last">Docking simulation study, additional data of radiosynthesis and biodistribution, reverse phase HPLC retention time, and distribution coefficient.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400895s/suppl_file/jm400895s_si_001.pdf">jm400895s_si_001.pdf (493.25 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400895s&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm400895s%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-20" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400895s" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998eab4b871243","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
